Professor John Mcmurray

  • Professor of Cardiology (Institute of Cardiovascular and Medical Sciences)

telephone: 01413303479
email: John.McMurray@glasgow.ac.uk

Research interests

John McMurray is Professor of Medical Cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, UK and Lead Consultant Cardiologist at the Western Infirmary, Glasgow. He served as the inaugural Eugene Braunwald Scholar in Cardiovascular (CV) Disease at the Brigham and Women’s Hospital, Boston, USA, and visiting Professor of Medicine, Harvard University, Boston, in 2010/2011. He is also Past-President of the Heart Failure Association of the European Society of Cardiology (ESC). 

Professor McMurray’s primary research interest is in heart failure (HF) and his main research activity is clinical trials. He is, or was, the principal investigator, and member of the executive committee or steering committee in a number of large trials in HF, other CV diseases, renal disease and diabetes. He chairs the event adjudication group at Glasgow University, which has served as the endpoint committee for many trials. He has also participated in many data monitoring/safety committees.

Professor McMurray sits on the editorial board of the New England Journal of Medicine, as well as several leading CV journals, including the European Heart Journal and European Journal of Heart Failure. He has published approximately 600 original papers, reviews, and book chapters and is the primary author or editor of 13 books and was the lead author of the World Health Organization and first Scottish Intercollegiate Guidelines Network Guidelines on the Management of HF. In addition he was a member of the 2008 ESC HF Guidelines Task Force, and Chair of the 2012 Task Force; Co-Chair of the Kidney Disease Improving Global Outcomes Anemia Guidelines Committee; and member of the 2013 American College of Cardiology/American Heart Association HF Guidelines Committee. He is a member of the National Institute for Health and Care Excellence (NICE) Acute HF Guidelines Committee and was recently appointed to NICE (Appraisal Committee A). Professor McMurray was recently identified as one of the 400 most influential biomedical researchers in the world and he was also included in the new 2014 listing of Highly Cited Researchers by Thomson-Reuters.1-2

  1. Boyack KW, Klavans R, Sorensen AA, Loannidis JP. A list of highly influential biomedical researchers, 1996-2011 Eur J Clin Invest 2013;43:1339-65.
  2. http://thomsonreuters.com/articles/2014/worlds-most-influential-scientific-minds-2014

 

Research:

Member:

Google Scholar

 

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • Palliative Care Needs in Patients with Heart Failure
    British Heart Foundation
    2013 - 2016
     
  • Diuretics, Worsening Renal Function and Cardiorenal Outcomes in Heart Failure
    European Society for Cardiology
    2013 - 2013
     
  • Diuretics, Worsening Renal Function and Cardiorenal Outcomes in Heart Failure
    European Society for Cardiology
    2013 - 2013
     
  • Clopidogrel compared to Aspirin in Chronic Heart failure (CACHE)"
    Department of Health
    2010 - 2015
     
  • Effect of metformin on progression of carotid atherosclerosis in non-diabetic patients with CHD optimally treated with conventional risk reducing agents
    Scottish Executive Health Department
    2008 - 2012
     
  • Microvolt T-wave alternans in chronic heart failure: a study of prevalence and incremental prognostic value.
    Scottish Executive Health Department
    2007 - 2009
     
  • Microvolt T-wave alternans in chronic heart failure: a study of prevalence and incremental prognostic value.
    NHS Endowment Funds
    2007 - 2008
     
  • Preventing hospitalisation early death from chronic heart failure in Primary Care:A randomised controlled trial of pharmacist-led medication review
    Greater Glasgow Primary Care NHS Trust
    2007 - 2009
     
  • Stroke in Scotland 1986-2004:epidemiology and impact on population and health care
    Scottish Executive Health Department
    2007 - 2009
     
  • Hydralazine in heart failure - a study of the mechanisms of action in human blood vessels
    British Heart Foundation
    2006 - 2009
     
  • Long term consequences of socioeconomic deprivation on cardiovascular outcomes: a 25 year follow up of the Renfrew / Paisley
    Scottish Executive Health Department
    2005 - 2008
     
  • Investigating the frequency and causes of anaemia in patients with chronic heart failure
    Scottish Executive Health Department
    2005 - 2007
     
  • High Fidelity Phenotyping combined with genomics, proteomics and metabonomics close to the patient
    British Heart Foundation
    2004 - 2008
     
  • Can guiding medical treatment by measurement of blood N-terminal pro BNP concentration improve outcome in chronic heart failure?
    British Heart Foundation
    2004 - 2006
     
  • Muscle wasting in chronic heart failure - a role for cyclin-dependent kinase inhibitors
    British Heart Foundation
    2003 - 2005
     

Publications

List by: Type | Date

Jump to: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1998 | 1997
Number of items: 530.

2014

Damman, K., Perez, A. C., Anand, I. S., Komajda, M., McKelvie, R. S., Zile, M. R., Massie, B., Carson, P. E., and McMurray, J. J.V. (2014) Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment. Journal of the American College of Cardiology, 64 (11). pp. 1106-1113. ISSN 0735-1097 (doi:10.1016/j.jacc.2014.01.087)

Bello, N. A., Claggett, B., Desai, A. S., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Pfeffer, M. A., and Solomon, S. D. (2014) Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circulation: Heart Failure, 7 (4). pp. 590-595. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.113.001281)

Böhm, M. et al. (2014) Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve). European Journal of Heart Failure, 16 (7). pp. 778-787. ISSN 1388-9842 (doi:10.1002/ejhf.85)

Campbell, R. T., and McMurray, J. J.V. (2014) Comorbidities and differential diagnosis in heart failure with preserved ejection fraction. Heart Failure Clinics, 10 (3). pp. 481-501. ISSN 1551-7136 (doi:10.1016/j.hfc.2014.04.009)

Holman, R. R. et al. (2014) Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial. American Heart Journal, 168 (1). 23-29.e2. ISSN 0002-8703 (doi:10.1016/j.ahj.2014.03.021)

McMurray, J. J. V. et al. (2014) Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). European Journal of Heart Failure, 16 (7). pp. 817-825. ISSN 1388-9842 (doi:10.1002/ejhf.115)

Jhund, P. S. et al. (2014) Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial. European Journal of Heart Failure, 16 (6). pp. 671-677. ISSN 1388-9842 (doi:10.1002/ejhf.76)

Kalogeropoulos, A. P. et al. (2014) High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. Journal of Cardiac Failure, 20 (5). pp. 319-326. ISSN 1071-9164 (doi:10.1016/j.cardfail.2014.02.002)

Sliwa, K. et al. (2014) EURObservational research programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. European Journal of Heart Failure, 16 (5). pp. 583-591. ISSN 1388-9842 (doi:10.1002/ejhf.68)

Perez-Moreno, A. C. et al. (2014) Fatique as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC: Heart Failure, 2 (2). pp. 187-197. ISSN 0735-1097 (doi:10.1016/j.jchf.2014.01.001)

Preiss, D., Lloyd, S.M., Ford, I., McMurray, J.J.V., Holman, R.R., Welsh, P., Fisher, M., Packard, C.J., and Sattar, N. (2014) Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes and Endocrinology, 2 (2). pp. 116-124. ISSN 2213-8587 (doi:10.1016/S2213-8587(13)70152-9)

Calvo, G. et al. (2014) Large streamlined trials in cardiovascular disease. European Heart Journal, 35 (9). pp. 544-548. ISSN 0195-668X (doi:10.1093/eurheartj/eht535)

Hood, Jr., W. B., Dans, A. L., Guyatt, G. H., Jaeschke, R., and McMurray, J. J. (2014) Digitalis for treatment of heart failure in patients in sinus rhythm. Cochrane Database of Systematic Reviews, 2014 (4). CD002901. ISSN 1469-493X (doi:10.1002/14651858.CD002901.pub3)

MacDonald, T. M. et al. (2014) Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia. BMJ Open, 4 (7). e005354. ISSN 2044-6055 (doi:10.1136/bmjopen-2014-005354)

Wallentin, L. et al. (2014) Response to letter regarding article, "Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation". Circulation, 129 (2). e21-e22. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.113.005709)

2013

Wong, C.M. et al. (2013) Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme. Journal of the American College of Cardiology, 62 (20). pp. 1845-1854. ISSN 0735-1097 (doi:10.1016/j.jacc.2013.05.072)

Zannad, F. et al. (2013) Clinical outcome endpoints in heart failure trials: a European society of cardiology heart failure association consensus document. European Journal of Heart Failure, 15 (10). pp. 1082-1094. ISSN 1388-9842 (doi:10.1093/eurjhf/hft095)

Inglis, S.C. et al. (2013) Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. International Journal of Cardiology, 168 (2). pp. 1094-1101. ISSN 0167-5273 (doi:10.1016/j.ijcard.2012.11.033)

Ball, J., Carrington, M.J., McMurray, J.J.V., and Stewart, S. (2013) Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. International Journal of Cardiology, 167 (5). pp. 1807-1824. ISSN 0167-5273 (doi:10.1016/j.ijcard.2012.12.093)

McMurray, J.J.V. et al. (2013) Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). European Journal of Heart Failure, 15 (9). pp. 1062-1073. ISSN 1388-9842 (doi:10.1093/eurjhf/hft052)

Weir, R. A.P. et al. (2013) Response to letter regarding article, "Galectin-3 and cardiac function in survivors of acute myocardial infarction". Circulation: Heart Failure, 6 (4). e58. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.113.000382)

Verheugt, F.W.A. et al. (2013) Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy. European Heart Journal, 34 (22). pp. 1621-1629. ISSN 0195-668X (doi:10.1093/eurheartj/eht013)

Hijazi, Z. et al. (2013) N-terminal Pro–B-Type natriuretic peptide for risk assessment in patients with atrial fibrillation. Journal of the American College of Cardiology, 61 (22). pp. 2274-2284. ISSN 0735-1097 (doi:10.1016/j.jacc.2012.11.082)

Weir, R. A.P. et al. (2013) Galectin-3 and cardiac function in survivors of acute myocardial infarction. Circulation: Heart Failure, 6 (3). pp. 492-498. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.112.000146)

Pocock, S.J. et al. (2013) Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. European Heart Journal, 34 (19). pp. 1404-1413. ISSN 0195-668X (doi:10.1093/eurheartj/ehs337)

Perez, A.C., Jhund, P., Preiss, D., Kjekshus, J., and McMurray, J.J.V. (2013) Effect of rosuvastatin on fatigue in patients with heart failure. Journal of the American College of Cardiology, 61 (10). pp. 1121-1122. ISSN 0735-1097 (doi:10.1016/j.jacc.2012.12.004)

McMurray, J.J.V. et al. (2013) Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF). European Journal of Heart Failure, 15 (3). pp. 334-341. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs204)

Swedberg, K. et al. (2013) Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure. New England Journal of Medicine, 368 (13). pp. 1210-1219. ISSN 0028-4793 (doi:10.1056/NEJMoa1214865)

Skali, H. et al. (2013) Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (trial to reduce cardiovascular events with aranesp therapy) placebo arm. American Journal of Kidney Diseases, 61 (2). pp. 238-246. ISSN 0272-6386 (doi:10.1053/j.ajkd.2012.08.043)

van Veldhuisen, D.J., and McMurray, J.J.V. (2013) Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel? European Journal of Heart Failure, 15 (1). pp. 5-8. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs194)

Inglis, S.C., Lewsey, J.D., Lowe, G.D.O., Jhund, P., Gillies, M., Stewart, S., Capewell, S., MacIntyre, K., and McMurray, J.J.V. (2013) Angina and intermittent claudication in 7403 participants of the 2003 Scottish Health Survey: impact on general and mental health, quality of life and five-year mortality. International Journal of Cardiology, 167 (5). pp. 2149-2155. ISSN 0167-5273 (doi:10.1016/j.ijcard.2012.05.099)

Jackson, C.E. et al. (2013) Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure. European Journal of Heart Failure, 15 (11). pp. 1253-1261. ISSN 1388-9842 (doi:10.1093/eurjhf/hft085)

Jackson, C.E. et al. (2013) Feasibility/eligibility of T-wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply. European Journal of Heart Failure, 14 (6). pp. 676-677. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs050)

Jankowska, E.A. et al. (2013) Iron status in patients with chronic heart failure. European Heart Journal, 34 (11). pp. 827-834. ISSN 0195-668X (doi:10.1093/eurheartj/ehs377)

MacDonald, M.R., McMurray, J.J.V., and Petrie, M.C. (2013) Letter by MacDonald et al regarding article, "catheter ablation of atrial fibrillation". Circulation, 127 (4). e433-e433. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.112.137604)

McMurray, J.J.V. et al. (2013) Left Ventricular Systolic Dysfunction, Heart Failure, and the Risk of Stroke and Systemic Embolism in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Circulation: Heart Failure, 6 (3). pp. 451-460. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.112.000143)

McMurray, J.J.V. et al. (2013) Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). European Journal of Heart Failure, 15 (9). pp. 1062-1073. ISSN 1388-9842 (doi:10.1093/eurjhf/hft052)

Poppe, K.K. et al. (2013) Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report. European Journal of Heart Failure, 15 (11). pp. 1220-1227. ISSN 1388-9842 (doi:10.1093/eurjhf/hft101)

Preiss, D. et al. (2013) Predictors of stroke in patients with impaired glucose tolerance: results from the nateglinide and valsartan in impaired glucose tolerance outcomes research trial. Stroke, 44 (9). pp. 2590-2593. ISSN 0039-2499 (doi:10.1161/STROKEAHA.113.001177)

Yancy, C.W., and McMurray, J.J.V. (2013) ECG — still the best for selecting patients for CRT. New England Journal of Medicine, 369 . pp. 1463-1464. ISSN 0028-4793 (doi:10.1056/NEJMe1310406)

2012

Campbell, R.T., Jhund, P.S., Castagno, D., Hawkins, N.M., Petrie, M.C., and McMurray, J.J.V. (2012) What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-Preserved, and I-PRESERVE? Journal of the American College of Cardiology, 60 (23). pp. 2349-2356. ISSN 0735-1097 (doi:10.1016/j.jacc.2012.04.064)

Gullestad, L., Ueland, T., Kjekshus, J., Nymo, S.H., Hulthe, J., Muntendam, P., McMurray, J.J.V., Wikstrand, J., and Aukrust, P. (2012) The predictive value of galectin-3 for mortality and cardiovascular events in the controlled rosuvastatin multinational trial in heart failure (CORONA). American Heart Journal, 164 (6). pp. 878-883. ISSN 0002-8703 (doi:10.1016/j.ahj.2012.08.021)

Preiss, D. et al. (2012) Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the nateglinide and valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial. BMJ Open, 2 (6). e001925. ISSN 2044-6055 (doi:10.1136/bmjopen-2012-001925)

Schwartz, G.G. et al. (2012) Effects of dalcetrapib in patients with a recent acute coronary syndrome. New England Journal of Medicine, 367 (22). pp. 2089-2099. ISSN 0028-4793 (doi:10.1056/NEJMoa1206797)

Felker, G.M. et al. (2012) Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. European Journal of Heart Failure, 14 (11). pp. 1257-1264. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs110)

Lopes, R.D. et al. (2012) Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet, 380 (9855). pp. 1749-1758. ISSN 0140-6736 (doi:10.1016/S0140-6736(12)60986-6)

Pettit, S.J., Jhund, P.S., Hawkins, N.M., Gardner, R.S., Haj-Yahia, S., McMurray, J.J.V., and Petrie, M.C. (2012) How small is too small? A systematic review of center volume and outcome after cardiac transplantation. Circulation: Cardiovascular Quality and Outcomes, 5 (6). pp. 783-790. ISSN 1941-7713 (doi:10.1161/CIRCOUTCOMES.112.966630)

McMurray, J.J.V., Haffner, S.M., Califf, R.M., and Holman, R.R. (2012) Prediabetes and the risk of diabetes. Lancet, 380 (9849). pp. 1225-1226. ISSN 0140-6736 (doi:10.1016/S0140-6736(12)61706-1)

Weir, R. A.P., Miller, A. M., Petrie, C. J., Clements, S., Steedman, T., Dargie, H. J., Squire, I. B., Ng, L. L., McInnes, I. B., and McMurray, J. J.V. (2012) Interleukin-21 – a biomarker of importance in predicting myocardial function following acute infarction? Cytokine, 60 (1). pp. 220-225. ISSN 1043-4666 (doi:10.1016/j.cyto.2012.06.002)

McMurray, J.J.V., Califf, R.M., Bethel, A.M., Haffner, S.M., and Holman, R.R. (2012) Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study. Journal of Clinical Hypertension, 14 (10). p. 731. ISSN 1524-6175 (doi:10.1111/j.1751-7176.2012.00687.x)

Seed, A., Kuc, R.E., Maguire, J.J., Hillier, C., Johnston, F., Essers, H., de Voogd, H.J., McMurray, J.J.V., and Davenport, A.P. (2012) The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans. Life Sciences, 91 (13-14). pp. 743-748. ISSN 0024-3205 (doi:10.1016/j.lfs.2012.03.022)

Solomon, S.D. et al. (2012) The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet, 380 (9851). pp. 1387-1395. ISSN 0140-6736 (doi:10.1016/S0140-6736(12)61227-6)

Gullestad, L. et al. (2012) Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European Heart Journal, 33 (18). pp. 2290-2296. ISSN 0195-668X (doi:10.1093/eurheartj/ehs077)

Preiss, D. et al. (2012) Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA: Journal of the American Medical Association, 308 (8). pp. 804-811. ISSN 0098-7484 (doi:10.1001/jama.2012.8439)

Welsh, P., and McMurray, J.J. (2012) B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway? Diabetologia, 55 (5). pp. 1240-1243. ISSN 0012-186X (doi:10.1007/s00125-012-2515-3)

Castagno, D., Petrie, M.C., Claggett, B., and McMurray, J. (2012) Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure. European Heart Journal, 33 (9). pp. 1137-1141. ISSN 0195-668X (doi:10.1093/eurheartj/ehs004)

Ezekowitz, J.A., Hernandez, A.F., O'Connor, C.M., Starling, R.C., Proulx, G., Weiss, M.H., Bakal, J.A., Califf, R.M., McMurray, J.J.V., and Armstrong, P.W. (2012) Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. Journal of the American College of Cardiology, 59 (16). pp. 1441-1448. ISSN 0735-1097 (doi:10.1016/j.jacc.2011.11.061)

MacDonald, M.R., McMurray, J.J.V., and Petrie, M.C. (2012) Catheter ablation for atrial fibrillation. New England Journal of Medicine, 366 (11). p. 1060. ISSN 0028-4793

Lowrie, R., Mair, F.S., Greenlaw, N., Forsyth, P., Jhund, P.S., McConnachie, A., Rae, B., and McMurray, J.J.V. (2012) Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. European Heart Journal, 33 (3). pp. 314-324. ISSN 0195-668X (doi:10.1093/eurheartj/ehr433)

McMurray, J.J.V. (2012) Heart failure in 2011: heart failure therapy — technology to the fore. Nature Reviews Cardiology, 9 (2). pp. 73-74. ISSN 1759-5002 (doi:10.1038/nrcardio.2011.212)

Anker, S.D., and McMurray, J.J.V. (2012) Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials? European Heart Journal, 33 (22). pp. 2764-2765. ISSN 0195-668X (doi:10.1093/eurheartj/ehs277)

Broch, K. et al. (2012) Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology. European Journal of Heart Failure, 14 (3). pp. 268-277. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs006)

Hawkins, N.M., Jhund, P.S., McMurray, J.J.M., and Capewell, S. (2012) Heart failure and socioeconomic status: accumulating evidence of inequality. European Journal of Heart Failure, 14 (2). pp. 138-146. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr168)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply. European Journal of Heart Failure, 14 (6). p. 678. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs077)

Jackson, C.E. et al. (2012) Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure. European Journal of Heart Failure, 14 (4). pp. 377-386. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs010)

Lam, C. S. P. et al. (2012) Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circulation: Heart Failure, 5 (5). pp. 571-578. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.112.970061)

McMurray, J.J.V. (2012) Heart failure in 2011: heart failure therapy—technology to the fore. Nature Reviews Cardiology, 9 (2). pp. 73-74. ISSN 1759-5002 (doi:10.1038/nrcardio.2011.212)

McMurray, J.J.V., Abraham, W.T., Dickstein, K., Kober, L., Massie, B.M., and Krum, H. (2012) Aliskiren, ALTITUDE, and the implications for ATMOSPHERE. European Journal of Heart Failure, 14 (4). pp. 341-343. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs033)

Parving, H.-H. et al. (2012) Baseline characteristics in the Aliskiren Trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE). Journal of the Renin-Angiotensin-Aldosterone System, 13 (3). pp. 387-393. ISSN 1470-3203 (doi:10.1177/1470320311434818)

Preiss, D. et al. (2012) Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure, 14 (8). pp. 909-915. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs067)

Rahimi, K., Bhala, N., Kamphuisen, P., Emberson, J., Biere-Rafi, S., Krane, V., Robertson, M., Wikstrand, J., and McMurray, J.J.V. (2012) Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLoS Medicine, 9 (9). e1001310. ISSN 1549-1676 (doi:10.1371/journal.pmed.1001310)

Rector, T.S., Carson, P.E., Anand, I.S., McMurray, J.J., Zile, M.R., McKelvie, R.S., Komajda, M., Kuskowski, M., and Massie, B.M. (2012) Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the Minnesota living with heart failure questionnaire in the Irbesartan in Heart Failure with Preserved Systolic Function (I-PRESERVE) trial. Circulation: Heart Failure, 5 (2). pp. 217-225. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.111.964221)

Rogers, J.K., McMurray, J.J.V., Pocock, S.J., Zannad, F., Krum, H., van Veldhuisen, D.J., Swedberg, K., Shi, H., Vincent, J., and Pitt, B. (2012) Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations. Circulation, 126 (19). pp. 2317-2323. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.112.110536)

Shah, A.M. et al. (2012) Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren. European Journal of Heart Failure, 14 (2). pp. 185-192. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr125)

Zannad, F., Gattis Stough, W., McMurray, J.J.V., Remme, W.J., Pitt, B., Borer, J.S., Geller, N.L., and Pocock, S.J. (2012) When to stop a clinical trial early for benefit: lessons learned and future approaches. Circulation: Heart Failure, 5 (2). pp. 294-302. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.111.965707)

Zannad, F. et al. (2012) Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. European Heart Journal, 33 (22). pp. 2782-2795. ISSN 0195-668X (doi:10.1093/eurheartj/ehs257)

Zile, M.R., Baicu, C.F., Gottdiener, J.S., Hetzel, S.J., McMurray, J.J., Komajda, M., McKelvie, R., Massie, B.M., and Carson, P.E. (2012) Response to letters regarding article, "Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction". Circulation, 126 (5). e64-e65. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.112.110809)

2011

Zile, M.R., Gottdiener, J.S., Hetzel, S.J., McMurray, J.J.V., Komajda, M., McKelvie, R., Baicu, C.F., Massie, B.M., and Carson, P.E. (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation, 124 (23). pp. 2491-2501. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.110.011031)

Desai, A.S. et al. (2011) Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKd. American Journal of Kidney Diseases, 58 (5). pp. 717-728. ISSN 0272-6386 (doi:10.1053/j.ajkd.2011.05.020)

Granger, C.B. et al. (2011) Apixaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 365 (11). pp. 981-992. ISSN 0028-4793 (doi:10.1056/NEJMoa1107039)

Cleland, J.G.F. et al. (2011) The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet, 378 (9792). pp. 676-683. ISSN 0140-6736 (doi:10.1016/S0140-6736(11)61126-4)

Sidik, N.P., Solomon, S.D., Latini, R., Maggioni, A.P., Wright, M., Gimpelewicz, C., Pitt, B., and McMurray, J.J.V. (2011) Effect of Aliskiren in Patients with Heart Failure According to Background Dose of ACE Inhibitor: A Retrospective Analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) Trial. Cardiovascular Drugs and Therapy, 25 (4). pp. 315-321. ISSN 0920-3206 (doi:10.1007/s10557-011-6319-3)

McMurray, J., and Ponikowski, P. (2011) Heart failure: not enough pump iron? Journal of the American College of Cardiology, 58 (5). pp. 481-482. ISSN 0735-1097 (doi:10.1016/j.jacc.2011.02.066)

O'Connor, C.M. et al. (2011) Effect of nesiritide in patients with acute decompensated heart failure. New England Journal of Medicine, 365 (1). pp. 32-43. ISSN 0028-4793 (doi:10.1056/NEJMoa1100171)

Verma, A., Pfeffer, M.A., Skali, H., Rouleau, J., Maggioni, A., McMurray, J.J.V., Califf, R.M., Velazquez, E.J., and Solomon, S.D. (2011) Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction. American Heart Journal, 161 (6). pp. 1156-1162. ISSN 0002-8703 (doi:10.1016/j.ahj.2011.03.024)

Hawkins, N.M., Petrie, M.C., MacDonald, M.R., Jhund, P.S., Fabbri, L.M., Wikstrand, J., and McMurray, J.J.V. (2011) Heart failure and chronic obstructive pulmonary diseas. Journal of the American College of Cardiology, 57 (21). pp. 2127-2138. ISSN 0735-1097 (doi:10.1016/j.jacc.2011.02.020)

MacDonald, M.R. et al. (2011) Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the rosiglitazone evaluated for cardiac outcomes and regulation of glycemia in diabetes (RECORD) study. Diabetes Care, 34 (6). pp. 1394-1396. ISSN 0149-5992 (doi:10.2337/dc10-2398)

Teo, K.K. et al. (2011) Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals. The ARB Trialists Collaboration. Journal of Hypertension, 29 (4). pp. 623-635. ISSN 0263-6352 (doi:10.1097/HJH.0b013e328344a7de )

Macpherson, K.J. et al. (2011) Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986 - 2005: a retrospective cohort study. BMC Neurology, 11 (1). p. 38. ISSN 1471-2377 (doi:10.1186/1471-2377-11-38)

Gheorghiade, M., Pang, P.S., O'Connor, C.M., Prasad, K., McMurray, J., Teerlink, J.R., Fiuzat, M., Sabbah, H., and Komajda, M. (2011) Clinical development of pharmacologic agents for acute heart failure syndromes: A proposal for a mechanistic translational phase. American Heart Journal, 161 (2). pp. 224-232. ISSN 00028703 (doi:10.1016/j.ahj.2010.10.023)

Anand, I.S. et al. (2011) Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Circulation: Heart Failure, 4 (5). pp. 569-577. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.111.962654)

Ariti, C.A., Cleland, J.G.F., Pocock, S.J., Pfeffer, M.A., Swedberg, K., Granger, C.B., McMurray, J.J.V., Michelson, E.L., Östergren, J., and Yusuf, S. (2011) Days alive and out of hospital and the patient journey in patients with heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. American Heart Journal, 162 (5). pp. 900-906. ISSN 0002-8703 (doi:10.1016/j.ahj.2011.08.003)

Castagno, D., Baird-Gunning, J., Jhund, P.S., Biondi-Zoccai, G., MacDonald, M.R., Petrie, M.C., Gaita, F., and McMurray, J.J.V. (2011) Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis. American Heart Journal, 162 (5). 938-948.e2. ISSN 0002-8703 (doi:10.1016/j.ahj.2011.07.030)

Gallanagh, S. et al. (2011) Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II). Cardiovascular Drugs and Therapy, 25 (1). pp. 77-85. ISSN 0920-3206 (doi:10.1007/s10557-011-6284-x)

Jackson, C.E. et al. (2011) Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study. European Journal of Heart Failure, 13 (7). pp. 746-754. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr031)

Krum, H. et al. (2011) Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy. Circulation: Heart Failure, 4 (5). pp. 561-568. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.110.960716)

Lainscak, M. et al. (2011) Self-care management of heart failure practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 13 (2). pp. 115-126. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq219)

Lewis, E.F. et al. (2011) Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. Clinical Journal of the American Society of Nephrology, 6 (4). pp. 845-855. ISSN 1555-9041 (doi:10.2215/​CJN.06450710 )

Lowrie, R. et al. (2011) The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics. European Journal of Heart Failure, 13 (8). pp. 917-924. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr083)

MacDonald, M. R. et al. (2011) Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart, 97 (9). pp. 740-747. ISSN 1355-6037 (doi:10.1136/hrt.2010.207340)

McMurray, J.J.V. (2011) CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure. European Journal of Heart Failure, 13 (9). pp. 929-936. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr093)

McMurray, J.J.V. (2011) Heart failure: Acute ischemic events in HF—should we include sudden death? Nature Reviews Cardiology, 8 (4). pp. 192-193. ISSN 1759-5002 (doi:10.1038/nrcardio.2011.22)

McMurray, J.J.V. (2011) Low Coenzyme Q(10) Levels and the Outcome of Statin Treatment in Heart Failure Reply. Journal of the American College of Cardiology, 57 (14). p. 1569. ISSN 07351097 (doi:10.1016/j.jacc.2010.12.018)

McMurray, J.J.V., and Smith, G.L. (2011) Calcium handling in the failing heart and SUMO — weighing the eviden. New England Journal of Medicine . ISSN 0028-4793 (doi:10.1056/NEJMcibr1110758)

McMurray, J.J.V. et al. (2011) Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT). American Heart Journal, 162 (4). 748-755.e3. ISSN 0002-8703 (doi:10.1016/j.ahj.2011.07.016)

Milo-Cotter, O. et al. (2011) Neurohormonal activation in acute heart failure: results from VERITAs. Cardiology, 119 (2). pp. 96-105. ISSN 0008-6312 (doi:10.1159/000330409)

Pitt, B., Latini, R., Maggioni, A.P., Solomon, S.D., Smith, B.A., Wright, M., Prescott, M.F., and McMurray, J.J.V. (2011) Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study. European Journal of Heart Failure, 13 (7). pp. 755-764. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr034)

Pouleur, A.-C. et al. (2011) Response to Letter Regarding Article, "Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both". Circulation, 123 (18). e586. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.111.021600)

Preiss, D., Sattar, N., and McMurray, J.J. (2011) A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. American Heart Journal, 161 (1). p. 210. ISSN 0002-8703 (doi:10.1016/j.ahj.2010.10.019)

Shah, A.M. et al. (2011) Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both. American Heart Journal, 162 (4). pp. 685-691. ISSN 0002-8703 (doi:10.1016/j.ahj.2011.07.015)

Sidik, N.P., Solomon, S.D., Latini, R., Maggioni, A.P., Wright, M., Gimpelewicz, C.R., Pitt, B., and McMurray, J.J.V. (2011) Effect of Aliskiren in Patients with Heart Failure According to Background Dose of ACE Inhibitor: A Retrospective Analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) Trial. Cardiovascular Drugs and Therapy, 25 (4). pp. 315-321. ISSN 0920-3206 (doi:10.1007/s10557-011-6319-3)

Skali, H. et al. (2011) Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with darbepoetin alfa: the trial to reduce cardiovascular events with aranesp therapy (TREAT) experience. Circulation, 124 (25). pp. 2903-2908. ISSN 0009-7322 (doi:10.1161/​CIRCULATIONAHA.111.030411)

Thune, J. J. et al. (2011) Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction. European Journal of Heart Failure, 13 (2). pp. 148-153. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq194)

Weir, R.A.P., Clements, S., Steedman, T., Dargie, H.J., McMurray, J.J.V., Squire, I.B., and Ng, L.L. (2011) Plasma TIMP-4 Predicts Left Ventricular Remodeling After Acute Myocardial Infarction. Journal of Cardiac Failure, 17 (6). pp. 465-471. ISSN 1071-9164 (doi:10.1016/j.cardfail.2011.02.002)

Weir, R.A.P., Tsorlalis, I.K., Steedman, T., Dargie, H.J., Fraser, R., McMurray, J.J.V., and Connell, J.M.C. (2011) Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction. European Journal of Heart Failure, 13 (12). pp. 1305-1313. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr129)

Ye, S. et al. (2011) Circumstances and Outcomes of Sudden Unexpected Death in Patients With High-Risk Myocardial Infarction: Implications for Prevention. Circulation, 123 (23). pp. 2674-2680. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.110.990655)

2010

Sattar, N. et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 375 (9716). pp. 735-742. ISSN 0140-6736 (doi:10.1016/S0140-6736(09)61965-6)

Preiss, D., Sattar, N., and McMurray, J.J. (2010) Event rates in trials of patients with Type 2 diabetes. JAMA: Journal of the American Medical Association, 303 (8). pp. 732-733. ISSN 0098-7484 (doi:10.1001/jama.2010.137)

McMurray, J.J. (2010) Systolic heart failure. New England Journal of Medicine, 362 (3). pp. 228-238. ISSN 0028-4793 (doi:10.1056/NEJMcp0909392)

Weir, R.A.P., Miller, A.M., Murphy, G., Clements, S., Steedman, T., Connell, J., McInnes, I., Dargie, H., and McMurray, J.J. (2010) Serum soluble ST2 a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. Journal of the American College of Cardiology, 55 (3). pp. 243-250. ISSN 0735-1097 (doi:10.1016/j.jacc.2009.08.047)

Hawkins, N.M., Jhund, P.S., Simpson, C.R., Petrie, M.C., MacDonald, M.R., Dunn, F.G., MacIntyre, K., and McMurray, J.J.V. (2010) Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. European Journal of Heart Failure, 12 (1). pp. 17-24. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp160)

Lorgelly, P.K. et al. (2010) An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial. European Journal of Heart Failure, 12 (1). pp. 66-74. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp172)

Piccini, J.P., Zhang, M., Pieper, K., Solomon, S.D., Al-Khatib, S.M., Van de Werf, F., Pfeffer, M.A., McMurray, J.J., Califf, R.M., and Velazquez, E.J. (2010) Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial. European Heart Journal, 31 (2). pp. 211-221. ISSN 0195-668X (doi:10.1093/eurheartj/ehp425)

Castagno, D. et al. (2010) Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial. European Journal of Heart Failure, 12 (6). pp. 607-616. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq038)

Chang, S. M. et al. (2010) Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure, 12 (7). pp. 738-745. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq065)

Cleland, J.G.F., McMurray, J.J.V., and Kjekshus, J. (2010) Statins and Heart Failure - Reply. Journal of the American College of Cardiology, 55 (15). p. 1646. ISSN 0735-1097 (doi:10.1016/j.jacc.2010.01.018)

Desai, A., Lewis, E., Solomon, S., McMurray, J. J. V., and Pfeffer, M. (2010) Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis. European Journal of Heart Failure, 12 (9). pp. 936-942. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq094)

Dickstein, K. et al. (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy * Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. European Journal of Heart Failure, 12 (11). pp. 1143-1153. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq192)

Dickstein, K. et al. (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy * Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace, 12 (11). pp. 1526-1536. ISSN 1099-5129 (doi:10.1093/europace/euq392)

Dickstein, K. et al. (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. European Heart Journal, 31 (21). pp. 2677-2687. ISSN 0195-668X (doi:10.1093/eurheartj/ehq337)

Felker, G. M. et al. (2010) Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes Lessons Learned and Directions Forward. Circulation: Heart Failure, 3 (2). pp. 314-325. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.109.893222)

Gheorghiade, M. et al. (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. European Journal of Heart Failure, 12 (5). pp. 423-433. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq045)

Hawkins, N. M. et al. (2010) Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme. European Journal of Heart Failure, 12 (6). pp. 557-565. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq040)

Hogg, K. J., and McMurray, J. J. V. (2010) HEART FAILURE Hospital-at-home care for CHF-verdict, 'not proven'. Nature Reviews Cardiology, 7 (2). pp. 63-64. ISSN 1759-5002 (doi:10.1038/nrcardio.2009.225)

Hogg, K.J., and McMurray, J.J.V. (2010) Evaluating dyspnoea in acute heart failure: progress at last! European Heart Journal, 31 (7). pp. 771-772. ISSN 0195-668X (doi:10.1093/eurheartj/ehq015)

Holman, R. R. et al. (2010) Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine, 362 (16). pp. 1463-1476. ISSN 0028-4793 (doi:10.1056/NEJMoa1001122)

Hung, C.L. et al. (2010) Longitudinal and Circumferential Strain Rate, Left Ventricular Remodeling, and Prognosis After Myocardial Infarction. Journal of the American College of Cardiology, 56 (22). pp. 1812-1822. ISSN 0735-1097 (doi:10.1016/j.jacc.2010.06.044)

Inglis, S. C. et al. (2010) Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). European Journal of Heart Failure, 12 (7). pp. 698-705. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq070)

Jankowska, E. A. et al. (2010) Iron deficiency: an ominous sign in patients with systolic chronic heart failure. European Heart Journal, 31 (15). pp. 1872-1880. ISSN 0195-668X (doi:10.1093/eurheartj/ehq158)

Komajda, M., McMurray, J. J. V., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Pocock, S. J., Curtis, P. S., Jones, N. P., and Home, P. D. (2010) Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. European Heart Journal, 31 (7). pp. 824-831. ISSN 0195-668X (doi:10.1093/eurheartj/ehp604)

Komajda, M., Carson, P. E., Hetzel, S., McKelvie, R., McMurray, J., Ptaszynska, A., Zile, M. R., DeMets, D., and Massie, B. M. (2010) Factors Associated with Outcome in Heart Failure with Preserved Ejection Fraction: Findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circulation: Heart Failure, 4 (1). pp. 27-35. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.109.932996)

Krum, H., McMurray, J. J. V., Horton, E., Gerlock, T., Holzhauer, B., Zuurman, L., Haffner, S. M., Bethel, M. A., Holman, R. R., and Califf, R. M. (2010) Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials. Cardiovascular Therapeutics, 28 (2). pp. 124-132. ISSN 1755-5914 (doi:10.1111/j.1755-5922.2010.00146.x)

Krum, H. et al. (2010) Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to minimize outcomes in patients with heart failure (ATMOSPHERE)study. European Journal of Heart Failure, 13 (1). pp. 107-114. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq212)

Langhorne, P. et al. (2010) Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data. Journal of Neurology, Neurosurgery and Psychiatry, 81 (2). pp. 1301-1305. ISSN 0022-3050 (doi:10.1136/jnnp.2009.195131)

Lewsey, J. et al. (2010) Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland. BMC Medicine, 8 . p. 23. ISSN 1741-7015 (doi:10.1186/1741-7015-8-23)

Lopes, R. D. et al. (2010) Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale. American Heart Journal, 159 (3). pp. 331-339. ISSN 0002-8703 (doi:10.1016/j.ahj.2009.07.035)

MacDonald, M. R., Eurich, D. T., Majumdar, S. R., Lewsey, J. D., Bhagra, S., Jhund, P. S., Petrie, M. C., McMurray, J. J. V., Petrie, J.R., and McAlister, F. A. (2010) Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care, 33 (6). pp. 1213-1218. ISSN 0149-5992 (doi:10.2337/dc09-2227)

McKelvie, R.S., Komajda, M., McMurray, J., Zile, M., Ptaszynska, A., Donovan, M., Carson, P., and Massie, B.M. (2010) Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial. Journal of Cardiac Failure, 16 (2). pp. 128-134. ISSN 1071-9164 (doi:10.1016/j.cardfail.2009.09.007)

McMurray, J. J. et al. (2010) Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine, 362 (16). pp. 1477-1490. ISSN 0028-4793 (doi:10.1056/NEJMoa1001121)

McMurray, J. J. V., and Swedberg, K. (2010) HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure-lessons learnt from a decade of trials. European Journal of Heart Failure, 12 (2). pp. 99-103. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp197)

McMurray, J.J.V., Dunselman, P., Wedel, H., Cleland, J.G.F., Lindberg, M., Hjalmarson, Å., Kjekshus, J., Waagstein, F., Apetrei, E., and Barrios, V. (2010) Coenzyme Q10, Rosuvastatin, and Clinical Outcomes in Heart FailureA Pre-Specified Substudy of CORONA (Controlled Rosuvastatin Multinational Study in Heart Failure). Journal of the American College of Cardiology, 56 (15). pp. 1196-1204. ISSN 0735-1097 (doi:10.1016/j.jacc.2010.02.075)

Nilsson, K. R. et al. (2010) Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart, 96 (11). pp. 838-842. ISSN 1355-6037 (doi:10.1136/hrt.2009.180182)

Park, J.H., Balmain, S., Berry, C., Morton, J.J., and McMurray, J.J.V. (2010) Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart, 96 (7). pp. 533-538. ISSN 1355-6037 (doi:10.1136/hrt.2009.175257)

Pouleur, A.-C. et al. (2010) Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. Circulation, 122 (6). pp. 597-602. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.110.940619)

Rocchiccioli, J.P., McMurray, J.J.V., and Dominiczak, A.F. (2010) Biomarkers in heart failure: a clinical review. Heart Failure Reviews, 15 (4). pp. 251-273. ISSN 1382-4147 (doi:10.1007/s10741-008-9123-9)

Shah, A. M. et al. (2010) The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. European Journal of Heart Failure, 12 (11). pp. 1229-1237. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq179)

Shamshad, F., Kenchaiah, S., Finn, P.V., Soler-Soler, J., McMurray, J.J.V., Velazquez, E.J., Maggioni, A. P., Califf, R.M., Swedberg, K., and Kober, L. (2010) Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). American Heart Journal, 160 (1). pp. 145-151. ISSN 0002-8703 (doi:10.1016/j.ahj.2010.02.037)

Sliwa, K. et al. (2010) Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy A Proof-of-Concept Pilot Study. Circulation, 121 (13). pp. 1465-1473. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.109.901496)

Sliwa, K. et al. (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure, 12 (8). pp. 767-778. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq120)

Solomon, S.D. et al. (2010) Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes. New England Journal of Medicine, 363 (12). pp. 1146-1155. ISSN 0028-4793 (doi:10.1056/NEJMoa1005109)

Thune, J. J. et al. (2010) Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction. European Journal of Heart Failure, 13 (2). pp. 148-153. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq194)

Weir, R. A. P., Murphy, C. A., Petrie, C. J., Martin, T. N., Balmain, S., Clements, S., Steedman, T., Wagner, G. S., Dargie, H. J., and McMurray, J. J. V. (2010) Microvascular Obstruction Remains a Portent of Adverse Remodeling in Optimally Treated Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction. Circulation: Cardiovascular Imaging, 3 (4). pp. 360-367. ISSN 1941-9651 (doi:10.1161/CIRCIMAGING.109.897439)

Weir, R.A.P., Murphy, C.A., Petrie, C.J., Martin, T.N., Clements, S., Steedman, T., Wagner, G.S., McMurray, J.J.V., and Dargie, H.J. (2010) Monocyte chemoattractant protein-1: A dichotomous role in cardiac remodeling following acute myocardial infarction in man? Cytokine, 50 (2). pp. 158-162. ISSN 1043-4666 (doi:10.1016/j.cyto.2010.02.020)

Zannad, F., McMurray, J.J.V., Drexler, H., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., and Pitt, B. (2010) Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure, 12 (6). pp. 617-622. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq049)

Zannad, F., McMurray, J.J.V., Krum, H., van Veldhuisen, D.J., Swedberg, K., Shi, H., Vincent, J., Pocock, S.J., and Pitt, B. (2010) Eplerenone in patients with systolic heart failure and mild symptoms. New England Journal of Medicine, 364 (1). pp. 11-21. ISSN 0028-4793 (doi:10.1056/NEJMoa1009492)

Zile, M. R. et al. (2010) Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial. Circulation, 121 (12). pp. 1393-1405. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.109.909614)

2009

Freel, E.M., Tsorlalis, I.K., Lewsey, J.D., Latini, R., Maggioni, A.P., Solomon, S., Pitt, B., Connell, J.M.C., and McMurray, J.J.V. (2009) Aldosterone status associates with insulin resistance in patients with heart failure-data from the ALOFT study. Heart, 95 (23). pp. 1920-1924. ISSN 1355-6037 (doi:10.1136/hrt.2009.173344)

Schwartz, G.G. et al. (2009) Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. American Heart Journal, 158 (6). pp. 896-901. ISSN 0002-8703 (doi:10.1016/j.ahj.2009.09.017)

Lewsey, J. et al. (2009) Age- and sex-specific trends in fatal incidence and hospitalized incidence of stroke in Scotland, 1986 to 2005. Circulation: Cardiovascular Quality and Outcomes, 2 (5). pp. 475-483. ISSN 1941-7713 (doi:10.1161/CIRCOUTCOMES.108.825968)

Berry, C., Pieper, K., White, H., Solomon, S., Van de Werf, F., Velazquez, E., Maggioni, A., Califf, R., Pfeffer, M., and McMurray, J. (2009) Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). European Heart Journal, 30 (12). pp. 1450-1456. ISSN 0195-668X (doi:10.1093/eurheartj/ehp102)

Lewsey, J.D. et al. (2009) Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke, 40 (4). pp. 1038-1043. ISSN 0039-2499 (doi:10.1161/STROKEAHA.108.542787)

Jhund, P.S., MacIntyre, K., Simpson, C.R., Lewsey, J.D., Stewart, S., Redpath, A., Chalmers, J.W.T., Capewell, S., and McMurray, J.J.V. (2009) Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation, 119 (4). pp. 515-523. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.108.812172)

Abrahamsson, P., Dobson, J., Granger, C., McMurray, J., Michelson, E., Pfeffer, M., Pocock, S., Solomon, S., Yusuf, S., and Swedberg, K. (2009) Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure. European Heart Journal, 30 (3). pp. 338-345.

Allen, L. A., Felker, G. M., Pocock, S., McMurray, J. J.V., Pfeffer, M. A., Swedberg, K., Wang, D., Yusuf, S., Michelson, E. L., and Granger, C. B. (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. European Journal of Heart Failure, 11 (2). pp. 170-177. ISSN 1388-9842 (doi:10.1093/eurjhf/hfn031)

Califf, R., Lokhnygina, Y., Velazquez, E., McMurray, J., Leimberger, J., Lewis, E., Diaz, R., Murin, J., and Pfeffer, M. (2009) Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial). American Journal of Cardiology, 104 (2). pp. 151-157.

Cleland, J. et al. (2009) Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart. Journal of the American College of Cardiology, 54 (20). pp. 1850-1859.

Dickstein, K., and McMurray, J. (2009) Should beta-blockade continue to be withheld from patients with chronic heart failure and asthma? Reply. European Heart Journal, 30 (10). pp. 1287-1288.

Gheorghiade, M. et al. (2009) Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group. American Heart Journal, 157 (6). pp. 957-970.

Granger, B. B., Ekman, I., Granger, C. B., Ostergren, J., Olofsson, B., Michelson, E., McMurray, J. J.V., Yusuf, S., Pfeffer, M. A., and Swedberg, K. (2009) Adherence to medication according to sex and age in the CHARM programme. European Journal of Heart Failure, 11 (11). pp. 1092-1098. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp142)

Hawkins, N. M., Huang, Z., Pieper, K. S., Solomon, S. D., Kober, L., Velazquez, E. J., Swedberg, K., Pfeffer, M. A., McMurray, J. J.V., and Maggioni, A. P. (2009) Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). European Journal of Heart Failure, 11 (3). pp. 292-298. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp001)

Hawkins, N.M., MacDonald, M.R., Petrie, M.C., Chalmers, G., Carter, R., Dunn, F.G., and McMurray, J.J. (2009) Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial. European Journal of Heart Failure, 11 (7). pp. 684-690. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp066)

Hawkins, N., Petrie, M., Burgess, M., and McMurray, J. (2009) Selecting Patients for Cardiac Resynchronization Therapy The Fallacy of Echocardiographic Dyssynchrony. Journal of the American College of Cardiology, 53 (21). pp. 1944-1959.

Hawkins, N., Petrie, M., Jhund, P., Chalmers, G., Dunn, F., and McMurray, J. (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. European Journal of Heart Failure, 11 (2). 130-U17.

Hawkins, N., Petrie, M., Jhund, P., Chalmers, G., Dunn, F., and McMurray, J. (2009) Heart failure and chronic obstructive pulmonary disease: lung function test interpretation: reply. European Journal of Heart Failure, 11 (6). pp. 632-633.

Hernandez, A. et al. (2009) Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). American Heart Journal, 157 (2). pp. 271-277.

Heymans, S. et al. (2009) Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 11 (2). pp. 119-129. ISSN 1388-9842 (doi:10.1093/eurjhf/hfn043)

Home, P., Pocock, S., Beck-Nielsen, H., Curtis, P., Gomis, R., Hanefeld, M., Jones, N., Komajda, M., and McMurray, J. (2009) Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet, 373 (9681). pp. 2125-2135.

Hood, W.B., Dans, A., Guyatt, G.H., Jaeschke, R., and McMurray, J.J.V. (2009) Digitalis for treatment of congestive heart failure in patients in sinus rhythm. Cochrane Database of Systematic Reviews (2). CD002901. ISSN 1469-493X (doi:10.1002/14651858.CD002901.pub2)

Jaarsma, T. et al. (2009) Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 11 (5). pp. 433-443. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp041)

Jackson, C. et al. (2009) Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet, 374 (9689). pp. 543-550. ISSN 0140-6736 (doi:10.1016/S0140-6736(09)61378-7)

Jackson, C.E., Dalzell, J.R., Bezlyak, V., Tsorlalis, I.K., Myles, R.C., Spooner, R., Ford, I., Petrie, M.C., Cobbe, S., and McMurray, J.J. (2009) Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. European Journal of Heart Failure, 11 (12). pp. 1152-1154. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp157)

MacDonald, M.R., Petrie, M.C., Fisher, M., and McMurray, J.J.V. (2009) Pharmacologic management of patients with both heart failure and diabetes. Current Heart Failure Reports, 6 (2). pp. 126-132. ISSN 1546-9530 (doi:10.1007/s11897-009-0019-3)

McMurray, J.J. et al. (2009) Effects of statin therapy according to plasma high-sensitivity c-reactive protein concentration in the controlled rosuvastatin multinational trial in heart failure (CORONA): a retrospective analysis. Circulation, 120 (22). 2188-2U51. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.109.849117)

McMurray, J.J.V., Granger, C.B., Ostergren, J., Yusuf, S., Pfeffer, M.A., and Swedberg, K. (2009) Dual Renin-Angiotensin System Blockade in Heart Failure. Journal of the American College of Cardiology, 54 (3). p. 278. ISSN 0735-1097 (doi:10.1016/j.jacc.2009.02.073 )

McMurray, J. et al. (2009) Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial. European Journal of Heart Failure, 11 (8). pp. 795-801.

McMurray, J., Jhund, P., MacIntyre, K., and Stewart, S. (2009) Heart failure in the UK. Heart, 95 (2). p. 156.

Meris, A. et al. (2009) Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo Study. European Heart Journal, 30 (1). pp. 56-65.

Moukarbel, G., Signorovitch, J., Pfeffer, M., McMurray, J., White, H., Maggioni, A., Velazquez, E., Califf, R., Scheiman, J., and Solomon, S. (2009) Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial. European Heart Journal, 30 (18). pp. 2226-2232.

Parving, H. et al. (2009) Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrology, Dialysis, Transplantation, 24 (5). pp. 1663-1671. ISSN 0931-0509

Pfeffer, M.A. et al. (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. New England Journal of Medicine, 361 (21). pp. 2019-2032. ISSN 0028-4793 (doi:10.1056/NEJMoa0907845)

Pfeffer, M.A. et al. (2009) Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). American Journal of Kidney Diseases, 54 (1). pp. 59-69. ISSN 0272-6386 (doi:10.1053/j.ajkd.2009.04.008)

Preiss, D. et al. (2009) Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32 (5). pp. 915-920.

Sochalski, J., Jaarsma, T., Krumholz, H., Laramee, A., McMurray, J., Naylor, M., Rich, M., Riegel, B., and Stewart, S. (2009) What Works In Chronic Care Management: The Case Of Heart Failure. Health Affairs, 28 (1). pp. 179-189.

Somaratne, J., Berry, C., McMurray, J., Poppe, K., Doughty, R., and Whalley, G. (2009) The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. European Journal of Heart Failure, 11 (9). pp. 855-862.

Stanton, T., Hawkins, N. M., Hogg, K. J., Goodfield, N. E.R., Petrie, M. C., and McMurray, J. J.V. (2009) Three-dimensional echocardiography for optimization of cardiac resynchronization therapy: reply. European Heart Journal, 30 (4). pp. 505-506. ISSN 0195-668X (doi:10.1093/eurheartj/ehp002)

Wedel, H. et al. (2009) Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. European Journal of Heart Failure, 11 (3). pp. 281-291.

Weir, R. A.P., Chong, K. S., Dalzell, J. R., Petrie, C. J., Murphy, C. A., Steedman, T., Mark, P.B., McDonagh, T. A., Dargie, H. J., and McMurray, J. J.V. (2009) Plasma apelin concentration is depressed following acute myocardial infarction in man. European Journal of Heart Failure, 11 (6). pp. 551-558. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp043)

Weir, R.A.P., Mark, P.B., Petrie, C.J., Clements, S., Steedman, T., Ford, I., Ng, L.L., Squire, I.B., Wagner, G.S., and McMurray, J.J.V. (2009) Left ventricular remodeling after acute myocardial infarction: Does eplerenone have an effect? American Heart Journal, 157 (6). pp. 1088-1096. ISSN 0002-8703 (doi:10.1016/j.ahj.2009.04.001)

Weir, R., Martin, T., Petrie, C., Murphy, A., Clements, S., Steedman, T., Wagner, G., McMurray, J., and Dargie, H. (2009) Cardiac and Extracardiac Abnormalities Detected by Cardiac Magnetic Resonance in a Post-Myocardial Infarction Cohort. Cardiology, 113 (1). pp. 1-8.

2008

Anavekar, N.S. et al. (2008) Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO study). American Journal of Cardiology, 101 (5). pp. 607-612. ISSN 0002-9149 (doi:10.1016/j.amjcard.2007.09.115)

Anavekar, N.S., Solomon, S.D., McMurray, J.J., Maggioni, A., Rouleau, J.L., Califf, R., White, H., Kober, L., Velazquez, E., and Pfeffer, M.A. (2008) Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus. American Journal of Cardiology, 101 (7). pp. 925-929. ISSN 0002-9149 (doi:10.1016/j.amjcard.2007.11.037)

Anderson, R.E. et al. (2008) High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. American Heart Journal, 155 (4). pp. 706-711. ISSN 0002-8703 (doi:10.1016/j.ahj.2007.11.016)

Berry, C., Brett, M., Stevenson, K., McMurray, J.J., and Norrie, J. (2008) Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart, 94 (3). pp. 296-304. ISSN 1355-6037 (doi:10.1136/hrt.2006.110999)

Bethel, M., Holman, R., Haffner, S., Califf, R., Huntsman-Labed, A., Hua, T., and McMurray, J. (2008) Determining the most appropriate components for a composite clinical trial outcome. American Heart Journal, 156 (4). pp. 633-640. ISSN 0002-8703 (doi:10.1016/j.ahj.2008.05.018)

Califf, R., Boolell, M., Haffner, S., Bethel, M., McMurray, J., Duggal, A., and Holman, R. (2008) Prevention of diabetes and cardiovascular' disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. American Heart Journal, 156 (4). pp. 623-632. ISSN 0002-8703 (doi:10.1016/j.ahj.2008.05.017 )

Carrington, M., Murphy, N.F., Strange, G., Peacock, A., McMurray, J.J., and Stewart, S. (2008) Prognostic impact of pulmonary arterial hypertension: A population-based analysis. International Journal of Cardiology, 124 (2). pp. 183-187. ISSN 0167-5273 (doi:10.1016/j.ijcard.2006.12.045 )

Clark, A.M., Reid, M.E., Morrison, C.E., Capewell, S., Murdoch, D.L., and McMurray, J.J. (2008) The complex nature of informal care in home-based heart failure management. Journal of Advanced Nursing, 61 (4). pp. 373-383. ISSN 0309-2402 (doi:10.1111/j.1365-2648.2007.04527.x)

Cleland, J. et al. (2008) The Selective Cardiac Myosin Activator, CK-1827452, Increases Systolic Function in a Concentration-Dependent Manner in Patients with Stable Heart Failure (10/8/08). Journal of Cardiac Failure, 14 (9). pp. 797-798. ISSN 1071-9164

Cohen-Solal, A., McMurray, J., Swedberg, K., Pfeffer, M., Puu, M., Solomon, S., Michelson, E., Yusuf, S., and Granger, C. (2008) Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity programme. European Heart Journal, 29 (24). pp. 3022-3028. ISSN 0195-668X (doi:10.1093/eurheartj/ehn476 )

Dickstein, K. et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Journal of Heart Failure, 10 (10). pp. 933-989. ISSN 1388-9842 (doi:10.1016/j.ejheart.2008.08.005)

Dickstein, K. et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal, 29 (19). pp. 2388-2442. ISSN 0195-668X (doi:10.1093/eurheartj/ehn309)

Gerstein, H. C., Swedberg, K., Carlsson, J., McMurray, J. J. V., Michelson, E. L., Olofsson, B., Pfeffer, M. A., and Yusuf, S. (2008) The Hemoglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure: An Analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Archives of Internal Medicine, 168 (15). pp. 1699-1704. ISSN 0003-9926 (doi:10.1001/archinte.168.15.1699)

Jhund, P., and McMurray, J. (2008) Heart Failure After Acute Myocardial Infarction A Lost Battle in the War on Heart Failure? Circulation, 118 (20). pp. 2019-2021. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.108.813493 )

Kjekshus, J., McMurray, J.J., and Wikstrand, J. (2008) Rosuvastatin in older patients with systolic heart failure - Reply. New England Journal of Medicine, 358 (12). p. 1301. ISSN 0028-4793

Kober, L., Torp-Pedersen, C., McMurray, J.J., Gotzsche, O., Levy, S., Crijns, H., Amlie, J., Carlsen, J., and Dronedarone Study, G. (2008) Increased mortality after dronedarone therapy for severe heart failure. New England Journal of Medicine, 358 (25). pp. 2678-2687. ISSN 0028-4793 (doi:10.1056/NEJMoa0800456)

Lewis, E.F. et al. (2008) Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. European Heart Journal, 29 (6). pp. 748-756. ISSN 0195-668X (doi:10.1093/eurheartj/ehn062)

MacDonald, M.R., Hawkins, N.M., Balmain, S., Dalzell, J., McMurray, J.J., and Petrie, M.C. (2008) Transthoracic echocardiography: a survey of current practice in the UK. QJM: An International Journal of Medicine, 101 (5). pp. 345-349. ISSN 1460-2725

MacDonald, M.R. et al. (2008) Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland. Circulation: Heart Failure, 1 (4). pp. 234-241. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.108.794008)

MacDonald, M.R., Petrie, M.C., Hawkins, N.M., Petrie, J.R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., and McMurray, J.J.V. (2008) Diabetes, left ventricular systolic dysfunction, and chronic heart failure. European Heart Journal, 29 (10). pp. 1224-1240. ISSN 0195-668X (doi:10.1093/eurheartj/ehn156 )

MacDonald, M.R. et al. (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal, 29 (11). pp. 1377-1385. ISSN 0195-668X (doi:10.1093/eurheartj/ehn153)

Massie, B. et al. (2008) Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction. New England Journal of Medicine, 359 (23). pp. 2456-2467. ISSN 0028-4793

McMurray, J.J. (2008) ACE inhibitors in cardiovascular disease - Unbeatable? New England Journal of Medicine, 358 (15). pp. 1615-1616. ISSN 0028-4793 (doi:10.1056/NEJMe0801925)

McMurray, J.J.V., Pitt, B., Latini, R., Maggioni, A.P., Solomon, S.D., Keefe, D.L., Ford, J., Verma, A., and Lewsey, J. (2008) Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circulation: Heart Failure, 1 (1). pp. 17-24. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.107.740704)

McMurray, J., Carson, P., Komajda, M., McKelvie, R., Zile, M., Ptaszynska, A., Staiger, C., Donovan, J., and Massie, B. (2008) Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. European Journal of Heart Failure, 10 (2). pp. 149-156.

Meredith, P. et al. (2008) Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program. Journal of the American College of Cardiology, 52 (24). pp. 2000-2007.

Murphy, C.L., and McMurray, J.J. (2008) Approaches to the treatment of anaemia in patients with chronic heart failure. Heart Failure Reviews, 13 (4). pp. 431-438. ISSN 1382-4147

Pocock, S. J. et al. (2008) Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. European Heart Journal, 29 (21). pp. 2641-2650. ISSN 0195-668X (doi:10.1093/eurheartj/ehn420)

Prisant, L.M., Thomas, K.L., Lewis, E.F., Huang, Z., Francis, G.S., Weaver, W.D., Pfeffer, M.A., McMurray, J.J., Califf, R.M., and Velazquez, E.J. (2008) Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. Journal of the American College of Cardiology, 51 (19). pp. 1865-1871. (doi:10.1016/j.jacc.2007.12.050)

Radauceanu, A. et al. (2008) Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure. Journal of Cardiac Failure, 14 (6). pp. 467-474. ISSN 1071-9164 (doi:10.1016/j.cardfail.2008.02.014)

Remme, W. J. et al. (2008) Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. European Heart Journal, 29 (14). pp. 1739-1752. ISSN 0195-668X (doi:10.1093/eurheartj/ehn196)

Rocchiccioli, J.P., and McMurray, J. (2008) Medical management of advanced heart failure. Progress in Palliative Care, 16 (5-6). pp. 229-240. ISSN 0969-9260 (doi:10.1179/096992608X346233)

Stanton, T., Hawkins, N.M., Hogg, K.J., Goodfield, N.E.R., Petrie, M.C., and McMurray, J.J.V. (2008) How should we optimize cardiac resynchronization therapy? European Heart Journal, 29 (20). pp. 2458-2472. ISSN 0195-668X (doi:10.1093/eurheartj/ehn380 )

Stewart, S., Wilkinson, D., Hansen, C., Vaghela, V., Mvungi, R., McMurray, J., and Sliwa, K. (2008) Predominance of Heart Failure in the Heart of Soweto Study Cohort Emerging Challenges for Urban African Communities. Circulation, 118 (23). pp. 2360-2367. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.108.786244)

Tardif, J.C. et al. (2008) Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet, 371 (9626). pp. 1761-1768. ISSN 0140-6736 (doi:10.1016/S0140-6736(08)60763-1)

Taylor, G.L., Murphy, N.F., Berry, C., Christie, J., Finlayson, A., MacIntyre, K., Morrison, C., and McMurray, J.J. (2008) Long-term outcome of low-risk patients attending a rapid-assessment chest pain clinic. Heart, 94 (5). pp. 628-632. (doi:10.1136/hrt.2007.125344)

Thomas, K.L., Al Khatib, S.M., Lokhnygina, Y., Solomon, S.D., Kober, L., McMurray, J.J., Califf, R.M., and Velazquez, E.J. (2008) Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. American Heart Journal, 155 . pp. 87-93. (doi:10.1016/j.ahj.2007.09.010)

Thune, J.J. et al. (2008) Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction. Hypertension, 51 . pp. 48-54. ISSN 0194-911X (doi:10.1161/​HYPERTENSIONAHA.107.093682 )

Thune, J.J. et al. (2008) Response to the J-point revisited. Hypertension, 51 (5). E35-E35. ISSN 0194-911X

Torp-Pedersen, C., Kober, L., Carlsen, J.E., Akkan, D., Bruun, N.E., Dacoronias, D., Dickstein, K., Haghfelt, T., Ohlin, H., and McMurray, J.J. (2008) A randomised trial of a pre-synaptic stimulator of DA(2)-dopaminergic and alpha(2)-adrenergic receptors on morbidity and mortality in patients with heart failure. European Journal of Heart Failure, 10 . pp. 89-95. ISSN 1388-9842 (doi:10.1016/j.ejheart.2007.10.012)

Verma, A. et al. (2008) Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial InfarctionThe VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC: Cardiovascular Imaging, 1 (5). pp. 582-591. ISSN 1936878X (doi:10.1016/j.jcmg.2008.05.012)

Weir, R.A.P. et al. (2008) Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. European Journal of Heart Failure, 10 (2). pp. 157-163. ISSN 1388-9842 (doi:10.1016/j.ejheart.2007.12.006)

2007

McMurray, J.J.V. et al. (2007) Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS Randomized controlled trials. JAMA: Journal of the American Medical Association, 298 (17). pp. 2009-2019. ISSN 0098-7484 (doi:10.1001/jama.298.17.2009)

Amigoni, M. et al. (2007) Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. European Heart Journal, 28 . pp. 326-333. (doi:10.1093/eurheartj/ehl464)

Balmain, S., Padmanabhan, N., Ferrell, W., Morton, J., and McMurray, J. (2007) Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function. European Journal of Heart Failure, 9 . pp. 865-871. (doi:10.1016/j.ejheart.2007.06.003)

Berry, C., Murphy, N., De Vito, G., Galloway, S., Seed, A., Fisher, C., Sattar, N., Vallance, P., Hillis, W., and McMurray, J. (2007) Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker. European Journal of Heart Failure, 9 . pp. 429-434. (doi:10.1016/j.ejheart.2006.10.005)

Berry, C., Murphy, N., De Vito, G., Galloway, S., Seed, A., Fisher, C., Sattar, N., Vallance, P., Hillis, W., and McMurray, J. (2007) Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker (vol 9, pg 429, 2007). European Journal of Heart Failure, 9 . p. 1074.

Dargie, H., Hildebrandt, P., Riegger, G., McMurray, J., McMorn, S., Roberts, J., Zambanini, A., and Wilding, J. (2007) A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association functional class I or II heart failure. Journal of the American College of Cardiology, 49 . pp. 1696-1704. (doi:10.1016/j.jacc.2006.10.077)

Desai, A. et al. (2007) Incidence and predictors of hyperkalemia in patients with heart failure. Journal of the American College of Cardiology, 50 . pp. 1959-1966.

Dickstein, K., Drexler, H., Mcmurray, J., and Bohm, M. (2007) Abstracts of the Heart Failure Congress 2007 - Hamburg, Germany, 9-12 June, 2007 - Welcome address. European Journal of Heart Failure, 6 . IX-IX.

Felker, G. et al. (2007) Red cell distribution width as a novel prognostic marker in heart failure - Data from the CHARM program and the Duke Databank. Journal of the American College of Cardiology, 50 . pp. 40-47. (doi:10.1016/j.jacc.2007.02.067)

Granger, C., and McMurray, J. (2007) Efficacy and safety in clinical trials - Reply. Journal of the American College of Cardiology, 49 (6). p. 729.

Hawkins, N. et al. (2007) Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart, 93 . pp. 59-64. (doi:10.1136/hrt.2005.083949)

Hawkins, N. et al. (2007) Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme. European Journal of Heart Failure, 9 . pp. 510-517. (doi:10.1016/j.ejheart.2006.11.006)

Home, P., Pocock, S., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Jones, N., Komajda, M., McMurray, J., and Grp, R. (2007) Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis. New England Journal of Medicine, 357 . pp. 28-38. ISSN 0028-4793 (doi:10.1056/NEJMoa073394)

Kenchaiah, S. et al. (2007) Body mass index and prognosis in patients with chronic heart failure - Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation, 116 . pp. 627-636. (doi:10.1161/CIRCULATIONAHA.106.679779)

Kjekshus, J. et al. (2007) Rosuvastatin in older patients with systolic heart failure. New England Journal of Medicine, 357 . pp. 2248-2261. ISSN 0028-4793 (doi:10.1056/NEJMoa0706201)

Lewis, E. et al. (2007) Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. European Journal of Heart Failure, 9 (1). pp. 83-91.

McEntegart, M., Awede, B., Petrie, M., Sattar, N., Dunn, F., MacFarlane, N., and McMurray, J. (2007) Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. European Heart Journal, 28 . pp. 829-835. (doi:10.1093/eurheartj/ehm033)

McInnes, G.T. (2007) Diabetes and hypertension. In: Fisher, M. and McMurray, J.J. (eds.) Diabetic Cardiology. Series: Diabetes in practice . Wiley, Chichester, pp. 135-174. ISBN 9780470862049

Metra, M. et al. (2007) Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 9 . pp. 684-694. (doi:10.1016/j.ejheart.2007.04.003)

Murphy, A., and McMurray, J. (2007) Heart failure: are we neglecting the silent majority? European Heart Journal, 28 (9). pp. 1047-1048.

Murphy, N., Simpson, C., Jhund, P., Stewart, S., Kirkpatrick, M., Chalmers, J., MacIntyre, K., and McMurray, J. (2007) A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart, 93 . pp. 606-612. (doi:10.1136/hrt.2006.107573)

Myles, R., Jackson, C., Tsorlalis, I., Petrie, M., McMurray, J., and Cobbe, S. (2007) Is microvolt T-wave alternans the answer to risk stratification in heart failure? Circulation, 116 . pp. 2984-2991.

O'Meara, E. et al. (2007) Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure - Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program. Circulation, 115 . pp. 3111-3120. (doi:10.1161/CIRCULATIONAHA.106.673442)

Peacock, A., Murphy, N., McMurray, J., Caballero, L., and Stewart, S. (2007) An epidemiological study of pulmonary arterial hypertension. European Respiratory Journal, 30 . pp. 104-109. (doi:10.1183/09031936.00092306)

Petrie, M., and McMurray, J. (2007) Dysglycemia and heart failure hospitalization - What is the link? Circulation, 115 (11). pp. 1334-1335.

Pfeffer, M. et al. (2007) An ongoing study of anemia correction in chronic kidney disease. New England Journal of Medicine, 356 (9). pp. 959-961. ISSN 0028-4793

Recio-Mayoral, A., Kaski, J., McMurray, J., Horowitz, J., van Veldhuisen, D., and Remme, W. (2007) Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY. Cardiovascular Drugs and Therapy, 21 . pp. 459-465.

Sampson, U., Pfeffer, M., McMurray, J., Lokhnygina, Y., White, H., Solomon, S., and Valsartan Acute, M. (2007) Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT trial. European Heart Journal, 28 . pp. 685-691. (doi:10.1093/eurheartj/ehl197)

Seed, A., Gardner, R., Mcmurray, J., Hillier, C., Murdoch, D., MacFadyen, R., Bobillier, A., Mann, J., and McDonagh, T. (2007) Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure. European Journal of Heart Failure, 9 . pp. 1120-1127.

Solomon, S. et al. (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation, 116 . pp. 1482-1487. (doi:10.1161/CIRCULATIONAHA.107.696906)

Solomon, S. et al. (2007) Response to letter regarding article, 'Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas'. Circulation, 115 (12). E349-E349.

Stephenson, K. et al. (2007) Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience. Heart Rhythm, 4 . pp. 308-313. (doi:10.1016/j.hrthm.2006.11.021)

Stewart, S., Murphy, N., Walker, A., McGuire, A., and McMurray, J. (2007) Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK (vol 90, pg 282, 2004). Heart, 93 . p. 1472.

Verma, A., Anavekar, N., Meris, A., Thune, J., Arnold, J., Ghali, J., Velazquez, E., McMurray, J., Pfeffer, M., and Solomon, S. (2007) The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction - The VALIANT Echo study. Journal of the American College of Cardiology, 50 . pp. 1238-1245.

van Veldhuisen, D., and McMurray, J. (2007) Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. European Journal of Heart Failure, 9 (2). pp. 110-112.

van Veldhuisen, D., McMurray, J., and Comm, R. (2007) Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial (vol 9, pg 110, 2007). European Journal of Heart Failure, 9 (3). p. 323.

2006

Murphy, N.F., Stewart, S., Hart, C., MacIntyre, K., Hole, D.J., and McMurray, J.J.V. (2006) A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew–Paisley study. Heart, 92 (12). pp. 1739-1746. ISSN 1355-6037 (doi:10.1136/hrt.2006.090118)

Murphy, N.F., MacIntyre, K., Stewart, S., Hart, C., Hole, D., and McMurray, J. (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew–Paisley study). European Heart Journal, 27 (1). pp. 96-106. ISSN 0195-668X (doi:10.1093/eurheartj/ehi506)

Berry, C., Norrie, J., Hogg, K., Brett, M., Stevenson, K., and McMurray, J. (2006) The prevalence, nature, and importance of hematologic abnormalities in heart failure. American Heart Journal, 151 (6). pp. 1313-1321.

Capewell, S., Unal, B., Critchley, J., and McMurray, J. (2006) Over 20 000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients. Heart, 92 (4). pp. 521-523.

Capewell, S., Murphy, N.F., MacIntyre, K., Frame, S., Stewart, S., Chalmers, J.W.T., Boyd, J., Finlayson, A., Redpath, A., and McMurray, J.J.V. (2006) Short-term and long-term outcomes in 133 429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study. Heart, 92 (11). pp. 1563-1570. ISSN 1355-6037 (doi:10.1136/hrt.2005.085399)

Ducharme, A. et al. (2006) Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. American Heart Journal, 151 (5). pp. 985-991. ISSN 0002-8703

Granger, C., and McMurray, J. (2006) Using measures of disease progression to determine therapeutic effect - A sirens' song. Journal of the American College of Cardiology, 48 (3). pp. 434-437.

Hawkins, N., Petrie, M., MacDonald, M., Hogg, K., and McMurray, J. (2006) QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence? European Heart Journal, 27 (24). pp. 3074-3075.

Hawkins, N., Petrie, M., MacDonald, M., Hogg, K., and McMurray, J. (2006) Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? European Heart Journal, 27 (11). pp. 1270-1281.

Hillege, H. et al. (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation, 113 . pp. 671-678. (doi:10.1161/CIRCULATIONAHA.105.580506)

Hogg, K., and McMurray, J. (2006) The treatment of heart failure with preserved ejection fraction ("diastolic heart failure"). Heart Failure Reviews, 11 . pp. 141-146. (doi:10.1007/s10741-006-9488-6)

Hogg, K., and McMurray, J. (2006) The treatment of heart failure with preserved ejection fraction ('diastolic heart failure'). Heart Failure Reviews, 11 (2). pp. 141-146.

Janardhanan, R. et al. (2006) Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. American Heart Journal, 152 . pp. 183-189. (doi:10.1016/j.ahj.2005.11.013)

Jhund, P., and McMurray, J. (2006) Does aspirin reduce the benefit of an angiotensin-converting enzyme inhibitor? - Choosing between the scylla of observational studies and the charybdis of subgroup analysis. Circulation, 113 (22). pp. 2566-2568.

Kauf, T. et al. (2006) The cost of acute myocardial infarction in the new millennium: Evidence from a multinational registry. American Heart Journal, 151 . pp. 206-212. (doi:10.1016/j.ahj.2005.02.028)

Kober, L. et al. (2006) Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. European Journal of Heart Failure, 8 . pp. 591-598. (doi:10.1016/j.ejheart.2005.11.007)

MacIntyre, K., Murphy, N., Chalmers, J., Capewell, S., Frame, S., Finlayson, A., Pell, J., Redpath, A., and McMurray, J. (2006) Hospital burden of suspected acute coronary syndromes: recent trends. Heart, 92 (5). pp. 691-692.

McMurray, J. et al. (2006) The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction - An analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Journal of the American College of Cardiology, 47 . pp. 726-733. (doi:10.1016/j.jacc.2005.09.055)

McMurray, J. (2006) Beta-blockers and heart failure in older people: reply. European Heart Journal, 27 (7). pp. 888-889.

McMurray, J. (2006) Drug safety in cardiovascular disease: A call to ACTION. Cardiovascular Drugs and Therapy, 20 (1). pp. 9-10.

McMurray, J. (2006) Renin angiotensin blockade in heart failure with preserved ejection fraction: the signal gets stronger. European Heart Journal, 27 (19). pp. 2257-2259.

McMurray, J. et al. (2006) Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal, 27 (12). pp. 1447-1458.

McMurray, J., Califf, R., and Pfeffer, M. (2006) Of statistical significance: 'Trends' toward significance and optimism bias - Reply. Journal of the American College of Cardiology, 48 (7). p. 1471.

McMurray, J. et al. (2006) Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM)-Added trial. American Heart Journal, 151 . pp. 985-991. (doi:10.1016/j.ahj.2006.02.028)

Mcmurray, J., and Swedberg, K. (2006) Treatment of chronic heart failure: a comparison between the major guidelines. European Heart Journal, 27 (15). pp. 1773-1777.

Murphy, N.F., Simpson, C.R., MacIntyre, K., McAlister, F.A., Chalmers, J., and McMurray, J.J.V. (2006) Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study. Heart, 92 (8). pp. 1047-1054. ISSN 1355-6037 (doi:10.1136/hrt.2005.069419)

Murphy, N., MacIntyre, K., Stewart, S., Hart, C., Hole, D., and McMurray, J. (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15000 middle-aged men and women (the Renfrew-Paisley study). European Heart Journal, 27 . pp. 96-106. (doi:10.1093/eurheartj/ehi506)

Murphy, N., Stewart, S., Hart, C., MacIntyre, K., Hole, D., and McMurray, J. (2006) A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew Paisley study. Heart, 92 . pp. 1739-1746. (doi:10.1136/hrt.2006.090118)

O'Meara, E. et al. (2006) Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure - Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation, 113 . pp. 986-994. (doi:10.1161/CIRCULATIONAHA.105.582577)

Olsson, L., Swedberg, K., Ducharme, A., Granger, C., Michelson, E., McMurray, J., Puu, M., Yusuf, S., Pfeffer, M., and Investigators, C. (2006) Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program. Journal of the American College of Cardiology, 47 . pp. 1997-2004. (doi:10.1016/j.jacc.2006.01.060)

Pitt, B., Ferrari, R., Gheorghiade, M., van Veldhuisen, D., Krum, H., McMurray, J., and Lopez-Sendon, J. (2006) Aldosterone blockade in post-acute myocardial infarction heart failure. Clinical Cardiology, 29 . pp. 434-438.

Pocock, S. et al. (2006) Predictors of mortality and morbidity in patients with chronic heart failure. European Heart Journal, 27 . pp. 65-75. (doi:10.1093/eurheartj/ehi555)

Reed, S. et al. (2006) Geographic variation in the treatment of acute myocardial infarction in the VALsartan in acute myocardial iNfarcTion (VALIANT) trial. American Heart Journal, 152 . pp. 500-508. (doi:10.1016/j.ahj.2006.02.032)

Reid, M., Clark, A., Murdoch, D., Morrison, C., Capewell, S., and McMurray, J. (2006) Patients strategies for managing medication for chronic heart failure. International Journal of Cardiology, 109 . pp. 66-73. (doi:10.1016/j.ijcard.2005.05.051)

Solomon, S. et al. (2006) Effect of Celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation, 114 (10). pp. 1028-1035.

Stewart, S., and McMurray, J. (2006) Chilling findings: The need for winter vigilance in heart failure. Journal of Cardiac Failure, 12 (2). pp. 120-121.

Stewart, S., Murphy, N., McMurray, J., Jhund, P., Hart, C., and Hole, D. (2006) Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: An analysis of the Renfrew/Paisley Study. European Journal of Heart Failure, 8 . pp. 856-863. (doi:10.1016/j.ejheart.2006.02.008)

Stewart, S., Wilkinson, D., Becker, A., Askew, D., Ntyintyane, L., McMurray, J., and Sliwa, K. (2006) Mapping the emergence of heart disease in a black, urban population in Africa: The Heart of Soweto Study. International Journal of Cardiology, 108 . pp. 101-108. (doi:10.1016/j.ijcard.2006.01.001)

Valeur, N., Nielsen, O., McMurray, J., Torp-Pedersen, C., Kober, L., and Grp, T. (2006) Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. European Journal of Heart Failure, 8 . pp. 577-584. (doi:10.1016/j.ejheart.2005.11.017)

Walker, A., McMurray, J., Stewart, S., Berger, W., McMahon, A., Dargie, H., Fox, K., Hillis, S., Henderson, N., and Ford, I. (2006) Economic evaluation of the impact of nicorandil in angina (IONA) trial. Heart, 92 . pp. 619-624. (doi:10.1136/hrt.2003.026385)

Weir, R., and McMurray, J. (2006) Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction. Curr Heart Fail Rep, 3 (4). pp. 175-180.

Weir, R., McMurray, J., Granger, C., Puu, M., Ostergren, J., Yusuf, S., Swedberg, K., and Pfeffer, M. (2006) Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial. European Heart Journal, 27 (Suppl.).

Weir, R., McMurray, J., and Velazquez, E. (2006) Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: Prevalence, clinical characteristics, and prognostic importance. American Journal of Cardiology, 97 . 13F-25F. (doi:10.1016/j.amjcard.2006.03.005)

Yerra, L., Anavekar, N., Skali, H., Zelenkofske, S., Velazquez, E., Mcmurray, J., Pfeffer, M., and Solomon, S. (2006) Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. Heart Rhythm, 3 (3). pp. 313-316.

2005

Clark, A.M., McMurray, J.J.V., Morrison, C.E., Murdoch, D.L., Capewell, S., and Reid, M.E. (2005) A qualitative study of the contribution of pharmacists to heart failure management in Scotland. Pharmacy World and Science, 27 (6). pp. 453-458. ISSN 0928-1231 (doi:10.1007/s11096-005-1637-9)

Demers, C. et al. (2005) Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure. JAMA: Journal of the American Medical Association, 294 (14). pp. 1794-1798. ISSN 0098-7484 (doi:10.1001/jama.294.14.1794)

Anavekar, N., McMurray, J., and Pfeffer, M. (2005) Chronic renal disease and cardiovascular risk - Reply. New England Journal of Medicine, 352 (2). p. 200. ISSN 0028-4793

Berry, C., Hogg, K., Norrie, J., Stevenson, K., Brett, M., and McMurray, J. (2005) Heart failure with preserved left ventricular systolic function: a hospital cohort study. Heart, 91 . pp. 907-913. (doi:10.1136/hrt.2004.041996)

Berry, C., Norrie, J., and McMurray, J. (2005) Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis. Cardiovascular Drugs and Therapy, 19 . pp. 149-151. (doi:10.1007/s10557-005-3405-4)

Blue, L., and McMurray, J. (2005) How much responsibility should heart failure nurses take? European Journal of Heart Failure, 7 . pp. 351-361. (doi:10.1016/j.ejheart.2005.01.005)

Boehm, M., Hjalmarson, A., Kjekshus, J., Laufs, U., McMurray, J., and van Veldhuisen, D.J. (2005) Heart failure and statins - Why do we need a clinical trial? Zeitschrift für Kardiologie, 94 (4). pp. 223-230. ISSN 0300-5860 (doi:10.1007/s00392-005-0210-9)

Carson, P., Massie, B., McKelvie, R., McMurray, J., Komajda, M., Zile, M., Ptaszynska, A., Frangin, G., and Investigators, I. (2005) The Irbesartan in Heart Failure with Preserved Systolic Function (I-PRESERVE) trial: Rationale and design. Journal of Cardiac Failure, 11 . pp. 576-585. (doi:10.1016/j.cardfail.2005.06.432)

Clark, A., McMurray, J., Morrison, C., Murdoch, D., Capewell, S., and Reid, M. (2005) A qualitative study of the contribution of pharmacists to heart failure management in Scotland. Pharmacy World and Science, 27 . pp. 453-458. ISSN 0928-1231 (doi:10.1007/s11096-005-1637-9)

Cowie, M., Mcmurray, J., Cleland, J., McDonagh, T., and Pearson, M. (2005) Question and answer session. Heart, 91 . p. 31.

Dargie, H. et al. (2005) Determinants of coronary events in patients with stable angina: Results from the Impact of Nicorandil in Angina Study. American Heart Journal, 150 . (doi:10.1016/j.ahj.2005.03.040)

Granger, B., Swedberg, K., Ekman, I., Granger, C., Olofsson, B., McMurray, J., Yusuf, S., Michelson, E., Pfeffer, M., and Investigators, C. (2005) Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet, 366 . pp. 2005-2011. ISSN 0140-6736 (doi:10.1016/S0140-6736(05)67760-4)

Hogg, K., and Mcmurray, J. (2005) Neurohumoral pathways in heart failure with preserved systolic function. Progress in Cardiovascular Diseases, 47 (6). pp. 357-366.

Kjekshus, J., Dunselman, P., Blideskog, M., Eskilson, C., Hjalmarson, A., McMurray, J., Waagstein, F., Wedel, H., Wessman, P., and Wikstrand, J. (2005) A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristics. European Journal of Heart Failure, 7 (6). pp. 1059-1069. ISSN 1388-9842 (doi:10.1016/j.ejheart.2005.09.005)

MacIntrye, I., Jhund, P., and McMurray, J. (2005) Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure. Cardiovascular Drugs and Therapy, 19 . pp. 261-265. (doi:10.1007/s10557-005-3309-3)

McMurray, J. et al. (2005) Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice. European Journal of Heart Failure, 7 . pp. 710-721. (doi:10.1016/j.ejheart.2005.07.002)

McMurray, J., Kober, L., Robertson, M., Dargie, H., Colucci, W., Lopez-Sendon, J., Remme, W., Sharpe, D., and Ford, I. (2005) Antiarrhythmic effect of carvedilol after acute myocardial infarction - Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. Journal of the American College of Cardiology, 45 . pp. 525-530.

McMurray, J. (2005) Optimising the use of angiotensin receptor blockers in the management of chronic heart failure. Journal of the Renin-Angiotensin-Aldosterone System, 6 . S2-S5. ISSN 1470-3203

McMurray, J., Kober, L., Robertson, M., Dargie, H., Colucci, W., Lopez-Sendon, J., Remme, W., Sharpe, N., and Ford, I. (2005) Antiarrythmic effect of carvedilol after acute myocardial infarction. Journal of the American College of Cardiology, 45 (4). pp. 525-530. ISSN 0735-1097 (doi:10.1016/j.jacc.2004.09.076)

McMurray, J. (2005) Angiotensin receptor blockers and myocardial infarction - Analysis of evidence is incomplete and inaccurate. British Medical Journal, 330 (7502). p. 1269. ISSN 0959-535X

McMurray, J. (2005) Chronic kidney disease in patients with cardiac disease: A review of evidence-based treatment. Kidney International, 68 (4). pp. 1419-1426. ISSN 0085-2538

McMurray, J. (2005) Making sense of SENIORS. European Heart Journal, 26 (3). pp. 203-206.

McMurray, J. (2005) Val-HeFT: do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy? Nature Clinical Practice Cardiovascular Medicine, 2 (3). pp. 128-129.

McMurray, J. (2005) The role of angiotensin II receptor blockers in the management of heart failure. European Heart Journal Supplements, 7 . J10-J14. (doi:10.1093/eurheartj/sui057)

McMurray, J., and Pfeffer, M. (2005) Heart failure. Lancet, 365 . pp. 1877-1889.

Mcmurray, J. (2005) Angiotensin receptor blockers and myocardial infarction: analysis of evidence is incomplete and inaccurate. British Medical Journal, 330 (7502). p. 1269. ISSN 0959-535X

Mcmurray, J. (2005) Baseline left ventricular wall thickness after myocardial infarction predicts death or heart failure: Findings from the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Circulation, 112 (17, Su). U588.

Mcmurray, J. (2005) Extent of coronary artery disease and cardiovascular outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: Findings from the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Circulation, 112 (17, Su). U568.

Mcmurray, J. (2005) Possible beneficial interaction between statins and combination anglotensin receptor blocker (ARB) and ACE inhibitor treatment in patients with myocardial infarction: A post hoc analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Circulation, 112 (17, Su). U545.

Mcmurray, J. (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). European Heart Journal, 26 (3). pp. 215-225. (doi:10.1093/eurheartj/ehi115)

Miller, P., Drummond, M., Langkilde, L., McMurray, J., and Ogren, M. (2005) Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation. European Heart Journal Supplements, 7 (C). C41-C54.

Mix, T. et al. (2005) Rationale - Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease. American Heart Journal, 149 . pp. 408-413. (doi:10.7016/j.ahj.2004.09.047)

Murphy, N., MacIntyre, K., Stewart, S., Capewell, S., and McMurray, J. (2005) Reduced between-hospital variation in short term survival after acute myocardial infarction: the result of improved cardiac care? Heart, 91 . pp. 726-730. (doi:10.1136/hrt.2004.042929)

O'Meara, E. et al. (2005) Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure, 7 (4). pp. 650-656.

O'Meara, E., and McMurray, J. (2005) Myocardial metabolic manipulation: a new therapeutic approach in heart failure? Heart, 91 (2). pp. 131-132.

Packer, M. et al. (2005) Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: Results of a pilot study. Journal of Cardiac Failure, 11 . pp. 12-20. (doi:10.1016/j.cardfail.2004.05.006)

Pfeffer, M., Solomon, S., Singh, A., Ivanovich, P., and McMurray, J. (2005) Uncertainty in the treatment of anemia in chronic kidney disease. Rev Cardiovasc Med, 6 Supp . S35-S41.

Reed, S. et al. (2005) Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). American Heart Journal, 150 . pp. 323-329. (doi:10.1016/j.ahj.2004.08.037)

Remme, W. et al. (2005) Public awareness of heart failure in Europe: first results from SHAPE. European Heart Journal, 26 . pp. 2413-2421. (doi:10.1093/eurheartj/ehi447)

Solomon, S. et al. (2005) Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation, 112 . pp. 3738-3744. (doi:10.1161/CIRCULATIONAHA.105.561423)

Solomon, S. et al. (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. New England Journal of Medicine, 352 . pp. 1071-1080. ISSN 0028-4793

Solomon, S. et al. (2005) Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation, 111 (25). pp. 3411-3419.

Solomon, S., Wittes, J., McMurray, J., and Co, A. (2005) Cardiovascular risk associated with celecoxib - The authors reply. New England Journal of Medicine, 352 (25). p. 2649. ISSN 0028-4793

Solomon, S. et al. (2005) Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. New England Journal of Medicine, 352 . pp. 2581-2588. ISSN 0028-4793

Stewart, S., McAlister, F., and McMurray, J. (2005) Heart failure management programs reduce readmissions and prolong survival. Arch Intern Med, 165 (11). p. 1311.

Stewart, S., McMurray, J., Hebborn, A., Coats, A., Packer, M., and Grp, C. (2005) Carvedilol reduces the costs of medical care in severe heart failure: An economic analysis of the COPERNICUS study applied to the United Kingdom. International Journal of Cardiology, 100 . pp. 143-149. (doi:10.1016/j.ijcard.2004.12.003)

Szummer, K. et al. (2005) Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry. European Heart Journal, 26 . pp. 2114-2119. (doi:10.1093/eurheartj/ehi352)

Teerlink, J. et al. (2005) Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). American Heart Journal, 150 . pp. 46-53. (doi:10.1016/j.ahj.2005.04.035)

Voors, A., Petrie, C., Petrie, M., Charlesworth, A., Hillege, H., Zijlstra, F., McMurray, J., and van Veldhuisen, D. (2005) Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. European Heart Journal, 26 . pp. 1759-1764. (doi:10.1093/eurheartj/ehi270)

Weir, R., and McMurray, J. (2005) Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction. Heart, 91 . pp. 17-20. (doi:10.1136/hrt.2005.062042)

White, H. et al. (2005) Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction - Results from the Valsartan in Acute Myocardial Infarc. Circulation, 112 . pp. 3391-3399. (doi:10.1161/CIRCULATIONHA.105.551143)

Yusuf, S. et al. (2005) Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation, 112 . pp. 48-53. (doi:10.1161/CIRCULATIONAHA.104.528166)

2004

Murphy, N.F., Stewart, S., MacIntyre, K., Capewell, S., and McMurray, J.J.V. (2004) Seasonal variation in morbidity and mortality related to atrial fibrillation. International Journal of Cardiology, 97 (2). pp. 283-288. ISSN 0167-5273 (doi:10.1016/j.ijcard.2004.03.041)

Riegel, B., Naylor, M., Stewart, S., McMurray, J.J.V., and Rich, M.W. (2004) Interventions to prevent readmission for congestive heart failure. JAMA: Journal of the American Medical Association, 291 (23). p. 2816. ISSN 0098-7484 (doi:10.1001/jama.291.23.2816-a)

McAlister, F.A., Murphy, N.F., Simpson, C.R., Stewart, S., MacIntyre, K., Kirkpatrick, M., Chalmers, J., Redpath, A., Capewell, S., and McMurray, J.J.V. (2004) Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study. British Medical Journal, 328 (7448). pp. 1110-1113. ISSN 0959-535X (doi:10.1136/bmj.38043.414074.EE)

Aguilar, D. et al. (2004) Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction - The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation, 110 . pp. 1572-1578. (doi:10.1161/01.CIR.0000142047.28024.F2)

Anand, I., McMurray, J., Cohn, J., Konstam, M., Notter, T., Quitzau, K., Ruschitzka, F., Luscher, T., and Investigators, E. (2004) Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin(A) Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet, 364 . pp. 347-354.

Anand, I., McMurray, J., Whitmore, J., Warren, M., Pham, A., McCamish, M., and Burton, P. (2004) Anemia and its relationship to clinical outcome in heart failure. Circulation, 110 . pp. 149-154. (doi:10.1161/01.CIR.0000134279.79571.73)

Anavekar, N. et al. (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. New England Journal of Medicine, 351 . pp. 1285-1295. ISSN 0028-4793

Bunton, D., Petrie, M., Hillier, C., Johnston, F., and McMurray, J. (2004) The clinical relevance of adrenomedullin: a promising profile? Pharmacology and Therapeutics, 103 . pp. 179-201. (doi:10.1016/j.pharmthera.2004.07.002)

Dargie, H. et al. (2004) Impact of nicorandil in angina: subgroup analyses. Heart, 90 . pp. 1427-1430. (doi:10.1136/hrt.2003.026310)

Hogg, K., and McMurray, J. (2004) Treatment of heart failure with preserved systolic function: a review of the evidence. European Heart Journal Supplements, 6 (H). H61-H66.

Hogg, K., Swedberg, K., and McMurray, J. (2004) Heart failure with preserved left ventricular Systolic function - Epidemiology clinical characteristics and prognosis. Journal of the American College of Cardiology, 43 . pp. 317-327. (doi:10.1016/j.jacc.2003.09.046)

Hood, W., Dans, A., Guyatt, G., Jaeschke, R., and McMurray, J. (2004) Digitalis for treatment of congestive heart failure in patients in sinus rhythm: A systematic review and meta-analysis. Journal of Cardiac Failure, 10 . pp. 155-164. (doi:10.1016/j.cardfail.2003.12.005)

Jhund, P., Dawson, N., Davie, A., Norrie, J., O'Kane, K., and McMurray, J. (2004) 17 beta oestradiol does not attenuate the response to angiotensin I and II during long term therapy in postmenopausal women. Cardiovascular Drugs and Therapy, 18 . pp. 31-36.

Kober, L., Maggioni, A., McMurray, J., Velazquez, E., Zelenkofske, S., Zannad, F., Van de Werf, F., and Swedberg, K. (2004) Increased risk of both mortality and morbidity with prior as well as current atrial fibrillation after MI: results of VALIANT. European Heart Journal, 25 (Suppl.). p. 243.

Lopez-Sendon, J. et al. (2004) Expert consensus document on beta-adrenergic receptor blockers. European Heart Journal, 25 (15). pp. 1341-1362.

Lopez-Sendon, J. et al. (2004) Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease - The task force on ACE-inhibitors of the European Society of Cardiolgy. European Heart Journal, 25 (16). pp. 1454-1470.

Lopez-Sendon, J. et al. (2004) Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. Revista Espanola de Cardiologia, 57 (12). pp. 1213-1232.

Mann, D. et al. (2004) Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL). Circulation, 109 (13). pp. 1594-1602.

McAlister, F., Stewart, S., Ferrua, S., and Mcmurray, J. (2004) Multidisciplinary strategies for the management of heart failure patients at high risk for admission - A systematic review of randomized trials. Journal of the American College of Cardiology, 44 (4). pp. 810-819.

McMurray, J.J. (2004) Angiotensin inhibition in heart failure. Journal of the Renin-Angiotensin-Aldosterone System, 5 . S17-S22. ISSN 1470-3203

McMurray, J.J. (2004) The optimal management of heart failure - Introduction. Journal of the Renin-Angiotensin-Aldosterone System, 5 . S1-S1. ISSN 1470-3203

McMurray, J., and O'Meara, E. (2004) Treatment of heart failure with spironolactone - Trial and tribulations. New England Journal of Medicine, 351 (6). pp. 526-528. ISSN 0028-4793

McMurray, J., and Pfeffer, M. (2004) The year in heart failure. Journal of the American College of Cardiology, 44 (12). pp. 2398-2405.

McMurray, J. (2004) What are the clinical consequences of anemia in patients with chronic heart failure? Journal of Cardiac Failure, 10 . S10-S12. (doi:10.1016/j.cardfail.2004.01.001)

McMurray, J., Pfeffer, M., Swedberg, K., and Dzau, V. (2004) Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? Circulation, 110 . pp. 3281-3288. (doi:10.1161/01.CIR.0000147274.83071.68)

Meredith, P.A., Murray, L.S., and McMurray, J.J. (2004) A putative placebo comparison of the SCOPE and LIFE trials. Journal of the Renin-Angiotensin-Aldosterone System, 5 . pp. 59-63. ISSN 1470-3203

Murphy, N., McMurray, J., and MacIntyre, K. (2004) Discharge rates for suspected acute coronary syndromes - Clinical assessment tools need improving - Reply. British Medical Journal, 329 (7458). p. 173. ISSN 0959-535X

Murphy, N., MacIntyre, K., Capewell, S., Stewart, S., Pell, J., Chalmers, P., Redpath, A., Frame, S., Boyd, J., and McMurray, J. (2004) Hospital discharge rates for suspected acute coronary syndromes between 1990 and 2000: population based analysis. British Medical Journal, 328 . pp. 1413-1414. ISSN 0959-535X

Murphy, N., Simpson, C., McAlister, F., Stewart, S., MacIntyre, K., Kirkpatrick, M., Chalmers, J., Redpath, A., Capewell, S., and McMurray, J. (2004) National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland. Heart, 90 . pp. 1129-1136. (doi:10.1136/hrt.2003.029553)

O'Meara, E., Murphy, C., and McMurray, J. (2004) Anemia and heart failure. Curr Heart Fail Rep, 1 (4). pp. 176-182.

O'Meara, E., Solomon, S., McMurray, J., Pfeffer, M., Yusuf, S., Michelson, E., Granger, C., Olofsson, B., Young, J., and Swedberg, K. (2004) Effect of candesartan on New York Heart Association functional class - Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal, 25 . pp. 1920-1926. (doi:10.1016/j.ehj.2004.07.025)

Petrie, M., Hogg, K., Caruana, L., and McMurray, J. (2004) Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction? Heart, 90 . pp. 511-517. (doi:10.1136/hrt.2003.011403)

Pfeffer, M., McMurray, J., and Califf, R. (2004) Valsartan, captopril, or both in myocardial infarction - Reply. New England Journal of Medicine, 350 (9). pp. 944-945. ISSN 0028-4793

Remme, W. et al. (2004) Increasing awareness and perception of heart failure in Europe and improving care - Rationale and design of the SHAPE study. Cardiovascular Drugs and Therapy, 18 (2). pp. 153-159.

Solomon, S. et al. (2004) Effect of candesartan on cause-specific mortality in heart failure patients - The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation, 110 . pp. 2180-2183. (doi:10.1161/01.CIR.0000144474.65922.AA)

Stewart, S., Murphy, N., Walker, A., McGuire, A., and McMurray, J. (2004) Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart, 90 . pp. 286-292. (doi:10.1136/hrt.2002.008748)

Swedberg, K., and McMurray, J. (2004) Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT? European Heart Journal, 25 (5). pp. 357-358.

Velazquez, E. et al. (2004) An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. European Heart Journal, 25 . pp. 1911-1919. (doi:10.1016/j.ehj.2004.08.006)

Young, J. et al. (2004) Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction - Results of the CHARM low-left ventricular ejection fraction trials. Circulation, 110 . pp. 2618-2626. (doi:10.1161/01.CIR.0000146819.43235.A9)

2003

Dunselman, P., Hjalmarson, A., Kjekshus, J., McMurray, J., Waagstein, F., and Executive Comm, C. (2003) The statin wars. Lancet, 362 (9398). p. 1854.

Fisher, C., Al Benna, S., Kirk, A., Morton, J., and McMurray, J. (2003) Transcardiac and transpulmonary gradients in the putative new cardiovascular hormone relaxin. Heart, 89 (7). pp. 789-790.

Fisher, C., Berry, C., Blue, L., Morton, J., and McMurray, J. (2003) N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart, 89 . pp. 879-881.

Granger, C., McMurray, J., Yusuf, S., Held, P., Michelson, E., Olofsson, B., Ostergren, J., Pfeffer, M., Swedberg, K., and CHARM Investigators Comm, (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet, 362 . pp. 772-776.

McMurray, J. et al. (2003) Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) program. European Journal of Heart Failure, 5 . pp. 261-270. (doi:10.1016/S1388-9842(03)00052-7)

McMurray, J., and Hillier, C. (2003) The rise and fall of myotrophin in heart failure. Journal of the American College of Cardiology, 42 (4). pp. 726-727.

McMurray, J., Pfeffer, M., Swedberg, K., Granger, C., and Yusuf, S. (2003) The CHARM programme - Reply. Lancet, 362 (9396). pp. 1678-1679.

McMurray, J., Ostergren, J., Swedberg, K., Granger, C., Held, P., Michelson, E., Olofsson, B., Yusuf, S., Pfeffer, M., and Comm, C. (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet, 362 . pp. 767-771.

McMurray, J., and Stewart, S. (2003) The burden of heart failure. European Heart Journal Supplements, 5 . pp. 3-13.

Mcmurray, J. (2003) Effects of newly diagnosed and previously known diabetes mellitus on 1-year outcomes of acute myocardial infarction: The VALIANT Trial. Circulation, 108 (17 Sup). IV-745.

Mcmurray, J. (2003) Influence of renal function on one-year cardiovascular outcomes in the VALIANT trial. Circulation, 108 (17 Sup). IV-485.

Mcmurray, J. (2003) One-year mortality, stroke, and myocardial infarction rates remain high in the elderly despite beta-blockade plus angiotensin-converting-enzyme inhibition, angiotensin receptor blockade, or both: The VALIANT Trial. Circulation, 108 (17 Sup). IV-695.

Mcmurray, J. (2003) Relationship between left ventricular structure and function and plasma neurohormones in patients with heart failure: Results from the EARTH Trial. Circulation, 108 (17 Sup). IV-519.

Mcmurray, J. (2003) SHAPE: A Pan-European general public heart failure awareness and perception survey. Circulation, 108 (17 Sup). IV-693.

Ostergren, J., and McMurray, J.J.V. (2003) Angiotensin receptor blockers in heart failure. Journal of the Renin-Angiotensin-Aldosterone System, 4 . pp. 171-175. ISSN 1470-3203

Petrie, M., and McMurray, J. (2003) It cannot be cardiac failure because the heart is not enlarged on the chest X-ray. European Journal of Heart Failure, 5 (2). pp. 117-119.

Pfeffer, M. et al. (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. New England Journal of Medicine, 349 . pp. 1893-1906. ISSN 0028-4793

Pfeffer, M., Swedberg, K., Granger, C., Held, P., McMurray, J., Michelson, E., Olofsson, B., Ostergren, J., Yusuf, S., and Comm, C. (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet, 362 . pp. 759-766.

Senior, R., Galasko, G., McMurray, J., and Mayet, J. (2003) Screening for left ventricular dysfunction in the community: role of hand held echocardiography and brain natriuretic peptides. Heart, 89 . pp. 24-28.

Stewart, S., MacIntyre, K., Capewell, S., and McMurray, J. (2003) Heart failure and the aging population: an increasing burden in the 21st century? Heart, 89 . pp. 49-53.

Stewart, S., Murphy, N., Walker, A., McGuire, A., and McMurray, J. (2003) The current cost of angina pectoris to the National Health Service in the UK. Heart, 89 . pp. 848-853.

Velazquez, E. et al. (2003) VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context. European Journal of Heart Failure, 5 . pp. 537-544.

Yusuf, S., Pfeffer, M., Swedberg, K., Granger, C., Held, P., McMurray, J., Michelson, E., Olofsson, B., Ostergren, J., and Comm, C. (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet, 362 . pp. 777-781.

2002

Stewart, S., Hart, C. L., Hole, D. J., and McMurray, J. J.V. (2002) A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. American Journal of Medicine , 113 (5). pp. 359-364. ISSN 0002-9343 (doi:10.1016/S0002-9343(02)01236-6)

Berry, C., and McMurray, J. (2002) Editorial comment - Amlodipine for all undergoing PCI? The evidence is unconvincing. International Journal of Cardiology, 84 (1). pp. 30-32.

Berry, C., and Mcmurray, J. (2002) CHF: a GP guide to management. Practitioner, 246 (1639). 669-72, 675.

Berry, C., Davie, A., Mcmurray, J., and Schmitz, G. (2002) Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease. HMG-COA Reductase Inhibitors . pp. 135-147.

Byrne, J., Murdoch, D., Morrison, C., and McMurray, J. (2002) An audit of activity and outcome from a daily and a weekly "one stop" rapid assessment chest pain clinic. Postgraduate Medical Journal, 78 . pp. 43-46.

Byrne, J., Murdoch, D., Morrison, C., and McMurray, J. (2002) An audit of activity and outcome from a daily and a weekly 'one stop' rapid assessment chest pain clinic. Postgraduate Medical Journal, 78 (915). pp. 43-46.

Davie, A., and McMurray, J. (2002) Cost-effectiveness of invasive strategy in unstable coronary disease - what are we waiting for? European Heart Journal, 23 (1). pp. 1-3.

Davie, A., and McMurray, J. (2002) Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor. British Journal of Clinical Pharmacology, 53 . pp. 37-42.

De Vito, G., Galloway, S., Nimmo, M., Maas, P., and McMurray, J. (2002) Effects of central sympathetic inhibition on heart rate variability during steady-state exercise in healthy humans. Clinical Physiology and Functional Imaging, 22 . pp. 32-38.

Fisher, C., MacLean, M., Morecroft, I., Seed, A., Johnston, F., Hillier, C., and McMurray, J. (2002) Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation, 106 . pp. 292-295. (doi:10.1161/01.CIR.0000025630.05387.45)

Fisher, C., and McMurray, J. (2002) Current management of heart failure. Practitioner, 246 (1635). pp. 438-443.

Krum, H., and McMurray, J. (2002) Statins and chronic heart failure: Do we need a large-scale outcome trial? Journal of the American College of Cardiology, 39 . pp. 1567-1573.

McMurray, J., and Pfeffer, M. (2002) New therapeutic options in congestive heart failure - Part II. Circulation, 105 . pp. 2223-2228. (doi:10.1161/01.CIR.0000014771.38666.22)

McMurray, J., and Pfeffer, M. (2002) New therapeutic options in congestive heart failure: Part I. Circulation, 105 . pp. 2099-2106. (doi:10.1161/01.CIR.0000014763.63528.9D)

McMurray, J.J. (2002) Heart failure in 10 years time: Focus on pharmacological treatment. Heart (London), 88 (Supple). ii40-ii46.

McMurray, J., and Davie, A. (2002) Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation, 106 (20). E147-E147.

McMurray, J., Struthers, A., and Mcmurray, J. (2002) The role of the specialist nurse - Question and answer session. Heart, 88 . p. 35.

Packer, M., Califf, R., Konstam, M., Krum, H., McMurray, J., Rouleau, J., Swedberg, K., and Grp, O. (2002) Comparison of omapatrilat chronic and enalapril in patients with heart failure - The omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE). Circulation, 106 . pp. 920-926. (doi:10.1161/01.CIR.0000029801.86489.50)

Pell, J. P., MacIntyre, K., Walsh, D., Capewell, S., McMurray, J.J., Chalmers, J.W., Boyd, J.H., Finlayson, A.R., Stewart, S., and Redpath, A.D. (2002) Time trends in survival and readmission following coronary artery bypass grafting in Scotland, 1981-96: retrospective observational study. British Medical Journal, 324 . pp. 201-202. ISSN 0959-535X (doi:10.1136/bmj.324.7331.201)

Petrie, M., Caruana, L., Berry, C., and McMurray, J. (2002) 'Diastolic heart failure' or heart failure caused by subtle left ventricular systolic dysfunction? Heart, 87 (1). pp. 29-31.

Petrie, M., Caruana, L., Berry, C., and McMurray, J. (2002) "Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? Heart, 87 . pp. 29-31.

Pfeffer, M., and McMurray, J. (2002) Myocardial infarct - No one size fits all. Circulation, 105 (22). pp. 2577-2579.

Seed, A., Hillier, C., Berry, C., Johnston, F., Brown, A., Petrie, M., and McMurray, J. (2002) Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition. Clinical Science, 103 (1). 13P. ISSN 0143-5221

Seed, A., Hillier, C., Berry, C., Johnston, F., Petrie, M., and McMurray, J. (2002) Evidence that a novel orally active NEP/ECE inhibitor blocks the vasoconstrictor response to big endothelin in human resistance arteries. Clinical Science , 103 (1). 14P.

Stewart, S., Blue, L., Walker, A., Morrison, C., and McMurray, J. (2002) An economic analysis of specialist heart failure nurse management in the UK - Can we afford not to implement it? European Heart Journal, 23 . pp. 1369-1378. (doi:10.1053/euhj.2001.3114)

Stewart, S., Demers, C., Murdoch, D., McIntyre, K., MacLeod, M., Kendrick, S., Capewell, S., and McMurray, J. (2002) Substantial between-hospital variation in outcome following first emergency admission for heart failure. European Heart Journal, 23 . pp. 650-657. (doi:10.1053/euhj.2001.2890)

Stewart, S., Jenkins, A., Buchan, S., McGuire, A., Capewell, S., and McMurray, J. (2002) The current cost of heart failure to the National Health Service in the UK. European Journal of Heart Failure, 4 . pp. 361-371.

Stewart, S., MacIntyre, K., Chalmers, J., Boyd, J., Finlayson, A., Redpath, A., Pell, J., Capewell, S., and McMurray, J. (2002) Trends in case-fatality in 22,968 patients admitted for the first time with atrial fibrillation in Scotland, 1986-1995. International Journal of Cardiology, 82 . pp. 229-236.

Stewart, S., McIntyre, K., Capewell, S., and McMurray, J. (2002) Heart failure in a cold climate - Seasonal variation in heart failure-related morbidity and mortality. Journal of the American College of Cardiology, 39 . pp. 760-766.

Stewart, S., and McMurray, J. (2002) Palliative care for heart failure - Time to move beyond treating and curing to improving the end of life. British Medical Journal, 325 (7370). pp. 915-916. ISSN 0959-535X

2001

Berry, C., and McMurray, J. (2001) Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone. American Journal of Medicine , 111 (7). p. 587. ISSN 0002-9343 (doi:10.1016/S0002-9343(01)00927-5)

Stewart, S., Hart, C.L., Hole, D.J., and McMurray, J.J.V. (2001) Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart, 86 (5). pp. 516-521. ISSN 1355-6037 (doi:10.1136/heart.86.5.516)

Bacquet, P. et al. (2001) Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II). European Heart Journal, 22 . pp. 1021-1031.

Berry, C., Anderson, N., Kirk, A., Dominiczak, A., and McMurray, J. (2001) Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease. Heart, 86 (2). pp. 217-220.

Berry, C., Brosnan, M., Alexander, M., Hamilton, C., McMurray, J., and Dominiczak, A.F. (2001) Mechanisms of oxidative free radical generation in human arteries. Clinical Science , 101 (2). 7P.

Berry, C., and McMurray, J. (2001) Serious adverse events experienced by patients with chronic heart failure taking spironolactone. Heart, 85 (4). E8.

Berry, C., and McMurray, J. (2001) Undertreatment of heart failure has high cost to patients. British Medical Journal, 322 (7288). pp. 731-732. ISSN 0959-535X

Berry, C., Murdoch, D., and McMurray, J. (2001) Economics of chronic heart failure. European Journal of Heart Failure, 3 . pp. 283-291.

Berry, C., Norrie, J., and McMurray, J. (2001) Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2. American Journal of Cardiology, 87 (5). pp. 606-607.

Berry, C., Stewart, S., Payne, E., McArthur, J., and McMurray, J. (2001) Electrical cardioversion for atrial fibrillation: outcomes in 'real-life' clinical practice. International Journal of Cardiology, 81 . pp. 29-35.

Blue, L. et al. (2001) Randomised controlled trial of specialist nurse intervention in heart failure. British Medical Journal, 323 . pp. 715-718. ISSN 0959-535X (doi:10.1136/bmj.323.7315.715)

Capewell, S., MacIntyre, K., Stewart, S., Chalmers, J., Boyd, J., Finlayson, A., Redpath, A., Pell, J., and McMurray, J. (2001) Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study. Lancet, 358 . pp. 1213-1217.

Caruana, L., Petrie, M., McMurray, J., and MacFarlane, N. (2001) Altered diaphragm position and function in patients with chronic heart failure. European Journal of Heart Failure, 3 . pp. 183-187.

Coats, P., Johnston, F., MacDonald, J., McMurray, J., and Hillier, C. (2001) Signalling mechanisms underlying the myogenic response in human subcutaneous resistance arteries. Cardiovascular Research, 49 . pp. 828-837.

Coats, P., Johnston, F., MacDonald, J., McMurray, J., and Hillier, C. (2001) Endothelium-derived hyperpolarizing factor - Identification and mechanisms of action in human subcutaneous resistance arteries. Circulation, 103 . pp. 1702-1708.

Davie, A.P., Rumley, A., Lowe, G.D.O., and McMurray, J.J.V. (2001) Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure. Thrombosis and Haemostasis, 86 (6). pp. 1585-1586. ISSN 0340-6245

Fisher, C., Johnston, F., Hillier, C., and McMurray, J. (2001) Relaxin, a newly described cardiac hormone, is a more potent vasodilator than atrial natriuretic factor in human resistance arteries. Circulation, 104 (17 Sup). II.

Hillier, C., Berry, C., Petrie, M., O'Dwyer, P., Hamilton, C., Brown, A., and McMurray, J. (2001) Effects of urotensin II in human arteries and veins of varying caliber. Circulation, 103 . pp. 1378-1381.

Hillier, C., Petrie, M.C., Love, M.P., Johnston, F., MacLean, M.R., and McMurray, J.J.V. (2001) Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure. Clinical Science, 101 . pp. 45-51.

Jhund, P., Davie, A., and McMurray, J. (2001) Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. Journal of the American College of Cardiology, 37 . pp. 1234-1238.

Jhund, P., Dawson, N., Davie, A., Sattar, N., Norrie, J., O'Kane, K., and McMurray, J. (2001) Attenuation of endothelin-1 induced vasoconstriction by 17 beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease. Journal of the American College of Cardiology, 37 . pp. 1367-1373.

Love, M., and McMurray, J. (2001) Endothelin receptor antagonists and cardiovascular diseases of aging. Drugs and Aging, 18 (6). pp. 425-440.

Luscher, T., Ruschitzka, F., Anand, I., Konstam, M., Mcmurray, J., Notter, T., and Cohn, J. (2001) EARTH: EndothelinA receptor antagonist trial in heart failure. Rationale and design. Heartdrug, 1 (6). pp. 294-298.

MacIntyre, K., Stewart, S., Capewell, S., Chalmers, J., Pell, J., Boyd, J., Finlayson, A., Redpath, A., Gilmour, H., and McMurray, J. (2001) Gender and survival: A population-based study of 201,114 men and women following a first acute myocardial infarction. Journal of the American College of Cardiology, 38 . pp. 729-735.

MacIntyre, K., Stewart, S., Chalmers, J., Pell, J., Finlays, A., Boyd, J., Redpath, A., McMurray, J., and Capewell, S. (2001) Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis. British Medical Journal, 322 . pp. 1152-1153. ISSN 0959-535X (doi:10.1136/bmj.322.7295.1152)

McDonagh, T., Cunningham, A., Morrison, C., McMurray, J., Ford, I., Morton, J., and Dargie, H. (2001) Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart, 86 . pp. 21-26.

McDonald, J., Petrie, M., Padmanabhan, N., Hillier, C., Connell, J., and McMurray, J. (2001) Non-ace mediated angiotensin II production. Clinical Science , 100 (2). 8P.

McDonald, J., Padmanabhan, N., Petrie, M., Hillier, C., Connell, J., and McMurray, J. (2001) Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(D)(11)-Ala(12)] angiotensin I in human dorsal hand veins - In vivo demonstration of non-ACE production of angiotensin II in humans. Circulation, 104 . pp. 1805-1808.

McMurray, J.J.V. (2001) Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT? Journal of the Renin-Angiotensin-Aldosterone System, 2 . pp. 89-92. ISSN 1470-3203

McMurray, J. (2001) Reduced costs with bisoprolol treatment for heart failure: An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II). European Heart Journal, 22 (12). pp. 1021-1031.

McMurray, J. (2001) What is suspected heart failure with preserved left ventricular systolic function? Reply. British Medical Journal, 322 (7280). p. 239. ISSN 0959-535X

McMurray, J. (2001) Heart failure - Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction. Heart, 86 . pp. 97-103.

Mcmurray, J. (2001) Carvedilol reduces supraventricular and ventricular arrhythmias after myocardial infarction: Evidence from the CAPRICORN study. Circulation, 104 (17 Sup). II.

Mcmurray, J. (2001) Endothelium-derived hyperpolarizing factor in human pressurised small subcutaneous resistance arteries may be a product of phospholipase A2 and cytochrome P450 metabolism. British Journal of Pharmacology, 133 (Procee). 67P.

Mcmurray, J. (2001) An economic analysis of specialist heart failure nurse management in the UK: Can we afford not to implement it? Circulation, 104 (17 Sup). II.

Mcmurray, J. (2001) The incidence and natural history of heart failure during 20-year follow-up of 15,406 men and women: The Renfrew/Paisley Study. Circulation, 104 (17 Sup). II.

Mcmurray, J., Cohen-Solal, A., Dietz, R., Eichhorn, E., Erhardt, L., Hobbs, R., Maggioni, A., Pina, I., Soler-Soler, J., and Swedberg, K. (2001) Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. European Journal of Heart Failure, 3 (4). pp. 495-502.

Morris, S., McMurray, J., Spiers, A., and Jardine, A. (2001) Impaired endothelial function in isolated human uremic resistance arteries. Kidney International, 60 . pp. 1077-1082. ISSN 0085-2538

Murdoch, D., McDonagh, T., Farmer, R., Morton, J., McMurray, J., and Dargie, H. (2001) ADEPT: Addition of the AT(1) receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: Hemodynamic and neurohormonal effects. American Heart Journal, 141 . pp. 800-807. (doi:10.1067/mhj.2001.114802)

Petrie, M., and McMurray, J. (2001) Changes in notions about heart failure. Lancet, 358 (9280). pp. 432-434.

Petrie, M., Berry, C., Stewart, S., and McMurray, J. (2001) Failing ageing hearts. European Heart Journal, 22 . pp. 1978-1990. (doi:10.1053/euhj.2000.2558)

Petrie, M., Hillier, C., Johnston, F., and McMurray, J. (2001) Effect of neutral endopeptidase inhibition on the actions of adrenomedullin and endothelin-1 in resistance arteries from patients with chronic heart failure. Hypertension, 38 . pp. 412-416.

Petrie, M., McDonald, J., Hillier, C., Morton, J., and McMurray, J. (2001) Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans. British Journal of Clinical Pharmacology, 52 (2). pp. 165-168. ISSN 0306-5251 (doi:10.1046/j.0306-5251.2001.01428.x)

Petrie, M., Padmanabhan, N., McDonald, J., Hillier, C., Connell, J., and McMurray, J. (2001) Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. Journal of the American College of Cardiology, 37 (4). pp. 1056-1061. ISSN 0735-1097 (doi:10.1016/S0735-1097(01)01111-1)

Seed, A., and McMurray, J. (2001) Acute endothelin A receptor blockade in heart failure. Circulation, 103 (18). E94-E94. ISSN 0009-7322

Seed, A., Love, M.P., and McMurray, J.J. (2001) Clinical experience with endothelin receptor antagonists in chronic heart failure. Heart Failure Reviews, 6 (4). pp. 317-323. ISSN 1382-4147 (doi:10.1023/A:1011408425878)

Stewart, S., Blue, L., Capewell, S., Horowitz, J.D., and McMurray, J.J. (2001) Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure. European Journal of Heart Failure, 3 (2). pp. 249-255. ISSN 1388-9842 (doi:10.1016/S1388-9842(00)00144-6)

Stewart, S., MacIntyre, K., Hole, D.J., Capewell, S., and McMurray, J.J.V. (2001) More 'malignant' than cancer? Five-year survival following a first admission for heart failure. European Journal of Heart Failure, 3 (3). pp. 315-322. ISSN 1388-9842 (doi:10.1016/S1388-9842(00)00141-0)

Stewart, S., MacIntyre, K., MacLeod, M.M.C., Bailey, A.E.M., Capewell, S., and McMurray, J.J.V. (2001) Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. European Heart Journal, 22 (8). pp. 693-701. ISSN 0195-668X (doi:10.1053/euhj.2000.2511)

Stewart, S., MacIntyre, K., MacLeod, M.M.C., Bailey, A.E.M., Capewell, S., and McMurray, J.J.V. (2001) Trends in hospitalization for heart failure in Scotland, 1990-1996 - An epidemic that has reached its peak? European Heart Journal, 22 (3). pp. 209-217. ISSN 0195-668X (doi:10.1053/euhj.2000.2291)

2000

Capewell, S., Livingston, B.M., MacIntyre, K., Chalmers, J.W.T., Boyd, J., Finlayson, A., Redpath, A., Pell, J.P., Evans, C.J., and McMurray, J.J.V. (2000) Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in Scotland. European Heart Journal, 21 (22). pp. 1833-1840. ISSN 0195-668X (doi:10.1053/euhj.2000.2318)

Caruana, L., Petrie, M.C., Davie, A.P., and McMurray, J. (2000) Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. British Medical Journal, 321 . pp. 215-218. ISSN 0959-535X (doi:10.1136/bmj.321.7255.215)

1998

McDonagh, T., Robb, S.D., Murdoch, D.R., Morton, J.J., Ford, I., Morrison, C.E., Tunstall-Pedoe, H., McMurray, J., and Dargie, H. (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet, 351 (9095). pp. 9-13. ISSN 0140-6736 (doi:10.1016/S0140-6736(97)03034-1)

1997

Caro, J., Klittoch, W., McGuire, A., Ford, I., Norrie, J., Pettitt, D., McMurray, J., and Shepherd, J. (1997) The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. British Medical Journal, 315 . pp. 1577-1582. ISSN 0959-535X (doi:10.1136/bmj.315.7122.1577)

McDonagh, T.A., Morrison, C.E., Lawrence, A., Ford, I., Tunstall-Pedoe, H., McMurray, J.J.V., and Dargie, H.J. (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet, 350 (9081). pp. 829-833. ISSN 0140-6736 (doi:10.1016/S0140-6736(97)03033-X)

This list was generated on Fri Oct 31 15:22:29 2014 GMT.
Number of items: 530.

Article

Damman, K., Perez, A. C., Anand, I. S., Komajda, M., McKelvie, R. S., Zile, M. R., Massie, B., Carson, P. E., and McMurray, J. J.V. (2014) Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment. Journal of the American College of Cardiology, 64 (11). pp. 1106-1113. ISSN 0735-1097 (doi:10.1016/j.jacc.2014.01.087)

Bello, N. A., Claggett, B., Desai, A. S., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Pfeffer, M. A., and Solomon, S. D. (2014) Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circulation: Heart Failure, 7 (4). pp. 590-595. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.113.001281)

Böhm, M. et al. (2014) Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve). European Journal of Heart Failure, 16 (7). pp. 778-787. ISSN 1388-9842 (doi:10.1002/ejhf.85)

Campbell, R. T., and McMurray, J. J.V. (2014) Comorbidities and differential diagnosis in heart failure with preserved ejection fraction. Heart Failure Clinics, 10 (3). pp. 481-501. ISSN 1551-7136 (doi:10.1016/j.hfc.2014.04.009)

Holman, R. R. et al. (2014) Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial. American Heart Journal, 168 (1). 23-29.e2. ISSN 0002-8703 (doi:10.1016/j.ahj.2014.03.021)

McMurray, J. J. V. et al. (2014) Baseline characteristics and treatment of patients in prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). European Journal of Heart Failure, 16 (7). pp. 817-825. ISSN 1388-9842 (doi:10.1002/ejhf.115)

Jhund, P. S. et al. (2014) Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial. European Journal of Heart Failure, 16 (6). pp. 671-677. ISSN 1388-9842 (doi:10.1002/ejhf.76)

Kalogeropoulos, A. P. et al. (2014) High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. Journal of Cardiac Failure, 20 (5). pp. 319-326. ISSN 1071-9164 (doi:10.1016/j.cardfail.2014.02.002)

Sliwa, K. et al. (2014) EURObservational research programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. European Journal of Heart Failure, 16 (5). pp. 583-591. ISSN 1388-9842 (doi:10.1002/ejhf.68)

Perez-Moreno, A. C. et al. (2014) Fatique as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC: Heart Failure, 2 (2). pp. 187-197. ISSN 0735-1097 (doi:10.1016/j.jchf.2014.01.001)

Preiss, D., Lloyd, S.M., Ford, I., McMurray, J.J.V., Holman, R.R., Welsh, P., Fisher, M., Packard, C.J., and Sattar, N. (2014) Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. Lancet Diabetes and Endocrinology, 2 (2). pp. 116-124. ISSN 2213-8587 (doi:10.1016/S2213-8587(13)70152-9)

Calvo, G. et al. (2014) Large streamlined trials in cardiovascular disease. European Heart Journal, 35 (9). pp. 544-548. ISSN 0195-668X (doi:10.1093/eurheartj/eht535)

Hood, Jr., W. B., Dans, A. L., Guyatt, G. H., Jaeschke, R., and McMurray, J. J. (2014) Digitalis for treatment of heart failure in patients in sinus rhythm. Cochrane Database of Systematic Reviews, 2014 (4). CD002901. ISSN 1469-493X (doi:10.1002/14651858.CD002901.pub3)

MacDonald, T. M. et al. (2014) Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia. BMJ Open, 4 (7). e005354. ISSN 2044-6055 (doi:10.1136/bmjopen-2014-005354)

Wallentin, L. et al. (2014) Response to letter regarding article, "Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation". Circulation, 129 (2). e21-e22. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.113.005709)

Wong, C.M. et al. (2013) Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme. Journal of the American College of Cardiology, 62 (20). pp. 1845-1854. ISSN 0735-1097 (doi:10.1016/j.jacc.2013.05.072)

Zannad, F. et al. (2013) Clinical outcome endpoints in heart failure trials: a European society of cardiology heart failure association consensus document. European Journal of Heart Failure, 15 (10). pp. 1082-1094. ISSN 1388-9842 (doi:10.1093/eurjhf/hft095)

Inglis, S.C. et al. (2013) Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT. International Journal of Cardiology, 168 (2). pp. 1094-1101. ISSN 0167-5273 (doi:10.1016/j.ijcard.2012.11.033)

Ball, J., Carrington, M.J., McMurray, J.J.V., and Stewart, S. (2013) Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. International Journal of Cardiology, 167 (5). pp. 1807-1824. ISSN 0167-5273 (doi:10.1016/j.ijcard.2012.12.093)

McMurray, J.J.V. et al. (2013) Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). European Journal of Heart Failure, 15 (9). pp. 1062-1073. ISSN 1388-9842 (doi:10.1093/eurjhf/hft052)

Weir, R. A.P. et al. (2013) Response to letter regarding article, "Galectin-3 and cardiac function in survivors of acute myocardial infarction". Circulation: Heart Failure, 6 (4). e58. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.113.000382)

Verheugt, F.W.A. et al. (2013) Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy. European Heart Journal, 34 (22). pp. 1621-1629. ISSN 0195-668X (doi:10.1093/eurheartj/eht013)

Hijazi, Z. et al. (2013) N-terminal Pro–B-Type natriuretic peptide for risk assessment in patients with atrial fibrillation. Journal of the American College of Cardiology, 61 (22). pp. 2274-2284. ISSN 0735-1097 (doi:10.1016/j.jacc.2012.11.082)

Weir, R. A.P. et al. (2013) Galectin-3 and cardiac function in survivors of acute myocardial infarction. Circulation: Heart Failure, 6 (3). pp. 492-498. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.112.000146)

Pocock, S.J. et al. (2013) Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. European Heart Journal, 34 (19). pp. 1404-1413. ISSN 0195-668X (doi:10.1093/eurheartj/ehs337)

Perez, A.C., Jhund, P., Preiss, D., Kjekshus, J., and McMurray, J.J.V. (2013) Effect of rosuvastatin on fatigue in patients with heart failure. Journal of the American College of Cardiology, 61 (10). pp. 1121-1122. ISSN 0735-1097 (doi:10.1016/j.jacc.2012.12.004)

McMurray, J.J.V. et al. (2013) Baseline characteristics of patients in the reduction of events with darbepoetin alfa in heart failure trial (RED-HF). European Journal of Heart Failure, 15 (3). pp. 334-341. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs204)

Swedberg, K. et al. (2013) Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure. New England Journal of Medicine, 368 (13). pp. 1210-1219. ISSN 0028-4793 (doi:10.1056/NEJMoa1214865)

Skali, H. et al. (2013) Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (trial to reduce cardiovascular events with aranesp therapy) placebo arm. American Journal of Kidney Diseases, 61 (2). pp. 238-246. ISSN 0272-6386 (doi:10.1053/j.ajkd.2012.08.043)

van Veldhuisen, D.J., and McMurray, J.J.V. (2013) Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel? European Journal of Heart Failure, 15 (1). pp. 5-8. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs194)

Inglis, S.C., Lewsey, J.D., Lowe, G.D.O., Jhund, P., Gillies, M., Stewart, S., Capewell, S., MacIntyre, K., and McMurray, J.J.V. (2013) Angina and intermittent claudication in 7403 participants of the 2003 Scottish Health Survey: impact on general and mental health, quality of life and five-year mortality. International Journal of Cardiology, 167 (5). pp. 2149-2155. ISSN 0167-5273 (doi:10.1016/j.ijcard.2012.05.099)

Jackson, C.E. et al. (2013) Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure. European Journal of Heart Failure, 15 (11). pp. 1253-1261. ISSN 1388-9842 (doi:10.1093/eurjhf/hft085)

Jackson, C.E. et al. (2013) Feasibility/eligibility of T-wave alternans testing in patients with heart failure: should we rethink our current modus operandi?: reply. European Journal of Heart Failure, 14 (6). pp. 676-677. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs050)

Jankowska, E.A. et al. (2013) Iron status in patients with chronic heart failure. European Heart Journal, 34 (11). pp. 827-834. ISSN 0195-668X (doi:10.1093/eurheartj/ehs377)

MacDonald, M.R., McMurray, J.J.V., and Petrie, M.C. (2013) Letter by MacDonald et al regarding article, "catheter ablation of atrial fibrillation". Circulation, 127 (4). e433-e433. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.112.137604)

McMurray, J.J.V. et al. (2013) Left Ventricular Systolic Dysfunction, Heart Failure, and the Risk of Stroke and Systemic Embolism in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial. Circulation: Heart Failure, 6 (3). pp. 451-460. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.112.000143)

McMurray, J.J.V. et al. (2013) Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). European Journal of Heart Failure, 15 (9). pp. 1062-1073. ISSN 1388-9842 (doi:10.1093/eurjhf/hft052)

Poppe, K.K. et al. (2013) Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report. European Journal of Heart Failure, 15 (11). pp. 1220-1227. ISSN 1388-9842 (doi:10.1093/eurjhf/hft101)

Preiss, D. et al. (2013) Predictors of stroke in patients with impaired glucose tolerance: results from the nateglinide and valsartan in impaired glucose tolerance outcomes research trial. Stroke, 44 (9). pp. 2590-2593. ISSN 0039-2499 (doi:10.1161/STROKEAHA.113.001177)

Yancy, C.W., and McMurray, J.J.V. (2013) ECG — still the best for selecting patients for CRT. New England Journal of Medicine, 369 . pp. 1463-1464. ISSN 0028-4793 (doi:10.1056/NEJMe1310406)

Campbell, R.T., Jhund, P.S., Castagno, D., Hawkins, N.M., Petrie, M.C., and McMurray, J.J.V. (2012) What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-Preserved, and I-PRESERVE? Journal of the American College of Cardiology, 60 (23). pp. 2349-2356. ISSN 0735-1097 (doi:10.1016/j.jacc.2012.04.064)

Gullestad, L., Ueland, T., Kjekshus, J., Nymo, S.H., Hulthe, J., Muntendam, P., McMurray, J.J.V., Wikstrand, J., and Aukrust, P. (2012) The predictive value of galectin-3 for mortality and cardiovascular events in the controlled rosuvastatin multinational trial in heart failure (CORONA). American Heart Journal, 164 (6). pp. 878-883. ISSN 0002-8703 (doi:10.1016/j.ahj.2012.08.021)

Preiss, D. et al. (2012) Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the nateglinide and valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial. BMJ Open, 2 (6). e001925. ISSN 2044-6055 (doi:10.1136/bmjopen-2012-001925)

Schwartz, G.G. et al. (2012) Effects of dalcetrapib in patients with a recent acute coronary syndrome. New England Journal of Medicine, 367 (22). pp. 2089-2099. ISSN 0028-4793 (doi:10.1056/NEJMoa1206797)

Felker, G.M. et al. (2012) Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study. European Journal of Heart Failure, 14 (11). pp. 1257-1264. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs110)

Lopes, R.D. et al. (2012) Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet, 380 (9855). pp. 1749-1758. ISSN 0140-6736 (doi:10.1016/S0140-6736(12)60986-6)

Pettit, S.J., Jhund, P.S., Hawkins, N.M., Gardner, R.S., Haj-Yahia, S., McMurray, J.J.V., and Petrie, M.C. (2012) How small is too small? A systematic review of center volume and outcome after cardiac transplantation. Circulation: Cardiovascular Quality and Outcomes, 5 (6). pp. 783-790. ISSN 1941-7713 (doi:10.1161/CIRCOUTCOMES.112.966630)

McMurray, J.J.V., Haffner, S.M., Califf, R.M., and Holman, R.R. (2012) Prediabetes and the risk of diabetes. Lancet, 380 (9849). pp. 1225-1226. ISSN 0140-6736 (doi:10.1016/S0140-6736(12)61706-1)

Weir, R. A.P., Miller, A. M., Petrie, C. J., Clements, S., Steedman, T., Dargie, H. J., Squire, I. B., Ng, L. L., McInnes, I. B., and McMurray, J. J.V. (2012) Interleukin-21 – a biomarker of importance in predicting myocardial function following acute infarction? Cytokine, 60 (1). pp. 220-225. ISSN 1043-4666 (doi:10.1016/j.cyto.2012.06.002)

McMurray, J.J.V., Califf, R.M., Bethel, A.M., Haffner, S.M., and Holman, R.R. (2012) Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study. Journal of Clinical Hypertension, 14 (10). p. 731. ISSN 1524-6175 (doi:10.1111/j.1751-7176.2012.00687.x)

Seed, A., Kuc, R.E., Maguire, J.J., Hillier, C., Johnston, F., Essers, H., de Voogd, H.J., McMurray, J.J.V., and Davenport, A.P. (2012) The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans. Life Sciences, 91 (13-14). pp. 743-748. ISSN 0024-3205 (doi:10.1016/j.lfs.2012.03.022)

Solomon, S.D. et al. (2012) The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. Lancet, 380 (9851). pp. 1387-1395. ISSN 0140-6736 (doi:10.1016/S0140-6736(12)61227-6)

Gullestad, L. et al. (2012) Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). European Heart Journal, 33 (18). pp. 2290-2296. ISSN 0195-668X (doi:10.1093/eurheartj/ehs077)

Preiss, D. et al. (2012) Lipid-modifying therapies and risk of pancreatitis: a meta-analysis. JAMA: Journal of the American Medical Association, 308 (8). pp. 804-811. ISSN 0098-7484 (doi:10.1001/jama.2012.8439)

Welsh, P., and McMurray, J.J. (2012) B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway? Diabetologia, 55 (5). pp. 1240-1243. ISSN 0012-186X (doi:10.1007/s00125-012-2515-3)

Castagno, D., Petrie, M.C., Claggett, B., and McMurray, J. (2012) Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure. European Heart Journal, 33 (9). pp. 1137-1141. ISSN 0195-668X (doi:10.1093/eurheartj/ehs004)

Ezekowitz, J.A., Hernandez, A.F., O'Connor, C.M., Starling, R.C., Proulx, G., Weiss, M.H., Bakal, J.A., Califf, R.M., McMurray, J.J.V., and Armstrong, P.W. (2012) Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. Journal of the American College of Cardiology, 59 (16). pp. 1441-1448. ISSN 0735-1097 (doi:10.1016/j.jacc.2011.11.061)

MacDonald, M.R., McMurray, J.J.V., and Petrie, M.C. (2012) Catheter ablation for atrial fibrillation. New England Journal of Medicine, 366 (11). p. 1060. ISSN 0028-4793

Lowrie, R., Mair, F.S., Greenlaw, N., Forsyth, P., Jhund, P.S., McConnachie, A., Rae, B., and McMurray, J.J.V. (2012) Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. European Heart Journal, 33 (3). pp. 314-324. ISSN 0195-668X (doi:10.1093/eurheartj/ehr433)

McMurray, J.J.V. (2012) Heart failure in 2011: heart failure therapy — technology to the fore. Nature Reviews Cardiology, 9 (2). pp. 73-74. ISSN 1759-5002 (doi:10.1038/nrcardio.2011.212)

Anker, S.D., and McMurray, J.J.V. (2012) Time to move on from 'time-to-first': should all events be included in the analysis of clinical trials? European Heart Journal, 33 (22). pp. 2764-2765. ISSN 0195-668X (doi:10.1093/eurheartj/ehs277)

Broch, K. et al. (2012) Soluble ST2 is associated with adverse outcome in patients with heart failure of ischaemic aetiology. European Journal of Heart Failure, 14 (3). pp. 268-277. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs006)

Hawkins, N.M., Jhund, P.S., McMurray, J.J.M., and Capewell, S. (2012) Heart failure and socioeconomic status: accumulating evidence of inequality. European Journal of Heart Failure, 14 (2). pp. 138-146. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr168)

Jackson, C.E. et al. (2012) Microvolt T-wave alternans testing should be used to guide arrhythmic therapy in heart failure patients: reply. European Journal of Heart Failure, 14 (6). p. 678. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs077)

Jackson, C.E. et al. (2012) Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure. European Journal of Heart Failure, 14 (4). pp. 377-386. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs010)

Lam, C. S. P. et al. (2012) Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial. Circulation: Heart Failure, 5 (5). pp. 571-578. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.112.970061)

McMurray, J.J.V. (2012) Heart failure in 2011: heart failure therapy—technology to the fore. Nature Reviews Cardiology, 9 (2). pp. 73-74. ISSN 1759-5002 (doi:10.1038/nrcardio.2011.212)

McMurray, J.J.V., Abraham, W.T., Dickstein, K., Kober, L., Massie, B.M., and Krum, H. (2012) Aliskiren, ALTITUDE, and the implications for ATMOSPHERE. European Journal of Heart Failure, 14 (4). pp. 341-343. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs033)

Parving, H.-H. et al. (2012) Baseline characteristics in the Aliskiren Trial in type 2 diabetes using cardio-renal endpoints (ALTITUDE). Journal of the Renin-Angiotensin-Aldosterone System, 13 (3). pp. 387-393. ISSN 1470-3203 (doi:10.1177/1470320311434818)

Preiss, D. et al. (2012) Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure, 14 (8). pp. 909-915. ISSN 1388-9842 (doi:10.1093/eurjhf/hfs067)

Rahimi, K., Bhala, N., Kamphuisen, P., Emberson, J., Biere-Rafi, S., Krane, V., Robertson, M., Wikstrand, J., and McMurray, J.J.V. (2012) Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials. PLoS Medicine, 9 (9). e1001310. ISSN 1549-1676 (doi:10.1371/journal.pmed.1001310)

Rector, T.S., Carson, P.E., Anand, I.S., McMurray, J.J., Zile, M.R., McKelvie, R.S., Komajda, M., Kuskowski, M., and Massie, B.M. (2012) Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the Minnesota living with heart failure questionnaire in the Irbesartan in Heart Failure with Preserved Systolic Function (I-PRESERVE) trial. Circulation: Heart Failure, 5 (2). pp. 217-225. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.111.964221)

Rogers, J.K., McMurray, J.J.V., Pocock, S.J., Zannad, F., Krum, H., van Veldhuisen, D.J., Swedberg, K., Shi, H., Vincent, J., and Pitt, B. (2012) Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations. Circulation, 126 (19). pp. 2317-2323. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.112.110536)

Shah, A.M. et al. (2012) Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren. European Journal of Heart Failure, 14 (2). pp. 185-192. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr125)

Zannad, F., Gattis Stough, W., McMurray, J.J.V., Remme, W.J., Pitt, B., Borer, J.S., Geller, N.L., and Pocock, S.J. (2012) When to stop a clinical trial early for benefit: lessons learned and future approaches. Circulation: Heart Failure, 5 (2). pp. 294-302. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.111.965707)

Zannad, F. et al. (2012) Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. European Heart Journal, 33 (22). pp. 2782-2795. ISSN 0195-668X (doi:10.1093/eurheartj/ehs257)

Zile, M.R., Baicu, C.F., Gottdiener, J.S., Hetzel, S.J., McMurray, J.J., Komajda, M., McKelvie, R., Massie, B.M., and Carson, P.E. (2012) Response to letters regarding article, "Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction". Circulation, 126 (5). e64-e65. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.112.110809)

Zile, M.R., Gottdiener, J.S., Hetzel, S.J., McMurray, J.J.V., Komajda, M., McKelvie, R., Baicu, C.F., Massie, B.M., and Carson, P.E. (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation, 124 (23). pp. 2491-2501. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.110.011031)

Desai, A.S. et al. (2011) Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKd. American Journal of Kidney Diseases, 58 (5). pp. 717-728. ISSN 0272-6386 (doi:10.1053/j.ajkd.2011.05.020)

Granger, C.B. et al. (2011) Apixaban versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 365 (11). pp. 981-992. ISSN 0028-4793 (doi:10.1056/NEJMoa1107039)

Cleland, J.G.F. et al. (2011) The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. Lancet, 378 (9792). pp. 676-683. ISSN 0140-6736 (doi:10.1016/S0140-6736(11)61126-4)

Sidik, N.P., Solomon, S.D., Latini, R., Maggioni, A.P., Wright, M., Gimpelewicz, C., Pitt, B., and McMurray, J.J.V. (2011) Effect of Aliskiren in Patients with Heart Failure According to Background Dose of ACE Inhibitor: A Retrospective Analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) Trial. Cardiovascular Drugs and Therapy, 25 (4). pp. 315-321. ISSN 0920-3206 (doi:10.1007/s10557-011-6319-3)

McMurray, J., and Ponikowski, P. (2011) Heart failure: not enough pump iron? Journal of the American College of Cardiology, 58 (5). pp. 481-482. ISSN 0735-1097 (doi:10.1016/j.jacc.2011.02.066)

O'Connor, C.M. et al. (2011) Effect of nesiritide in patients with acute decompensated heart failure. New England Journal of Medicine, 365 (1). pp. 32-43. ISSN 0028-4793 (doi:10.1056/NEJMoa1100171)

Verma, A., Pfeffer, M.A., Skali, H., Rouleau, J., Maggioni, A., McMurray, J.J.V., Califf, R.M., Velazquez, E.J., and Solomon, S.D. (2011) Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction. American Heart Journal, 161 (6). pp. 1156-1162. ISSN 0002-8703 (doi:10.1016/j.ahj.2011.03.024)

Hawkins, N.M., Petrie, M.C., MacDonald, M.R., Jhund, P.S., Fabbri, L.M., Wikstrand, J., and McMurray, J.J.V. (2011) Heart failure and chronic obstructive pulmonary diseas. Journal of the American College of Cardiology, 57 (21). pp. 2127-2138. ISSN 0735-1097 (doi:10.1016/j.jacc.2011.02.020)

MacDonald, M.R. et al. (2011) Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the rosiglitazone evaluated for cardiac outcomes and regulation of glycemia in diabetes (RECORD) study. Diabetes Care, 34 (6). pp. 1394-1396. ISSN 0149-5992 (doi:10.2337/dc10-2398)

Teo, K.K. et al. (2011) Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals. The ARB Trialists Collaboration. Journal of Hypertension, 29 (4). pp. 623-635. ISSN 0263-6352 (doi:10.1097/HJH.0b013e328344a7de )

Macpherson, K.J. et al. (2011) Trends in incidence and in short term survival following a subarachnoid haemorrhage in Scotland, 1986 - 2005: a retrospective cohort study. BMC Neurology, 11 (1). p. 38. ISSN 1471-2377 (doi:10.1186/1471-2377-11-38)

Gheorghiade, M., Pang, P.S., O'Connor, C.M., Prasad, K., McMurray, J., Teerlink, J.R., Fiuzat, M., Sabbah, H., and Komajda, M. (2011) Clinical development of pharmacologic agents for acute heart failure syndromes: A proposal for a mechanistic translational phase. American Heart Journal, 161 (2). pp. 224-232. ISSN 00028703 (doi:10.1016/j.ahj.2010.10.023)

Anand, I.S. et al. (2011) Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Circulation: Heart Failure, 4 (5). pp. 569-577. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.111.962654)

Ariti, C.A., Cleland, J.G.F., Pocock, S.J., Pfeffer, M.A., Swedberg, K., Granger, C.B., McMurray, J.J.V., Michelson, E.L., Östergren, J., and Yusuf, S. (2011) Days alive and out of hospital and the patient journey in patients with heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. American Heart Journal, 162 (5). pp. 900-906. ISSN 0002-8703 (doi:10.1016/j.ahj.2011.08.003)

Castagno, D., Baird-Gunning, J., Jhund, P.S., Biondi-Zoccai, G., MacDonald, M.R., Petrie, M.C., Gaita, F., and McMurray, J.J.V. (2011) Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: Evidence from a 37,229 patient meta-analysis. American Heart Journal, 162 (5). 938-948.e2. ISSN 0002-8703 (doi:10.1016/j.ahj.2011.07.030)

Gallanagh, S. et al. (2011) Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II). Cardiovascular Drugs and Therapy, 25 (1). pp. 77-85. ISSN 0920-3206 (doi:10.1007/s10557-011-6284-x)

Jackson, C.E. et al. (2011) Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study. European Journal of Heart Failure, 13 (7). pp. 746-754. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr031)

Krum, H. et al. (2011) Relation of peripheral collagen markers to death and hospitalization in patients with heart failure and preserved ejection fraction: results of the I-PRESERVE collagen substudy. Circulation: Heart Failure, 4 (5). pp. 561-568. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.110.960716)

Lainscak, M. et al. (2011) Self-care management of heart failure practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 13 (2). pp. 115-126. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq219)

Lewis, E.F. et al. (2011) Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. Clinical Journal of the American Society of Nephrology, 6 (4). pp. 845-855. ISSN 1555-9041 (doi:10.2215/​CJN.06450710 )

Lowrie, R. et al. (2011) The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics. European Journal of Heart Failure, 13 (8). pp. 917-924. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr083)

MacDonald, M. R. et al. (2011) Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart, 97 (9). pp. 740-747. ISSN 1355-6037 (doi:10.1136/hrt.2010.207340)

McMurray, J.J.V. (2011) CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure. European Journal of Heart Failure, 13 (9). pp. 929-936. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr093)

McMurray, J.J.V. (2011) Heart failure: Acute ischemic events in HF—should we include sudden death? Nature Reviews Cardiology, 8 (4). pp. 192-193. ISSN 1759-5002 (doi:10.1038/nrcardio.2011.22)

McMurray, J.J.V. (2011) Low Coenzyme Q(10) Levels and the Outcome of Statin Treatment in Heart Failure Reply. Journal of the American College of Cardiology, 57 (14). p. 1569. ISSN 07351097 (doi:10.1016/j.jacc.2010.12.018)

McMurray, J.J.V., and Smith, G.L. (2011) Calcium handling in the failing heart and SUMO — weighing the eviden. New England Journal of Medicine . ISSN 0028-4793 (doi:10.1056/NEJMcibr1110758)

McMurray, J.J.V. et al. (2011) Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT). American Heart Journal, 162 (4). 748-755.e3. ISSN 0002-8703 (doi:10.1016/j.ahj.2011.07.016)

Milo-Cotter, O. et al. (2011) Neurohormonal activation in acute heart failure: results from VERITAs. Cardiology, 119 (2). pp. 96-105. ISSN 0008-6312 (doi:10.1159/000330409)

Pitt, B., Latini, R., Maggioni, A.P., Solomon, S.D., Smith, B.A., Wright, M., Prescott, M.F., and McMurray, J.J.V. (2011) Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study. European Journal of Heart Failure, 13 (7). pp. 755-764. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr034)

Pouleur, A.-C. et al. (2011) Response to Letter Regarding Article, "Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both". Circulation, 123 (18). e586. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.111.021600)

Preiss, D., Sattar, N., and McMurray, J.J. (2011) A systematic review of event rates in clinical trials in diabetes mellitus: The importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design. American Heart Journal, 161 (1). p. 210. ISSN 0002-8703 (doi:10.1016/j.ahj.2010.10.019)

Shah, A.M. et al. (2011) Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both. American Heart Journal, 162 (4). pp. 685-691. ISSN 0002-8703 (doi:10.1016/j.ahj.2011.07.015)

Sidik, N.P., Solomon, S.D., Latini, R., Maggioni, A.P., Wright, M., Gimpelewicz, C.R., Pitt, B., and McMurray, J.J.V. (2011) Effect of Aliskiren in Patients with Heart Failure According to Background Dose of ACE Inhibitor: A Retrospective Analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) Trial. Cardiovascular Drugs and Therapy, 25 (4). pp. 315-321. ISSN 0920-3206 (doi:10.1007/s10557-011-6319-3)

Skali, H. et al. (2011) Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with darbepoetin alfa: the trial to reduce cardiovascular events with aranesp therapy (TREAT) experience. Circulation, 124 (25). pp. 2903-2908. ISSN 0009-7322 (doi:10.1161/​CIRCULATIONAHA.111.030411)

Thune, J. J. et al. (2011) Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction. European Journal of Heart Failure, 13 (2). pp. 148-153. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq194)

Weir, R.A.P., Clements, S., Steedman, T., Dargie, H.J., McMurray, J.J.V., Squire, I.B., and Ng, L.L. (2011) Plasma TIMP-4 Predicts Left Ventricular Remodeling After Acute Myocardial Infarction. Journal of Cardiac Failure, 17 (6). pp. 465-471. ISSN 1071-9164 (doi:10.1016/j.cardfail.2011.02.002)

Weir, R.A.P., Tsorlalis, I.K., Steedman, T., Dargie, H.J., Fraser, R., McMurray, J.J.V., and Connell, J.M.C. (2011) Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction. European Journal of Heart Failure, 13 (12). pp. 1305-1313. ISSN 1388-9842 (doi:10.1093/eurjhf/hfr129)

Ye, S. et al. (2011) Circumstances and Outcomes of Sudden Unexpected Death in Patients With High-Risk Myocardial Infarction: Implications for Prevention. Circulation, 123 (23). pp. 2674-2680. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.110.990655)

Sattar, N. et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 375 (9716). pp. 735-742. ISSN 0140-6736 (doi:10.1016/S0140-6736(09)61965-6)

Preiss, D., Sattar, N., and McMurray, J.J. (2010) Event rates in trials of patients with Type 2 diabetes. JAMA: Journal of the American Medical Association, 303 (8). pp. 732-733. ISSN 0098-7484 (doi:10.1001/jama.2010.137)

McMurray, J.J. (2010) Systolic heart failure. New England Journal of Medicine, 362 (3). pp. 228-238. ISSN 0028-4793 (doi:10.1056/NEJMcp0909392)

Weir, R.A.P., Miller, A.M., Murphy, G., Clements, S., Steedman, T., Connell, J., McInnes, I., Dargie, H., and McMurray, J.J. (2010) Serum soluble ST2 a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. Journal of the American College of Cardiology, 55 (3). pp. 243-250. ISSN 0735-1097 (doi:10.1016/j.jacc.2009.08.047)

Hawkins, N.M., Jhund, P.S., Simpson, C.R., Petrie, M.C., MacDonald, M.R., Dunn, F.G., MacIntyre, K., and McMurray, J.J.V. (2010) Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. European Journal of Heart Failure, 12 (1). pp. 17-24. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp160)

Lorgelly, P.K. et al. (2010) An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial. European Journal of Heart Failure, 12 (1). pp. 66-74. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp172)

Piccini, J.P., Zhang, M., Pieper, K., Solomon, S.D., Al-Khatib, S.M., Van de Werf, F., Pfeffer, M.A., McMurray, J.J., Califf, R.M., and Velazquez, E.J. (2010) Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial. European Heart Journal, 31 (2). pp. 211-221. ISSN 0195-668X (doi:10.1093/eurheartj/ehp425)

Castagno, D. et al. (2010) Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial. European Journal of Heart Failure, 12 (6). pp. 607-616. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq038)

Chang, S. M. et al. (2010) Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure, 12 (7). pp. 738-745. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq065)

Cleland, J.G.F., McMurray, J.J.V., and Kjekshus, J. (2010) Statins and Heart Failure - Reply. Journal of the American College of Cardiology, 55 (15). p. 1646. ISSN 0735-1097 (doi:10.1016/j.jacc.2010.01.018)

Desai, A., Lewis, E., Solomon, S., McMurray, J. J. V., and Pfeffer, M. (2010) Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis. European Journal of Heart Failure, 12 (9). pp. 936-942. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq094)

Dickstein, K. et al. (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy * Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. European Journal of Heart Failure, 12 (11). pp. 1143-1153. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq192)

Dickstein, K. et al. (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy * Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace, 12 (11). pp. 1526-1536. ISSN 1099-5129 (doi:10.1093/europace/euq392)

Dickstein, K. et al. (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. European Heart Journal, 31 (21). pp. 2677-2687. ISSN 0195-668X (doi:10.1093/eurheartj/ehq337)

Felker, G. M. et al. (2010) Clinical Trials of Pharmacological Therapies in Acute Heart Failure Syndromes Lessons Learned and Directions Forward. Circulation: Heart Failure, 3 (2). pp. 314-325. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.109.893222)

Gheorghiade, M. et al. (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. European Journal of Heart Failure, 12 (5). pp. 423-433. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq045)

Hawkins, N. M. et al. (2010) Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme. European Journal of Heart Failure, 12 (6). pp. 557-565. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq040)

Hogg, K. J., and McMurray, J. J. V. (2010) HEART FAILURE Hospital-at-home care for CHF-verdict, 'not proven'. Nature Reviews Cardiology, 7 (2). pp. 63-64. ISSN 1759-5002 (doi:10.1038/nrcardio.2009.225)

Hogg, K.J., and McMurray, J.J.V. (2010) Evaluating dyspnoea in acute heart failure: progress at last! European Heart Journal, 31 (7). pp. 771-772. ISSN 0195-668X (doi:10.1093/eurheartj/ehq015)

Holman, R. R. et al. (2010) Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine, 362 (16). pp. 1463-1476. ISSN 0028-4793 (doi:10.1056/NEJMoa1001122)

Hung, C.L. et al. (2010) Longitudinal and Circumferential Strain Rate, Left Ventricular Remodeling, and Prognosis After Myocardial Infarction. Journal of the American College of Cardiology, 56 (22). pp. 1812-1822. ISSN 0735-1097 (doi:10.1016/j.jacc.2010.06.044)

Inglis, S. C. et al. (2010) Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). European Journal of Heart Failure, 12 (7). pp. 698-705. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq070)

Jankowska, E. A. et al. (2010) Iron deficiency: an ominous sign in patients with systolic chronic heart failure. European Heart Journal, 31 (15). pp. 1872-1880. ISSN 0195-668X (doi:10.1093/eurheartj/ehq158)

Komajda, M., McMurray, J. J. V., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Pocock, S. J., Curtis, P. S., Jones, N. P., and Home, P. D. (2010) Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. European Heart Journal, 31 (7). pp. 824-831. ISSN 0195-668X (doi:10.1093/eurheartj/ehp604)

Komajda, M., Carson, P. E., Hetzel, S., McKelvie, R., McMurray, J., Ptaszynska, A., Zile, M. R., DeMets, D., and Massie, B. M. (2010) Factors Associated with Outcome in Heart Failure with Preserved Ejection Fraction: Findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circulation: Heart Failure, 4 (1). pp. 27-35. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.109.932996)

Krum, H., McMurray, J. J. V., Horton, E., Gerlock, T., Holzhauer, B., Zuurman, L., Haffner, S. M., Bethel, M. A., Holman, R. R., and Califf, R. M. (2010) Baseline Characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial Population: Comparison with Other Diabetes Prevention Trials. Cardiovascular Therapeutics, 28 (2). pp. 124-132. ISSN 1755-5914 (doi:10.1111/j.1755-5922.2010.00146.x)

Krum, H. et al. (2010) Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to minimize outcomes in patients with heart failure (ATMOSPHERE)study. European Journal of Heart Failure, 13 (1). pp. 107-114. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq212)

Langhorne, P. et al. (2010) Estimating the impact of stroke unit care in a whole population: an epidemiological study using routine data. Journal of Neurology, Neurosurgery and Psychiatry, 81 (2). pp. 1301-1305. ISSN 0022-3050 (doi:10.1136/jnnp.2009.195131)

Lewsey, J. et al. (2010) Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland. BMC Medicine, 8 . p. 23. ISSN 1741-7015 (doi:10.1186/1741-7015-8-23)

Lopes, R. D. et al. (2010) Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale. American Heart Journal, 159 (3). pp. 331-339. ISSN 0002-8703 (doi:10.1016/j.ahj.2009.07.035)

MacDonald, M. R., Eurich, D. T., Majumdar, S. R., Lewsey, J. D., Bhagra, S., Jhund, P. S., Petrie, M. C., McMurray, J. J. V., Petrie, J.R., and McAlister, F. A. (2010) Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research Database. Diabetes Care, 33 (6). pp. 1213-1218. ISSN 0149-5992 (doi:10.2337/dc09-2227)

McKelvie, R.S., Komajda, M., McMurray, J., Zile, M., Ptaszynska, A., Donovan, M., Carson, P., and Massie, B.M. (2010) Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial. Journal of Cardiac Failure, 16 (2). pp. 128-134. ISSN 1071-9164 (doi:10.1016/j.cardfail.2009.09.007)

McMurray, J. J. et al. (2010) Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine, 362 (16). pp. 1477-1490. ISSN 0028-4793 (doi:10.1056/NEJMoa1001121)

McMurray, J. J. V., and Swedberg, K. (2010) HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure-lessons learnt from a decade of trials. European Journal of Heart Failure, 12 (2). pp. 99-103. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp197)

McMurray, J.J.V., Dunselman, P., Wedel, H., Cleland, J.G.F., Lindberg, M., Hjalmarson, Å., Kjekshus, J., Waagstein, F., Apetrei, E., and Barrios, V. (2010) Coenzyme Q10, Rosuvastatin, and Clinical Outcomes in Heart FailureA Pre-Specified Substudy of CORONA (Controlled Rosuvastatin Multinational Study in Heart Failure). Journal of the American College of Cardiology, 56 (15). pp. 1196-1204. ISSN 0735-1097 (doi:10.1016/j.jacc.2010.02.075)

Nilsson, K. R. et al. (2010) Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial. Heart, 96 (11). pp. 838-842. ISSN 1355-6037 (doi:10.1136/hrt.2009.180182)

Park, J.H., Balmain, S., Berry, C., Morton, J.J., and McMurray, J.J.V. (2010) Potentially detrimental cardiovascular effects of oxygen in patients with chronic left ventricular systolic dysfunction. Heart, 96 (7). pp. 533-538. ISSN 1355-6037 (doi:10.1136/hrt.2009.175257)

Pouleur, A.-C. et al. (2010) Pathogenesis of Sudden Unexpected Death in a Clinical Trial of Patients With Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. Circulation, 122 (6). pp. 597-602. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.110.940619)

Rocchiccioli, J.P., McMurray, J.J.V., and Dominiczak, A.F. (2010) Biomarkers in heart failure: a clinical review. Heart Failure Reviews, 15 (4). pp. 251-273. ISSN 1382-4147 (doi:10.1007/s10741-008-9123-9)

Shah, A. M. et al. (2010) The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. European Journal of Heart Failure, 12 (11). pp. 1229-1237. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq179)

Shamshad, F., Kenchaiah, S., Finn, P.V., Soler-Soler, J., McMurray, J.J.V., Velazquez, E.J., Maggioni, A. P., Califf, R.M., Swedberg, K., and Kober, L. (2010) Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: The VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). American Heart Journal, 160 (1). pp. 145-151. ISSN 0002-8703 (doi:10.1016/j.ahj.2010.02.037)

Sliwa, K. et al. (2010) Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy A Proof-of-Concept Pilot Study. Circulation, 121 (13). pp. 1465-1473. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.109.901496)

Sliwa, K. et al. (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure, 12 (8). pp. 767-778. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq120)

Solomon, S.D. et al. (2010) Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes. New England Journal of Medicine, 363 (12). pp. 1146-1155. ISSN 0028-4793 (doi:10.1056/NEJMoa1005109)

Thune, J. J. et al. (2010) Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarction. European Journal of Heart Failure, 13 (2). pp. 148-153. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq194)

Weir, R. A. P., Murphy, C. A., Petrie, C. J., Martin, T. N., Balmain, S., Clements, S., Steedman, T., Wagner, G. S., Dargie, H. J., and McMurray, J. J. V. (2010) Microvascular Obstruction Remains a Portent of Adverse Remodeling in Optimally Treated Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction. Circulation: Cardiovascular Imaging, 3 (4). pp. 360-367. ISSN 1941-9651 (doi:10.1161/CIRCIMAGING.109.897439)

Weir, R.A.P., Murphy, C.A., Petrie, C.J., Martin, T.N., Clements, S., Steedman, T., Wagner, G.S., McMurray, J.J.V., and Dargie, H.J. (2010) Monocyte chemoattractant protein-1: A dichotomous role in cardiac remodeling following acute myocardial infarction in man? Cytokine, 50 (2). pp. 158-162. ISSN 1043-4666 (doi:10.1016/j.cyto.2010.02.020)

Zannad, F., McMurray, J.J.V., Drexler, H., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., and Pitt, B. (2010) Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF). European Journal of Heart Failure, 12 (6). pp. 617-622. ISSN 1388-9842 (doi:10.1093/eurjhf/hfq049)

Zannad, F., McMurray, J.J.V., Krum, H., van Veldhuisen, D.J., Swedberg, K., Shi, H., Vincent, J., Pocock, S.J., and Pitt, B. (2010) Eplerenone in patients with systolic heart failure and mild symptoms. New England Journal of Medicine, 364 (1). pp. 11-21. ISSN 0028-4793 (doi:10.1056/NEJMoa1009492)

Zile, M. R. et al. (2010) Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) Trial. Circulation, 121 (12). pp. 1393-1405. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.109.909614)

Freel, E.M., Tsorlalis, I.K., Lewsey, J.D., Latini, R., Maggioni, A.P., Solomon, S., Pitt, B., Connell, J.M.C., and McMurray, J.J.V. (2009) Aldosterone status associates with insulin resistance in patients with heart failure-data from the ALOFT study. Heart, 95 (23). pp. 1920-1924. ISSN 1355-6037 (doi:10.1136/hrt.2009.173344)

Schwartz, G.G. et al. (2009) Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. American Heart Journal, 158 (6). pp. 896-901. ISSN 0002-8703 (doi:10.1016/j.ahj.2009.09.017)

Lewsey, J. et al. (2009) Age- and sex-specific trends in fatal incidence and hospitalized incidence of stroke in Scotland, 1986 to 2005. Circulation: Cardiovascular Quality and Outcomes, 2 (5). pp. 475-483. ISSN 1941-7713 (doi:10.1161/CIRCOUTCOMES.108.825968)

Berry, C., Pieper, K., White, H., Solomon, S., Van de Werf, F., Velazquez, E., Maggioni, A., Califf, R., Pfeffer, M., and McMurray, J. (2009) Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). European Heart Journal, 30 (12). pp. 1450-1456. ISSN 0195-668X (doi:10.1093/eurheartj/ehp102)

Lewsey, J.D. et al. (2009) Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005. Stroke, 40 (4). pp. 1038-1043. ISSN 0039-2499 (doi:10.1161/STROKEAHA.108.542787)

Jhund, P.S., MacIntyre, K., Simpson, C.R., Lewsey, J.D., Stewart, S., Redpath, A., Chalmers, J.W.T., Capewell, S., and McMurray, J.J.V. (2009) Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation, 119 (4). pp. 515-523. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.108.812172)

Abrahamsson, P., Dobson, J., Granger, C., McMurray, J., Michelson, E., Pfeffer, M., Pocock, S., Solomon, S., Yusuf, S., and Swedberg, K. (2009) Impact of hospitalization for acute coronary events on subsequent mortality in patients with chronic heart failure. European Heart Journal, 30 (3). pp. 338-345.

Allen, L. A., Felker, G. M., Pocock, S., McMurray, J. J.V., Pfeffer, M. A., Swedberg, K., Wang, D., Yusuf, S., Michelson, E. L., and Granger, C. B. (2009) Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. European Journal of Heart Failure, 11 (2). pp. 170-177. ISSN 1388-9842 (doi:10.1093/eurjhf/hfn031)

Califf, R., Lokhnygina, Y., Velazquez, E., McMurray, J., Leimberger, J., Lewis, E., Diaz, R., Murin, J., and Pfeffer, M. (2009) Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial). American Journal of Cardiology, 104 (2). pp. 151-157.

Cleland, J. et al. (2009) Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin A Report From CORONA (Controlled Rosuvastatin Multinational Trial in Heart. Journal of the American College of Cardiology, 54 (20). pp. 1850-1859.

Dickstein, K., and McMurray, J. (2009) Should beta-blockade continue to be withheld from patients with chronic heart failure and asthma? Reply. European Heart Journal, 30 (10). pp. 1287-1288.

Gheorghiade, M. et al. (2009) Phase III clinical trial end points in acute heart failure syndromes: A virtual roundtable with the acute heart failure syndromes international working group. American Heart Journal, 157 (6). pp. 957-970.

Granger, B. B., Ekman, I., Granger, C. B., Ostergren, J., Olofsson, B., Michelson, E., McMurray, J. J.V., Yusuf, S., Pfeffer, M. A., and Swedberg, K. (2009) Adherence to medication according to sex and age in the CHARM programme. European Journal of Heart Failure, 11 (11). pp. 1092-1098. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp142)

Hawkins, N. M., Huang, Z., Pieper, K. S., Solomon, S. D., Kober, L., Velazquez, E. J., Swedberg, K., Pfeffer, M. A., McMurray, J. J.V., and Maggioni, A. P. (2009) Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). European Journal of Heart Failure, 11 (3). pp. 292-298. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp001)

Hawkins, N.M., MacDonald, M.R., Petrie, M.C., Chalmers, G., Carter, R., Dunn, F.G., and McMurray, J.J. (2009) Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial. European Journal of Heart Failure, 11 (7). pp. 684-690. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp066)

Hawkins, N., Petrie, M., Burgess, M., and McMurray, J. (2009) Selecting Patients for Cardiac Resynchronization Therapy The Fallacy of Echocardiographic Dyssynchrony. Journal of the American College of Cardiology, 53 (21). pp. 1944-1959.

Hawkins, N., Petrie, M., Jhund, P., Chalmers, G., Dunn, F., and McMurray, J. (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. European Journal of Heart Failure, 11 (2). 130-U17.

Hawkins, N., Petrie, M., Jhund, P., Chalmers, G., Dunn, F., and McMurray, J. (2009) Heart failure and chronic obstructive pulmonary disease: lung function test interpretation: reply. European Journal of Heart Failure, 11 (6). pp. 632-633.

Hernandez, A. et al. (2009) Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). American Heart Journal, 157 (2). pp. 271-277.

Heymans, S. et al. (2009) Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 11 (2). pp. 119-129. ISSN 1388-9842 (doi:10.1093/eurjhf/hfn043)

Home, P., Pocock, S., Beck-Nielsen, H., Curtis, P., Gomis, R., Hanefeld, M., Jones, N., Komajda, M., and McMurray, J. (2009) Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet, 373 (9681). pp. 2125-2135.

Hood, W.B., Dans, A., Guyatt, G.H., Jaeschke, R., and McMurray, J.J.V. (2009) Digitalis for treatment of congestive heart failure in patients in sinus rhythm. Cochrane Database of Systematic Reviews (2). CD002901. ISSN 1469-493X (doi:10.1002/14651858.CD002901.pub2)

Jaarsma, T. et al. (2009) Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 11 (5). pp. 433-443. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp041)

Jackson, C. et al. (2009) Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet, 374 (9689). pp. 543-550. ISSN 0140-6736 (doi:10.1016/S0140-6736(09)61378-7)

Jackson, C.E., Dalzell, J.R., Bezlyak, V., Tsorlalis, I.K., Myles, R.C., Spooner, R., Ford, I., Petrie, M.C., Cobbe, S., and McMurray, J.J. (2009) Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. European Journal of Heart Failure, 11 (12). pp. 1152-1154. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp157)

MacDonald, M.R., Petrie, M.C., Fisher, M., and McMurray, J.J.V. (2009) Pharmacologic management of patients with both heart failure and diabetes. Current Heart Failure Reports, 6 (2). pp. 126-132. ISSN 1546-9530 (doi:10.1007/s11897-009-0019-3)

McMurray, J.J. et al. (2009) Effects of statin therapy according to plasma high-sensitivity c-reactive protein concentration in the controlled rosuvastatin multinational trial in heart failure (CORONA): a retrospective analysis. Circulation, 120 (22). 2188-2U51. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.109.849117)

McMurray, J.J.V., Granger, C.B., Ostergren, J., Yusuf, S., Pfeffer, M.A., and Swedberg, K. (2009) Dual Renin-Angiotensin System Blockade in Heart Failure. Journal of the American College of Cardiology, 54 (3). p. 278. ISSN 0735-1097 (doi:10.1016/j.jacc.2009.02.073 )

McMurray, J. et al. (2009) Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial. European Journal of Heart Failure, 11 (8). pp. 795-801.

McMurray, J., Jhund, P., MacIntyre, K., and Stewart, S. (2009) Heart failure in the UK. Heart, 95 (2). p. 156.

Meris, A. et al. (2009) Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo Study. European Heart Journal, 30 (1). pp. 56-65.

Moukarbel, G., Signorovitch, J., Pfeffer, M., McMurray, J., White, H., Maggioni, A., Velazquez, E., Califf, R., Scheiman, J., and Solomon, S. (2009) Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial. European Heart Journal, 30 (18). pp. 2226-2232.

Parving, H. et al. (2009) Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrology, Dialysis, Transplantation, 24 (5). pp. 1663-1671. ISSN 0931-0509

Pfeffer, M.A. et al. (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. New England Journal of Medicine, 361 (21). pp. 2019-2032. ISSN 0028-4793 (doi:10.1056/NEJMoa0907845)

Pfeffer, M.A. et al. (2009) Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). American Journal of Kidney Diseases, 54 (1). pp. 59-69. ISSN 0272-6386 (doi:10.1053/j.ajkd.2009.04.008)

Preiss, D. et al. (2009) Predictors of Development in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care, 32 (5). pp. 915-920.

Sochalski, J., Jaarsma, T., Krumholz, H., Laramee, A., McMurray, J., Naylor, M., Rich, M., Riegel, B., and Stewart, S. (2009) What Works In Chronic Care Management: The Case Of Heart Failure. Health Affairs, 28 (1). pp. 179-189.

Somaratne, J., Berry, C., McMurray, J., Poppe, K., Doughty, R., and Whalley, G. (2009) The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. European Journal of Heart Failure, 11 (9). pp. 855-862.

Stanton, T., Hawkins, N. M., Hogg, K. J., Goodfield, N. E.R., Petrie, M. C., and McMurray, J. J.V. (2009) Three-dimensional echocardiography for optimization of cardiac resynchronization therapy: reply. European Heart Journal, 30 (4). pp. 505-506. ISSN 0195-668X (doi:10.1093/eurheartj/ehp002)

Wedel, H. et al. (2009) Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. European Journal of Heart Failure, 11 (3). pp. 281-291.

Weir, R. A.P., Chong, K. S., Dalzell, J. R., Petrie, C. J., Murphy, C. A., Steedman, T., Mark, P.B., McDonagh, T. A., Dargie, H. J., and McMurray, J. J.V. (2009) Plasma apelin concentration is depressed following acute myocardial infarction in man. European Journal of Heart Failure, 11 (6). pp. 551-558. ISSN 1388-9842 (doi:10.1093/eurjhf/hfp043)

Weir, R.A.P., Mark, P.B., Petrie, C.J., Clements, S., Steedman, T., Ford, I., Ng, L.L., Squire, I.B., Wagner, G.S., and McMurray, J.J.V. (2009) Left ventricular remodeling after acute myocardial infarction: Does eplerenone have an effect? American Heart Journal, 157 (6). pp. 1088-1096. ISSN 0002-8703 (doi:10.1016/j.ahj.2009.04.001)

Weir, R., Martin, T., Petrie, C., Murphy, A., Clements, S., Steedman, T., Wagner, G., McMurray, J., and Dargie, H. (2009) Cardiac and Extracardiac Abnormalities Detected by Cardiac Magnetic Resonance in a Post-Myocardial Infarction Cohort. Cardiology, 113 (1). pp. 1-8.

Anavekar, N.S. et al. (2008) Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO study). American Journal of Cardiology, 101 (5). pp. 607-612. ISSN 0002-9149 (doi:10.1016/j.amjcard.2007.09.115)

Anavekar, N.S., Solomon, S.D., McMurray, J.J., Maggioni, A., Rouleau, J.L., Califf, R., White, H., Kober, L., Velazquez, E., and Pfeffer, M.A. (2008) Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus. American Journal of Cardiology, 101 (7). pp. 925-929. ISSN 0002-9149 (doi:10.1016/j.amjcard.2007.11.037)

Anderson, R.E. et al. (2008) High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. American Heart Journal, 155 (4). pp. 706-711. ISSN 0002-8703 (doi:10.1016/j.ahj.2007.11.016)

Berry, C., Brett, M., Stevenson, K., McMurray, J.J., and Norrie, J. (2008) Nature and prognostic importance of abnormal glucose tolerance and diabetes in acute heart failure. Heart, 94 (3). pp. 296-304. ISSN 1355-6037 (doi:10.1136/hrt.2006.110999)

Bethel, M., Holman, R., Haffner, S., Califf, R., Huntsman-Labed, A., Hua, T., and McMurray, J. (2008) Determining the most appropriate components for a composite clinical trial outcome. American Heart Journal, 156 (4). pp. 633-640. ISSN 0002-8703 (doi:10.1016/j.ahj.2008.05.018)

Califf, R., Boolell, M., Haffner, S., Bethel, M., McMurray, J., Duggal, A., and Holman, R. (2008) Prevention of diabetes and cardiovascular' disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial. American Heart Journal, 156 (4). pp. 623-632. ISSN 0002-8703 (doi:10.1016/j.ahj.2008.05.017 )

Carrington, M., Murphy, N.F., Strange, G., Peacock, A., McMurray, J.J., and Stewart, S. (2008) Prognostic impact of pulmonary arterial hypertension: A population-based analysis. International Journal of Cardiology, 124 (2). pp. 183-187. ISSN 0167-5273 (doi:10.1016/j.ijcard.2006.12.045 )

Clark, A.M., Reid, M.E., Morrison, C.E., Capewell, S., Murdoch, D.L., and McMurray, J.J. (2008) The complex nature of informal care in home-based heart failure management. Journal of Advanced Nursing, 61 (4). pp. 373-383. ISSN 0309-2402 (doi:10.1111/j.1365-2648.2007.04527.x)

Cleland, J. et al. (2008) The Selective Cardiac Myosin Activator, CK-1827452, Increases Systolic Function in a Concentration-Dependent Manner in Patients with Stable Heart Failure (10/8/08). Journal of Cardiac Failure, 14 (9). pp. 797-798. ISSN 1071-9164

Cohen-Solal, A., McMurray, J., Swedberg, K., Pfeffer, M., Puu, M., Solomon, S., Michelson, E., Yusuf, S., and Granger, C. (2008) Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity programme. European Heart Journal, 29 (24). pp. 3022-3028. ISSN 0195-668X (doi:10.1093/eurheartj/ehn476 )

Dickstein, K. et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Journal of Heart Failure, 10 (10). pp. 933-989. ISSN 1388-9842 (doi:10.1016/j.ejheart.2008.08.005)

Dickstein, K. et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal, 29 (19). pp. 2388-2442. ISSN 0195-668X (doi:10.1093/eurheartj/ehn309)

Gerstein, H. C., Swedberg, K., Carlsson, J., McMurray, J. J. V., Michelson, E. L., Olofsson, B., Pfeffer, M. A., and Yusuf, S. (2008) The Hemoglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure: An Analysis of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Archives of Internal Medicine, 168 (15). pp. 1699-1704. ISSN 0003-9926 (doi:10.1001/archinte.168.15.1699)

Jhund, P., and McMurray, J. (2008) Heart Failure After Acute Myocardial Infarction A Lost Battle in the War on Heart Failure? Circulation, 118 (20). pp. 2019-2021. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.108.813493 )

Kjekshus, J., McMurray, J.J., and Wikstrand, J. (2008) Rosuvastatin in older patients with systolic heart failure - Reply. New England Journal of Medicine, 358 (12). p. 1301. ISSN 0028-4793

Kober, L., Torp-Pedersen, C., McMurray, J.J., Gotzsche, O., Levy, S., Crijns, H., Amlie, J., Carlsen, J., and Dronedarone Study, G. (2008) Increased mortality after dronedarone therapy for severe heart failure. New England Journal of Medicine, 358 (25). pp. 2678-2687. ISSN 0028-4793 (doi:10.1056/NEJMoa0800456)

Lewis, E.F. et al. (2008) Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study. European Heart Journal, 29 (6). pp. 748-756. ISSN 0195-668X (doi:10.1093/eurheartj/ehn062)

MacDonald, M.R., Hawkins, N.M., Balmain, S., Dalzell, J., McMurray, J.J., and Petrie, M.C. (2008) Transthoracic echocardiography: a survey of current practice in the UK. QJM: An International Journal of Medicine, 101 (5). pp. 345-349. ISSN 1460-2725

MacDonald, M.R. et al. (2008) Discordant short- and long-term outcomes associated with diabetes in patients with heart failure: importance of age and sex: a population study of 5.1 million people in Scotland. Circulation: Heart Failure, 1 (4). pp. 234-241. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.108.794008)

MacDonald, M.R., Petrie, M.C., Hawkins, N.M., Petrie, J.R., Fisher, M., McKelvie, R., Aguilar, D., Krum, H., and McMurray, J.J.V. (2008) Diabetes, left ventricular systolic dysfunction, and chronic heart failure. European Heart Journal, 29 (10). pp. 1224-1240. ISSN 0195-668X (doi:10.1093/eurheartj/ehn156 )

MacDonald, M.R. et al. (2008) Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal, 29 (11). pp. 1377-1385. ISSN 0195-668X (doi:10.1093/eurheartj/ehn153)

Massie, B. et al. (2008) Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction. New England Journal of Medicine, 359 (23). pp. 2456-2467. ISSN 0028-4793

McMurray, J.J. (2008) ACE inhibitors in cardiovascular disease - Unbeatable? New England Journal of Medicine, 358 (15). pp. 1615-1616. ISSN 0028-4793 (doi:10.1056/NEJMe0801925)

McMurray, J.J.V., Pitt, B., Latini, R., Maggioni, A.P., Solomon, S.D., Keefe, D.L., Ford, J., Verma, A., and Lewsey, J. (2008) Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circulation: Heart Failure, 1 (1). pp. 17-24. ISSN 1941-3289 (doi:10.1161/CIRCHEARTFAILURE.107.740704)

McMurray, J., Carson, P., Komajda, M., McKelvie, R., Zile, M., Ptaszynska, A., Staiger, C., Donovan, J., and Massie, B. (2008) Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. European Journal of Heart Failure, 10 (2). pp. 149-156.

Meredith, P. et al. (2008) Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program. Journal of the American College of Cardiology, 52 (24). pp. 2000-2007.

Murphy, C.L., and McMurray, J.J. (2008) Approaches to the treatment of anaemia in patients with chronic heart failure. Heart Failure Reviews, 13 (4). pp. 431-438. ISSN 1382-4147

Pocock, S. J. et al. (2008) Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. European Heart Journal, 29 (21). pp. 2641-2650. ISSN 0195-668X (doi:10.1093/eurheartj/ehn420)

Prisant, L.M., Thomas, K.L., Lewis, E.F., Huang, Z., Francis, G.S., Weaver, W.D., Pfeffer, M.A., McMurray, J.J., Califf, R.M., and Velazquez, E.J. (2008) Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. Journal of the American College of Cardiology, 51 (19). pp. 1865-1871. (doi:10.1016/j.jacc.2007.12.050)

Radauceanu, A. et al. (2008) Extracellular Matrix Turnover and Inflammatory Markers Independently Predict Functional Status and Outcome in Chronic Heart Failure. Journal of Cardiac Failure, 14 (6). pp. 467-474. ISSN 1071-9164 (doi:10.1016/j.cardfail.2008.02.014)

Remme, W. J. et al. (2008) Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. European Heart Journal, 29 (14). pp. 1739-1752. ISSN 0195-668X (doi:10.1093/eurheartj/ehn196)

Rocchiccioli, J.P., and McMurray, J. (2008) Medical management of advanced heart failure. Progress in Palliative Care, 16 (5-6). pp. 229-240. ISSN 0969-9260 (doi:10.1179/096992608X346233)

Stanton, T., Hawkins, N.M., Hogg, K.J., Goodfield, N.E.R., Petrie, M.C., and McMurray, J.J.V. (2008) How should we optimize cardiac resynchronization therapy? European Heart Journal, 29 (20). pp. 2458-2472. ISSN 0195-668X (doi:10.1093/eurheartj/ehn380 )

Stewart, S., Wilkinson, D., Hansen, C., Vaghela, V., Mvungi, R., McMurray, J., and Sliwa, K. (2008) Predominance of Heart Failure in the Heart of Soweto Study Cohort Emerging Challenges for Urban African Communities. Circulation, 118 (23). pp. 2360-2367. ISSN 0009-7322 (doi:10.1161/CIRCULATIONAHA.108.786244)

Tardif, J.C. et al. (2008) Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet, 371 (9626). pp. 1761-1768. ISSN 0140-6736 (doi:10.1016/S0140-6736(08)60763-1)

Taylor, G.L., Murphy, N.F., Berry, C., Christie, J., Finlayson, A., MacIntyre, K., Morrison, C., and McMurray, J.J. (2008) Long-term outcome of low-risk patients attending a rapid-assessment chest pain clinic. Heart, 94 (5). pp. 628-632. (doi:10.1136/hrt.2007.125344)

Thomas, K.L., Al Khatib, S.M., Lokhnygina, Y., Solomon, S.D., Kober, L., McMurray, J.J., Califf, R.M., and Velazquez, E.J. (2008) Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality. American Heart Journal, 155 . pp. 87-93. (doi:10.1016/j.ahj.2007.09.010)

Thune, J.J. et al. (2008) Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction. Hypertension, 51 . pp. 48-54. ISSN 0194-911X (doi:10.1161/​HYPERTENSIONAHA.107.093682 )

Thune, J.J. et al. (2008) Response to the J-point revisited. Hypertension, 51 (5). E35-E35. ISSN 0194-911X

Torp-Pedersen, C., Kober, L., Carlsen, J.E., Akkan, D., Bruun, N.E., Dacoronias, D., Dickstein, K., Haghfelt, T., Ohlin, H., and McMurray, J.J. (2008) A randomised trial of a pre-synaptic stimulator of DA(2)-dopaminergic and alpha(2)-adrenergic receptors on morbidity and mortality in patients with heart failure. European Journal of Heart Failure, 10 . pp. 89-95. ISSN 1388-9842 (doi:10.1016/j.ejheart.2007.10.012)

Verma, A. et al. (2008) Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial InfarctionThe VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC: Cardiovascular Imaging, 1 (5). pp. 582-591. ISSN 1936878X (doi:10.1016/j.jcmg.2008.05.012)

Weir, R.A.P. et al. (2008) Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. European Journal of Heart Failure, 10 (2). pp. 157-163. ISSN 1388-9842 (doi:10.1016/j.ejheart.2007.12.006)

McMurray, J.J.V. et al. (2007) Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS Randomized controlled trials. JAMA: Journal of the American Medical Association, 298 (17). pp. 2009-2019. ISSN 0098-7484 (doi:10.1001/jama.298.17.2009)

Amigoni, M. et al. (2007) Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function. European Heart Journal, 28 . pp. 326-333. (doi:10.1093/eurheartj/ehl464)

Balmain, S., Padmanabhan, N., Ferrell, W., Morton, J., and McMurray, J. (2007) Differences in arterial compliance, microvascular function and venous capacitance between patients with heart failure and either preserved or reduced left ventricular systolic function. European Journal of Heart Failure, 9 . pp. 865-871. (doi:10.1016/j.ejheart.2007.06.003)

Berry, C., Murphy, N., De Vito, G., Galloway, S., Seed, A., Fisher, C., Sattar, N., Vallance, P., Hillis, W., and McMurray, J. (2007) Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker. European Journal of Heart Failure, 9 . pp. 429-434. (doi:10.1016/j.ejheart.2006.10.005)

Berry, C., Murphy, N., De Vito, G., Galloway, S., Seed, A., Fisher, C., Sattar, N., Vallance, P., Hillis, W., and McMurray, J. (2007) Effects of aldosterone receptor blockade in patients with mild-moderate heart failure taking a beta-blocker (vol 9, pg 429, 2007). European Journal of Heart Failure, 9 . p. 1074.

Dargie, H., Hildebrandt, P., Riegger, G., McMurray, J., McMorn, S., Roberts, J., Zambanini, A., and Wilding, J. (2007) A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association functional class I or II heart failure. Journal of the American College of Cardiology, 49 . pp. 1696-1704. (doi:10.1016/j.jacc.2006.10.077)

Desai, A. et al. (2007) Incidence and predictors of hyperkalemia in patients with heart failure. Journal of the American College of Cardiology, 50 . pp. 1959-1966.

Dickstein, K., Drexler, H., Mcmurray, J., and Bohm, M. (2007) Abstracts of the Heart Failure Congress 2007 - Hamburg, Germany, 9-12 June, 2007 - Welcome address. European Journal of Heart Failure, 6 . IX-IX.

Felker, G. et al. (2007) Red cell distribution width as a novel prognostic marker in heart failure - Data from the CHARM program and the Duke Databank. Journal of the American College of Cardiology, 50 . pp. 40-47. (doi:10.1016/j.jacc.2007.02.067)

Granger, C., and McMurray, J. (2007) Efficacy and safety in clinical trials - Reply. Journal of the American College of Cardiology, 49 (6). p. 729.

Hawkins, N. et al. (2007) Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme. Heart, 93 . pp. 59-64. (doi:10.1136/hrt.2005.083949)

Hawkins, N. et al. (2007) Prevalence and prognostic impact of bundle branch block in patients with heart failure: Evidence from the CHARM programme. European Journal of Heart Failure, 9 . pp. 510-517. (doi:10.1016/j.ejheart.2006.11.006)

Home, P., Pocock, S., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Jones, N., Komajda, M., McMurray, J., and Grp, R. (2007) Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis. New England Journal of Medicine, 357 . pp. 28-38. ISSN 0028-4793 (doi:10.1056/NEJMoa073394)

Kenchaiah, S. et al. (2007) Body mass index and prognosis in patients with chronic heart failure - Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation, 116 . pp. 627-636. (doi:10.1161/CIRCULATIONAHA.106.679779)

Kjekshus, J. et al. (2007) Rosuvastatin in older patients with systolic heart failure. New England Journal of Medicine, 357 . pp. 2248-2261. ISSN 0028-4793 (doi:10.1056/NEJMoa0706201)

Lewis, E. et al. (2007) Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. European Journal of Heart Failure, 9 (1). pp. 83-91.

McEntegart, M., Awede, B., Petrie, M., Sattar, N., Dunn, F., MacFarlane, N., and McMurray, J. (2007) Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. European Heart Journal, 28 . pp. 829-835. (doi:10.1093/eurheartj/ehm033)

Metra, M. et al. (2007) Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure, 9 . pp. 684-694. (doi:10.1016/j.ejheart.2007.04.003)

Murphy, A., and McMurray, J. (2007) Heart failure: are we neglecting the silent majority? European Heart Journal, 28 (9). pp. 1047-1048.

Murphy, N., Simpson, C., Jhund, P., Stewart, S., Kirkpatrick, M., Chalmers, J., MacIntyre, K., and McMurray, J. (2007) A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart, 93 . pp. 606-612. (doi:10.1136/hrt.2006.107573)

Myles, R., Jackson, C., Tsorlalis, I., Petrie, M., McMurray, J., and Cobbe, S. (2007) Is microvolt T-wave alternans the answer to risk stratification in heart failure? Circulation, 116 . pp. 2984-2991.

O'Meara, E. et al. (2007) Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure - Results of the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program. Circulation, 115 . pp. 3111-3120. (doi:10.1161/CIRCULATIONAHA.106.673442)

Peacock, A., Murphy, N., McMurray, J., Caballero, L., and Stewart, S. (2007) An epidemiological study of pulmonary arterial hypertension. European Respiratory Journal, 30 . pp. 104-109. (doi:10.1183/09031936.00092306)

Petrie, M., and McMurray, J. (2007) Dysglycemia and heart failure hospitalization - What is the link? Circulation, 115 (11). pp. 1334-1335.

Pfeffer, M. et al. (2007) An ongoing study of anemia correction in chronic kidney disease. New England Journal of Medicine, 356 (9). pp. 959-961. ISSN 0028-4793

Recio-Mayoral, A., Kaski, J., McMurray, J., Horowitz, J., van Veldhuisen, D., and Remme, W. (2007) Clinical trials update from the European Society of Cardiology Congress in Vienna, 2007: PROSPECT, EVEREST, ARISE, ALOFT, FINESSE, Prague-8, CARESS in MI and ACUITY. Cardiovascular Drugs and Therapy, 21 . pp. 459-465.

Sampson, U., Pfeffer, M., McMurray, J., Lokhnygina, Y., White, H., Solomon, S., and Valsartan Acute, M. (2007) Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT trial. European Heart Journal, 28 . pp. 685-691. (doi:10.1093/eurheartj/ehl197)

Seed, A., Gardner, R., Mcmurray, J., Hillier, C., Murdoch, D., MacFadyen, R., Bobillier, A., Mann, J., and McDonagh, T. (2007) Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure. European Journal of Heart Failure, 9 . pp. 1120-1127.

Solomon, S. et al. (2007) Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation, 116 . pp. 1482-1487. (doi:10.1161/CIRCULATIONAHA.107.696906)

Solomon, S. et al. (2007) Response to letter regarding article, 'Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas'. Circulation, 115 (12). E349-E349.

Stephenson, K. et al. (2007) Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: The VALIANT experience. Heart Rhythm, 4 . pp. 308-313. (doi:10.1016/j.hrthm.2006.11.021)

Stewart, S., Murphy, N., Walker, A., McGuire, A., and McMurray, J. (2007) Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK (vol 90, pg 282, 2004). Heart, 93 . p. 1472.

Verma, A., Anavekar, N., Meris, A., Thune, J., Arnold, J., Ghali, J., Velazquez, E., McMurray, J., Pfeffer, M., and Solomon, S. (2007) The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction - The VALIANT Echo study. Journal of the American College of Cardiology, 50 . pp. 1238-1245.

van Veldhuisen, D., and McMurray, J. (2007) Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial. European Journal of Heart Failure, 9 (2). pp. 110-112.

van Veldhuisen, D., McMurray, J., and Comm, R. (2007) Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial (vol 9, pg 110, 2007). European Journal of Heart Failure, 9 (3). p. 323.

Murphy, N.F., Stewart, S., Hart, C., MacIntyre, K., Hole, D.J., and McMurray, J.J.V. (2006) A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew–Paisley study. Heart, 92 (12). pp. 1739-1746. ISSN 1355-6037 (doi:10.1136/hrt.2006.090118)

Murphy, N.F., MacIntyre, K., Stewart, S., Hart, C., Hole, D., and McMurray, J. (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew–Paisley study). European Heart Journal, 27 (1). pp. 96-106. ISSN 0195-668X (doi:10.1093/eurheartj/ehi506)

Berry, C., Norrie, J., Hogg, K., Brett, M., Stevenson, K., and McMurray, J. (2006) The prevalence, nature, and importance of hematologic abnormalities in heart failure. American Heart Journal, 151 (6). pp. 1313-1321.

Capewell, S., Unal, B., Critchley, J., and McMurray, J. (2006) Over 20 000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients. Heart, 92 (4). pp. 521-523.

Capewell, S., Murphy, N.F., MacIntyre, K., Frame, S., Stewart, S., Chalmers, J.W.T., Boyd, J., Finlayson, A., Redpath, A., and McMurray, J.J.V. (2006) Short-term and long-term outcomes in 133 429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study. Heart, 92 (11). pp. 1563-1570. ISSN 1355-6037 (doi:10.1136/hrt.2005.085399)

Ducharme, A. et al. (2006) Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program. American Heart Journal, 151 (5). pp. 985-991. ISSN 0002-8703

Granger, C., and McMurray, J. (2006) Using measures of disease progression to determine therapeutic effect - A sirens' song. Journal of the American College of Cardiology, 48 (3). pp. 434-437.

Hawkins, N., Petrie, M., MacDonald, M., Hogg, K., and McMurray, J. (2006) QRS duration alone to select patients for cardiac resynchronization therapy: flying in the face of the evidence? European Heart Journal, 27 (24). pp. 3074-3075.

Hawkins, N., Petrie, M., MacDonald, M., Hogg, K., and McMurray, J. (2006) Selecting patients for cardiac resynchronization therapy: electrical or mechanical dyssynchrony? European Heart Journal, 27 (11). pp. 1270-1281.

Hillege, H. et al. (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation, 113 . pp. 671-678. (doi:10.1161/CIRCULATIONAHA.105.580506)

Hogg, K., and McMurray, J. (2006) The treatment of heart failure with preserved ejection fraction ("diastolic heart failure"). Heart Failure Reviews, 11 . pp. 141-146. (doi:10.1007/s10741-006-9488-6)

Hogg, K., and McMurray, J. (2006) The treatment of heart failure with preserved ejection fraction ('diastolic heart failure'). Heart Failure Reviews, 11 (2). pp. 141-146.

Janardhanan, R. et al. (2006) Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. American Heart Journal, 152 . pp. 183-189. (doi:10.1016/j.ahj.2005.11.013)

Jhund, P., and McMurray, J. (2006) Does aspirin reduce the benefit of an angiotensin-converting enzyme inhibitor? - Choosing between the scylla of observational studies and the charybdis of subgroup analysis. Circulation, 113 (22). pp. 2566-2568.

Kauf, T. et al. (2006) The cost of acute myocardial infarction in the new millennium: Evidence from a multinational registry. American Heart Journal, 151 . pp. 206-212. (doi:10.1016/j.ahj.2005.02.028)

Kober, L. et al. (2006) Previously known and newly diagnosed atrial fibrillation: A major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. European Journal of Heart Failure, 8 . pp. 591-598. (doi:10.1016/j.ejheart.2005.11.007)

MacIntyre, K., Murphy, N., Chalmers, J., Capewell, S., Frame, S., Finlayson, A., Pell, J., Redpath, A., and McMurray, J. (2006) Hospital burden of suspected acute coronary syndromes: recent trends. Heart, 92 (5). pp. 691-692.

McMurray, J. et al. (2006) The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction - An analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Journal of the American College of Cardiology, 47 . pp. 726-733. (doi:10.1016/j.jacc.2005.09.055)

McMurray, J. (2006) Beta-blockers and heart failure in older people: reply. European Heart Journal, 27 (7). pp. 888-889.

McMurray, J. (2006) Drug safety in cardiovascular disease: A call to ACTION. Cardiovascular Drugs and Therapy, 20 (1). pp. 9-10.

McMurray, J. (2006) Renin angiotensin blockade in heart failure with preserved ejection fraction: the signal gets stronger. European Heart Journal, 27 (19). pp. 2257-2259.

McMurray, J. et al. (2006) Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal, 27 (12). pp. 1447-1458.

McMurray, J., Califf, R., and Pfeffer, M. (2006) Of statistical significance: 'Trends' toward significance and optimism bias - Reply. Journal of the American College of Cardiology, 48 (7). p. 1471.

McMurray, J. et al. (2006) Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM)-Added trial. American Heart Journal, 151 . pp. 985-991. (doi:10.1016/j.ahj.2006.02.028)

Mcmurray, J., and Swedberg, K. (2006) Treatment of chronic heart failure: a comparison between the major guidelines. European Heart Journal, 27 (15). pp. 1773-1777.

Murphy, N.F., Simpson, C.R., MacIntyre, K., McAlister, F.A., Chalmers, J., and McMurray, J.J.V. (2006) Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based study. Heart, 92 (8). pp. 1047-1054. ISSN 1355-6037 (doi:10.1136/hrt.2005.069419)

Murphy, N., MacIntyre, K., Stewart, S., Hart, C., Hole, D., and McMurray, J. (2006) Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15000 middle-aged men and women (the Renfrew-Paisley study). European Heart Journal, 27 . pp. 96-106. (doi:10.1093/eurheartj/ehi506)

Murphy, N., Stewart, S., Hart, C., MacIntyre, K., Hole, D., and McMurray, J. (2006) A population study of the long-term consequences of Rose angina: 20-year follow-up of the Renfrew Paisley study. Heart, 92 . pp. 1739-1746. (doi:10.1136/hrt.2006.090118)

O'Meara, E. et al. (2006) Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure - Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation, 113 . pp. 986-994. (doi:10.1161/CIRCULATIONAHA.105.582577)

Olsson, L., Swedberg, K., Ducharme, A., Granger, C., Michelson, E., McMurray, J., Puu, M., Yusuf, S., Pfeffer, M., and Investigators, C. (2006) Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction - Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and Morbidity (CHARM) program. Journal of the American College of Cardiology, 47 . pp. 1997-2004. (doi:10.1016/j.jacc.2006.01.060)

Pitt, B., Ferrari, R., Gheorghiade, M., van Veldhuisen, D., Krum, H., McMurray, J., and Lopez-Sendon, J. (2006) Aldosterone blockade in post-acute myocardial infarction heart failure. Clinical Cardiology, 29 . pp. 434-438.

Pocock, S. et al. (2006) Predictors of mortality and morbidity in patients with chronic heart failure. European Heart Journal, 27 . pp. 65-75. (doi:10.1093/eurheartj/ehi555)

Reed, S. et al. (2006) Geographic variation in the treatment of acute myocardial infarction in the VALsartan in acute myocardial iNfarcTion (VALIANT) trial. American Heart Journal, 152 . pp. 500-508. (doi:10.1016/j.ahj.2006.02.032)

Reid, M., Clark, A., Murdoch, D., Morrison, C., Capewell, S., and McMurray, J. (2006) Patients strategies for managing medication for chronic heart failure. International Journal of Cardiology, 109 . pp. 66-73. (doi:10.1016/j.ijcard.2005.05.051)

Solomon, S. et al. (2006) Effect of Celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation, 114 (10). pp. 1028-1035.

Stewart, S., and McMurray, J. (2006) Chilling findings: The need for winter vigilance in heart failure. Journal of Cardiac Failure, 12 (2). pp. 120-121.

Stewart, S., Murphy, N., McMurray, J., Jhund, P., Hart, C., and Hole, D. (2006) Effect of socioeconomic deprivation on the population risk of incident heart failure hospitalisation: An analysis of the Renfrew/Paisley Study. European Journal of Heart Failure, 8 . pp. 856-863. (doi:10.1016/j.ejheart.2006.02.008)

Stewart, S., Wilkinson, D., Becker, A., Askew, D., Ntyintyane, L., McMurray, J., and Sliwa, K. (2006) Mapping the emergence of heart disease in a black, urban population in Africa: The Heart of Soweto Study. International Journal of Cardiology, 108 . pp. 101-108. (doi:10.1016/j.ijcard.2006.01.001)

Valeur, N., Nielsen, O., McMurray, J., Torp-Pedersen, C., Kober, L., and Grp, T. (2006) Anaemia is an independent predictor of mortality in patients with left ventricular systolic dysfunction following acute myocardial infarction. European Journal of Heart Failure, 8 . pp. 577-584. (doi:10.1016/j.ejheart.2005.11.017)

Walker, A., McMurray, J., Stewart, S., Berger, W., McMahon, A., Dargie, H., Fox, K., Hillis, S., Henderson, N., and Ford, I. (2006) Economic evaluation of the impact of nicorandil in angina (IONA) trial. Heart, 92 . pp. 619-624. (doi:10.1136/hrt.2003.026385)

Weir, R., and McMurray, J. (2006) Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction. Curr Heart Fail Rep, 3 (4). pp. 175-180.

Weir, R., McMurray, J., Granger, C., Puu, M., Ostergren, J., Yusuf, S., Swedberg, K., and Pfeffer, M. (2006) Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial. European Heart Journal, 27 (Suppl.).

Weir, R., McMurray, J., and Velazquez, E. (2006) Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: Prevalence, clinical characteristics, and prognostic importance. American Journal of Cardiology, 97 . 13F-25F. (doi:10.1016/j.amjcard.2006.03.005)

Yerra, L., Anavekar, N., Skali, H., Zelenkofske, S., Velazquez, E., Mcmurray, J., Pfeffer, M., and Solomon, S. (2006) Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. Heart Rhythm, 3 (3). pp. 313-316.

Clark, A.M., McMurray, J.J.V., Morrison, C.E., Murdoch, D.L., Capewell, S., and Reid, M.E. (2005) A qualitative study of the contribution of pharmacists to heart failure management in Scotland. Pharmacy World and Science, 27 (6). pp. 453-458. ISSN 0928-1231 (doi:10.1007/s11096-005-1637-9)

Demers, C. et al. (2005) Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure. JAMA: Journal of the American Medical Association, 294 (14). pp. 1794-1798. ISSN 0098-7484 (doi:10.1001/jama.294.14.1794)

Anavekar, N., McMurray, J., and Pfeffer, M. (2005) Chronic renal disease and cardiovascular risk - Reply. New England Journal of Medicine, 352 (2). p. 200. ISSN 0028-4793

Berry, C., Hogg, K., Norrie, J., Stevenson, K., Brett, M., and McMurray, J. (2005) Heart failure with preserved left ventricular systolic function: a hospital cohort study. Heart, 91 . pp. 907-913. (doi:10.1136/hrt.2004.041996)

Berry, C., Norrie, J., and McMurray, J. (2005) Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis. Cardiovascular Drugs and Therapy, 19 . pp. 149-151. (doi:10.1007/s10557-005-3405-4)

Blue, L., and McMurray, J. (2005) How much responsibility should heart failure nurses take? European Journal of Heart Failure, 7 . pp. 351-361. (doi:10.1016/j.ejheart.2005.01.005)

Boehm, M., Hjalmarson, A., Kjekshus, J., Laufs, U., McMurray, J., and van Veldhuisen, D.J. (2005) Heart failure and statins - Why do we need a clinical trial? Zeitschrift für Kardiologie, 94 (4). pp. 223-230. ISSN 0300-5860 (doi:10.1007/s00392-005-0210-9)

Carson, P., Massie, B., McKelvie, R., McMurray, J., Komajda, M., Zile, M., Ptaszynska, A., Frangin, G., and Investigators, I. (2005) The Irbesartan in Heart Failure with Preserved Systolic Function (I-PRESERVE) trial: Rationale and design. Journal of Cardiac Failure, 11 . pp. 576-585. (doi:10.1016/j.cardfail.2005.06.432)

Clark, A., McMurray, J., Morrison, C., Murdoch, D., Capewell, S., and Reid, M. (2005) A qualitative study of the contribution of pharmacists to heart failure management in Scotland. Pharmacy World and Science, 27 . pp. 453-458. ISSN 0928-1231 (doi:10.1007/s11096-005-1637-9)

Cowie, M., Mcmurray, J., Cleland, J., McDonagh, T., and Pearson, M. (2005) Question and answer session. Heart, 91 . p. 31.

Dargie, H. et al. (2005) Determinants of coronary events in patients with stable angina: Results from the Impact of Nicorandil in Angina Study. American Heart Journal, 150 . (doi:10.1016/j.ahj.2005.03.040)

Granger, B., Swedberg, K., Ekman, I., Granger, C., Olofsson, B., McMurray, J., Yusuf, S., Michelson, E., Pfeffer, M., and Investigators, C. (2005) Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet, 366 . pp. 2005-2011. ISSN 0140-6736 (doi:10.1016/S0140-6736(05)67760-4)

Hogg, K., and Mcmurray, J. (2005) Neurohumoral pathways in heart failure with preserved systolic function. Progress in Cardiovascular Diseases, 47 (6). pp. 357-366.

Kjekshus, J., Dunselman, P., Blideskog, M., Eskilson, C., Hjalmarson, A., McMurray, J., Waagstein, F., Wedel, H., Wessman, P., and Wikstrand, J. (2005) A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristics. European Journal of Heart Failure, 7 (6). pp. 1059-1069. ISSN 1388-9842 (doi:10.1016/j.ejheart.2005.09.005)

MacIntrye, I., Jhund, P., and McMurray, J. (2005) Aspirin inhibits the acute arterial and venous vasodilator response to captopril in patients with chronic heart failure. Cardiovascular Drugs and Therapy, 19 . pp. 261-265. (doi:10.1007/s10557-005-3309-3)

McMurray, J. et al. (2005) Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice. European Journal of Heart Failure, 7 . pp. 710-721. (doi:10.1016/j.ejheart.2005.07.002)

McMurray, J., Kober, L., Robertson, M., Dargie, H., Colucci, W., Lopez-Sendon, J., Remme, W., Sharpe, D., and Ford, I. (2005) Antiarrhythmic effect of carvedilol after acute myocardial infarction - Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial. Journal of the American College of Cardiology, 45 . pp. 525-530.

McMurray, J. (2005) Optimising the use of angiotensin receptor blockers in the management of chronic heart failure. Journal of the Renin-Angiotensin-Aldosterone System, 6 . S2-S5. ISSN 1470-3203

McMurray, J., Kober, L., Robertson, M., Dargie, H., Colucci, W., Lopez-Sendon, J., Remme, W., Sharpe, N., and Ford, I. (2005) Antiarrythmic effect of carvedilol after acute myocardial infarction. Journal of the American College of Cardiology, 45 (4). pp. 525-530. ISSN 0735-1097 (doi:10.1016/j.jacc.2004.09.076)

McMurray, J. (2005) Angiotensin receptor blockers and myocardial infarction - Analysis of evidence is incomplete and inaccurate. British Medical Journal, 330 (7502). p. 1269. ISSN 0959-535X

McMurray, J. (2005) Chronic kidney disease in patients with cardiac disease: A review of evidence-based treatment. Kidney International, 68 (4). pp. 1419-1426. ISSN 0085-2538

McMurray, J. (2005) Making sense of SENIORS. European Heart Journal, 26 (3). pp. 203-206.

McMurray, J. (2005) Val-HeFT: do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy? Nature Clinical Practice Cardiovascular Medicine, 2 (3). pp. 128-129.

McMurray, J. (2005) The role of angiotensin II receptor blockers in the management of heart failure. European Heart Journal Supplements, 7 . J10-J14. (doi:10.1093/eurheartj/sui057)

McMurray, J., and Pfeffer, M. (2005) Heart failure. Lancet, 365 . pp. 1877-1889.

Mcmurray, J. (2005) Angiotensin receptor blockers and myocardial infarction: analysis of evidence is incomplete and inaccurate. British Medical Journal, 330 (7502). p. 1269. ISSN 0959-535X

Mcmurray, J. (2005) Baseline left ventricular wall thickness after myocardial infarction predicts death or heart failure: Findings from the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Circulation, 112 (17, Su). U588.

Mcmurray, J. (2005) Extent of coronary artery disease and cardiovascular outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: Findings from the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Circulation, 112 (17, Su). U568.

Mcmurray, J. (2005) Possible beneficial interaction between statins and combination anglotensin receptor blocker (ARB) and ACE inhibitor treatment in patients with myocardial infarction: A post hoc analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT). Circulation, 112 (17, Su). U545.

Mcmurray, J. (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). European Heart Journal, 26 (3). pp. 215-225. (doi:10.1093/eurheartj/ehi115)

Miller, P., Drummond, M., Langkilde, L., McMurray, J., and Ogren, M. (2005) Economic factors associated with antithrombotic treatments for stroke prevention in patients with atrial fibrillation. European Heart Journal Supplements, 7 (C). C41-C54.

Mix, T. et al. (2005) Rationale - Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease. American Heart Journal, 149 . pp. 408-413. (doi:10.7016/j.ahj.2004.09.047)

Murphy, N., MacIntyre, K., Stewart, S., Capewell, S., and McMurray, J. (2005) Reduced between-hospital variation in short term survival after acute myocardial infarction: the result of improved cardiac care? Heart, 91 . pp. 726-730. (doi:10.1136/hrt.2004.042929)

O'Meara, E. et al. (2005) Patient perception of the effect of treatment with candesartan in heart failure. Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure, 7 (4). pp. 650-656.

O'Meara, E., and McMurray, J. (2005) Myocardial metabolic manipulation: a new therapeutic approach in heart failure? Heart, 91 (2). pp. 131-132.

Packer, M. et al. (2005) Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: Results of a pilot study. Journal of Cardiac Failure, 11 . pp. 12-20. (doi:10.1016/j.cardfail.2004.05.006)

Pfeffer, M., Solomon, S., Singh, A., Ivanovich, P., and McMurray, J. (2005) Uncertainty in the treatment of anemia in chronic kidney disease. Rev Cardiovasc Med, 6 Supp . S35-S41.

Reed, S. et al. (2005) Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT). American Heart Journal, 150 . pp. 323-329. (doi:10.1016/j.ahj.2004.08.037)

Remme, W. et al. (2005) Public awareness of heart failure in Europe: first results from SHAPE. European Heart Journal, 26 . pp. 2413-2421. (doi:10.1093/eurheartj/ehi447)

Solomon, S. et al. (2005) Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation, 112 . pp. 3738-3744. (doi:10.1161/CIRCULATIONAHA.105.561423)

Solomon, S. et al. (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. New England Journal of Medicine, 352 . pp. 1071-1080. ISSN 0028-4793

Solomon, S. et al. (2005) Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction. Circulation, 111 (25). pp. 3411-3419.

Solomon, S., Wittes, J., McMurray, J., and Co, A. (2005) Cardiovascular risk associated with celecoxib - The authors reply. New England Journal of Medicine, 352 (25). p. 2649. ISSN 0028-4793

Solomon, S. et al. (2005) Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. New England Journal of Medicine, 352 . pp. 2581-2588. ISSN 0028-4793

Stewart, S., McAlister, F., and McMurray, J. (2005) Heart failure management programs reduce readmissions and prolong survival. Arch Intern Med, 165 (11). p. 1311.

Stewart, S., McMurray, J., Hebborn, A., Coats, A., Packer, M., and Grp, C. (2005) Carvedilol reduces the costs of medical care in severe heart failure: An economic analysis of the COPERNICUS study applied to the United Kingdom. International Journal of Cardiology, 100 . pp. 143-149. (doi:10.1016/j.ijcard.2004.12.003)

Szummer, K. et al. (2005) Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry. European Heart Journal, 26 . pp. 2114-2119. (doi:10.1093/eurheartj/ehi352)

Teerlink, J. et al. (2005) Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). American Heart Journal, 150 . pp. 46-53. (doi:10.1016/j.ahj.2005.04.035)

Voors, A., Petrie, C., Petrie, M., Charlesworth, A., Hillege, H., Zijlstra, F., McMurray, J., and van Veldhuisen, D. (2005) Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure. European Heart Journal, 26 . pp. 1759-1764. (doi:10.1093/eurheartj/ehi270)

Weir, R., and McMurray, J. (2005) Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction. Heart, 91 . pp. 17-20. (doi:10.1136/hrt.2005.062042)

White, H. et al. (2005) Mortality and morbidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction - Results from the Valsartan in Acute Myocardial Infarc. Circulation, 112 . pp. 3391-3399. (doi:10.1161/CIRCULATIONHA.105.551143)

Yusuf, S. et al. (2005) Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure. Circulation, 112 . pp. 48-53. (doi:10.1161/CIRCULATIONAHA.104.528166)

Murphy, N.F., Stewart, S., MacIntyre, K., Capewell, S., and McMurray, J.J.V. (2004) Seasonal variation in morbidity and mortality related to atrial fibrillation. International Journal of Cardiology, 97 (2). pp. 283-288. ISSN 0167-5273 (doi:10.1016/j.ijcard.2004.03.041)

Riegel, B., Naylor, M., Stewart, S., McMurray, J.J.V., and Rich, M.W. (2004) Interventions to prevent readmission for congestive heart failure. JAMA: Journal of the American Medical Association, 291 (23). p. 2816. ISSN 0098-7484 (doi:10.1001/jama.291.23.2816-a)

McAlister, F.A., Murphy, N.F., Simpson, C.R., Stewart, S., MacIntyre, K., Kirkpatrick, M., Chalmers, J., Redpath, A., Capewell, S., and McMurray, J.J.V. (2004) Influence of socioeconomic deprivation on the primary care burden and treatment of patients with a diagnosis of heart failure in general practice in Scotland: population based study. British Medical Journal, 328 (7448). pp. 1110-1113. ISSN 0959-535X (doi:10.1136/bmj.38043.414074.EE)

Aguilar, D. et al. (2004) Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction - The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation, 110 . pp. 1572-1578. (doi:10.1161/01.CIR.0000142047.28024.F2)

Anand, I., McMurray, J., Cohn, J., Konstam, M., Notter, T., Quitzau, K., Ruschitzka, F., Luscher, T., and Investigators, E. (2004) Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin(A) Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet, 364 . pp. 347-354.

Anand, I., McMurray, J., Whitmore, J., Warren, M., Pham, A., McCamish, M., and Burton, P. (2004) Anemia and its relationship to clinical outcome in heart failure. Circulation, 110 . pp. 149-154. (doi:10.1161/01.CIR.0000134279.79571.73)

Anavekar, N. et al. (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. New England Journal of Medicine, 351 . pp. 1285-1295. ISSN 0028-4793

Bunton, D., Petrie, M., Hillier, C., Johnston, F., and McMurray, J. (2004) The clinical relevance of adrenomedullin: a promising profile? Pharmacology and Therapeutics, 103 . pp. 179-201. (doi:10.1016/j.pharmthera.2004.07.002)

Dargie, H. et al. (2004) Impact of nicorandil in angina: subgroup analyses. Heart, 90 . pp. 1427-1430. (doi:10.1136/hrt.2003.026310)

Hogg, K., and McMurray, J. (2004) Treatment of heart failure with preserved systolic function: a review of the evidence. European Heart Journal Supplements, 6 (H). H61-H66.

Hogg, K., Swedberg, K., and McMurray, J. (2004) Heart failure with preserved left ventricular Systolic function - Epidemiology clinical characteristics and prognosis. Journal of the American College of Cardiology, 43 . pp. 317-327. (doi:10.1016/j.jacc.2003.09.046)

Hood, W., Dans, A., Guyatt, G., Jaeschke, R., and McMurray, J. (2004) Digitalis for treatment of congestive heart failure in patients in sinus rhythm: A systematic review and meta-analysis. Journal of Cardiac Failure, 10 . pp. 155-164. (doi:10.1016/j.cardfail.2003.12.005)

Jhund, P., Dawson, N., Davie, A., Norrie, J., O'Kane, K., and McMurray, J. (2004) 17 beta oestradiol does not attenuate the response to angiotensin I and II during long term therapy in postmenopausal women. Cardiovascular Drugs and Therapy, 18 . pp. 31-36.

Kober, L., Maggioni, A., McMurray, J., Velazquez, E., Zelenkofske, S., Zannad, F., Van de Werf, F., and Swedberg, K. (2004) Increased risk of both mortality and morbidity with prior as well as current atrial fibrillation after MI: results of VALIANT. European Heart Journal, 25 (Suppl.). p. 243.

Lopez-Sendon, J. et al. (2004) Expert consensus document on beta-adrenergic receptor blockers. European Heart Journal, 25 (15). pp. 1341-1362.

Lopez-Sendon, J. et al. (2004) Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease - The task force on ACE-inhibitors of the European Society of Cardiolgy. European Heart Journal, 25 (16). pp. 1454-1470.

Lopez-Sendon, J. et al. (2004) Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. Revista Espanola de Cardiologia, 57 (12). pp. 1213-1232.

Mann, D. et al. (2004) Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL). Circulation, 109 (13). pp. 1594-1602.

McAlister, F., Stewart, S., Ferrua, S., and Mcmurray, J. (2004) Multidisciplinary strategies for the management of heart failure patients at high risk for admission - A systematic review of randomized trials. Journal of the American College of Cardiology, 44 (4). pp. 810-819.

McMurray, J.J. (2004) Angiotensin inhibition in heart failure. Journal of the Renin-Angiotensin-Aldosterone System, 5 . S17-S22. ISSN 1470-3203

McMurray, J.J. (2004) The optimal management of heart failure - Introduction. Journal of the Renin-Angiotensin-Aldosterone System, 5 . S1-S1. ISSN 1470-3203

McMurray, J., and O'Meara, E. (2004) Treatment of heart failure with spironolactone - Trial and tribulations. New England Journal of Medicine, 351 (6). pp. 526-528. ISSN 0028-4793

McMurray, J., and Pfeffer, M. (2004) The year in heart failure. Journal of the American College of Cardiology, 44 (12). pp. 2398-2405.

McMurray, J. (2004) What are the clinical consequences of anemia in patients with chronic heart failure? Journal of Cardiac Failure, 10 . S10-S12. (doi:10.1016/j.cardfail.2004.01.001)

McMurray, J., Pfeffer, M., Swedberg, K., and Dzau, V. (2004) Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? Circulation, 110 . pp. 3281-3288. (doi:10.1161/01.CIR.0000147274.83071.68)

Meredith, P.A., Murray, L.S., and McMurray, J.J. (2004) A putative placebo comparison of the SCOPE and LIFE trials. Journal of the Renin-Angiotensin-Aldosterone System, 5 . pp. 59-63. ISSN 1470-3203

Murphy, N., McMurray, J., and MacIntyre, K. (2004) Discharge rates for suspected acute coronary syndromes - Clinical assessment tools need improving - Reply. British Medical Journal, 329 (7458). p. 173. ISSN 0959-535X

Murphy, N., MacIntyre, K., Capewell, S., Stewart, S., Pell, J., Chalmers, P., Redpath, A., Frame, S., Boyd, J., and McMurray, J. (2004) Hospital discharge rates for suspected acute coronary syndromes between 1990 and 2000: population based analysis. British Medical Journal, 328 . pp. 1413-1414. ISSN 0959-535X

Murphy, N., Simpson, C., McAlister, F., Stewart, S., MacIntyre, K., Kirkpatrick, M., Chalmers, J., Redpath, A., Capewell, S., and McMurray, J. (2004) National survey of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland. Heart, 90 . pp. 1129-1136. (doi:10.1136/hrt.2003.029553)

O'Meara, E., Murphy, C., and McMurray, J. (2004) Anemia and heart failure. Curr Heart Fail Rep, 1 (4). pp. 176-182.

O'Meara, E., Solomon, S., McMurray, J., Pfeffer, M., Yusuf, S., Michelson, E., Granger, C., Olofsson, B., Young, J., and Swedberg, K. (2004) Effect of candesartan on New York Heart Association functional class - Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. European Heart Journal, 25 . pp. 1920-1926. (doi:10.1016/j.ehj.2004.07.025)

Petrie, M., Hogg, K., Caruana, L., and McMurray, J. (2004) Poor concordance of commonly used echocardiographic measures of left ventricular diastolic function in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction? Heart, 90 . pp. 511-517. (doi:10.1136/hrt.2003.011403)

Pfeffer, M., McMurray, J., and Califf, R. (2004) Valsartan, captopril, or both in myocardial infarction - Reply. New England Journal of Medicine, 350 (9). pp. 944-945. ISSN 0028-4793

Remme, W. et al. (2004) Increasing awareness and perception of heart failure in Europe and improving care - Rationale and design of the SHAPE study. Cardiovascular Drugs and Therapy, 18 (2). pp. 153-159.

Solomon, S. et al. (2004) Effect of candesartan on cause-specific mortality in heart failure patients - The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation, 110 . pp. 2180-2183. (doi:10.1161/01.CIR.0000144474.65922.AA)

Stewart, S., Murphy, N., Walker, A., McGuire, A., and McMurray, J. (2004) Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart, 90 . pp. 286-292. (doi:10.1136/hrt.2002.008748)

Swedberg, K., and McMurray, J. (2004) Angiotensin receptor blockers and heart failure: still CHARMing after VALIANT? European Heart Journal, 25 (5). pp. 357-358.

Velazquez, E. et al. (2004) An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. European Heart Journal, 25 . pp. 1911-1919. (doi:10.1016/j.ehj.2004.08.006)

Young, J. et al. (2004) Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction - Results of the CHARM low-left ventricular ejection fraction trials. Circulation, 110 . pp. 2618-2626. (doi:10.1161/01.CIR.0000146819.43235.A9)

Dunselman, P., Hjalmarson, A., Kjekshus, J., McMurray, J., Waagstein, F., and Executive Comm, C. (2003) The statin wars. Lancet, 362 (9398). p. 1854.

Fisher, C., Al Benna, S., Kirk, A., Morton, J., and McMurray, J. (2003) Transcardiac and transpulmonary gradients in the putative new cardiovascular hormone relaxin. Heart, 89 (7). pp. 789-790.

Fisher, C., Berry, C., Blue, L., Morton, J., and McMurray, J. (2003) N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart, 89 . pp. 879-881.

Granger, C., McMurray, J., Yusuf, S., Held, P., Michelson, E., Olofsson, B., Ostergren, J., Pfeffer, M., Swedberg, K., and CHARM Investigators Comm, (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet, 362 . pp. 772-776.

McMurray, J. et al. (2003) Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure - Assessment of Reduction in Mortality and morbidity (CHARM) program. European Journal of Heart Failure, 5 . pp. 261-270. (doi:10.1016/S1388-9842(03)00052-7)

McMurray, J., and Hillier, C. (2003) The rise and fall of myotrophin in heart failure. Journal of the American College of Cardiology, 42 (4). pp. 726-727.

McMurray, J., Pfeffer, M., Swedberg, K., Granger, C., and Yusuf, S. (2003) The CHARM programme - Reply. Lancet, 362 (9396). pp. 1678-1679.

McMurray, J., Ostergren, J., Swedberg, K., Granger, C., Held, P., Michelson, E., Olofsson, B., Yusuf, S., Pfeffer, M., and Comm, C. (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet, 362 . pp. 767-771.

McMurray, J., and Stewart, S. (2003) The burden of heart failure. European Heart Journal Supplements, 5 . pp. 3-13.

Mcmurray, J. (2003) Effects of newly diagnosed and previously known diabetes mellitus on 1-year outcomes of acute myocardial infarction: The VALIANT Trial. Circulation, 108 (17 Sup). IV-745.

Mcmurray, J. (2003) Influence of renal function on one-year cardiovascular outcomes in the VALIANT trial. Circulation, 108 (17 Sup). IV-485.

Mcmurray, J. (2003) One-year mortality, stroke, and myocardial infarction rates remain high in the elderly despite beta-blockade plus angiotensin-converting-enzyme inhibition, angiotensin receptor blockade, or both: The VALIANT Trial. Circulation, 108 (17 Sup). IV-695.

Mcmurray, J. (2003) Relationship between left ventricular structure and function and plasma neurohormones in patients with heart failure: Results from the EARTH Trial. Circulation, 108 (17 Sup). IV-519.

Mcmurray, J. (2003) SHAPE: A Pan-European general public heart failure awareness and perception survey. Circulation, 108 (17 Sup). IV-693.

Ostergren, J., and McMurray, J.J.V. (2003) Angiotensin receptor blockers in heart failure. Journal of the Renin-Angiotensin-Aldosterone System, 4 . pp. 171-175. ISSN 1470-3203

Petrie, M., and McMurray, J. (2003) It cannot be cardiac failure because the heart is not enlarged on the chest X-ray. European Journal of Heart Failure, 5 (2). pp. 117-119.

Pfeffer, M. et al. (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. New England Journal of Medicine, 349 . pp. 1893-1906. ISSN 0028-4793

Pfeffer, M., Swedberg, K., Granger, C., Held, P., McMurray, J., Michelson, E., Olofsson, B., Ostergren, J., Yusuf, S., and Comm, C. (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet, 362 . pp. 759-766.

Senior, R., Galasko, G., McMurray, J., and Mayet, J. (2003) Screening for left ventricular dysfunction in the community: role of hand held echocardiography and brain natriuretic peptides. Heart, 89 . pp. 24-28.

Stewart, S., MacIntyre, K., Capewell, S., and McMurray, J. (2003) Heart failure and the aging population: an increasing burden in the 21st century? Heart, 89 . pp. 49-53.

Stewart, S., Murphy, N., Walker, A., McGuire, A., and McMurray, J. (2003) The current cost of angina pectoris to the National Health Service in the UK. Heart, 89 . pp. 848-853.

Velazquez, E. et al. (2003) VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context. European Journal of Heart Failure, 5 . pp. 537-544.

Yusuf, S., Pfeffer, M., Swedberg, K., Granger, C., Held, P., McMurray, J., Michelson, E., Olofsson, B., Ostergren, J., and Comm, C. (2003) Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet, 362 . pp. 777-781.

Stewart, S., Hart, C. L., Hole, D. J., and McMurray, J. J.V. (2002) A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. American Journal of Medicine , 113 (5). pp. 359-364. ISSN 0002-9343 (doi:10.1016/S0002-9343(02)01236-6)

Berry, C., and McMurray, J. (2002) Editorial comment - Amlodipine for all undergoing PCI? The evidence is unconvincing. International Journal of Cardiology, 84 (1). pp. 30-32.

Berry, C., and Mcmurray, J. (2002) CHF: a GP guide to management. Practitioner, 246 (1639). 669-72, 675.

Berry, C., Davie, A., Mcmurray, J., and Schmitz, G. (2002) Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease. HMG-COA Reductase Inhibitors . pp. 135-147.

Byrne, J., Murdoch, D., Morrison, C., and McMurray, J. (2002) An audit of activity and outcome from a daily and a weekly "one stop" rapid assessment chest pain clinic. Postgraduate Medical Journal, 78 . pp. 43-46.

Byrne, J., Murdoch, D., Morrison, C., and McMurray, J. (2002) An audit of activity and outcome from a daily and a weekly 'one stop' rapid assessment chest pain clinic. Postgraduate Medical Journal, 78 (915). pp. 43-46.

Davie, A., and McMurray, J. (2002) Cost-effectiveness of invasive strategy in unstable coronary disease - what are we waiting for? European Heart Journal, 23 (1). pp. 1-3.

Davie, A., and McMurray, J. (2002) Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor. British Journal of Clinical Pharmacology, 53 . pp. 37-42.

De Vito, G., Galloway, S., Nimmo, M., Maas, P., and McMurray, J. (2002) Effects of central sympathetic inhibition on heart rate variability during steady-state exercise in healthy humans. Clinical Physiology and Functional Imaging, 22 . pp. 32-38.

Fisher, C., MacLean, M., Morecroft, I., Seed, A., Johnston, F., Hillier, C., and McMurray, J. (2002) Is the pregnancy hormone relaxin also a vasodilator peptide secreted by the heart? Circulation, 106 . pp. 292-295. (doi:10.1161/01.CIR.0000025630.05387.45)

Fisher, C., and McMurray, J. (2002) Current management of heart failure. Practitioner, 246 (1635). pp. 438-443.

Krum, H., and McMurray, J. (2002) Statins and chronic heart failure: Do we need a large-scale outcome trial? Journal of the American College of Cardiology, 39 . pp. 1567-1573.

McMurray, J., and Pfeffer, M. (2002) New therapeutic options in congestive heart failure - Part II. Circulation, 105 . pp. 2223-2228. (doi:10.1161/01.CIR.0000014771.38666.22)

McMurray, J., and Pfeffer, M. (2002) New therapeutic options in congestive heart failure: Part I. Circulation, 105 . pp. 2099-2106. (doi:10.1161/01.CIR.0000014763.63528.9D)

McMurray, J.J. (2002) Heart failure in 10 years time: Focus on pharmacological treatment. Heart (London), 88 (Supple). ii40-ii46.

McMurray, J., and Davie, A. (2002) Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation, 106 (20). E147-E147.

McMurray, J., Struthers, A., and Mcmurray, J. (2002) The role of the specialist nurse - Question and answer session. Heart, 88 . p. 35.

Packer, M., Califf, R., Konstam, M., Krum, H., McMurray, J., Rouleau, J., Swedberg, K., and Grp, O. (2002) Comparison of omapatrilat chronic and enalapril in patients with heart failure - The omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE). Circulation, 106 . pp. 920-926. (doi:10.1161/01.CIR.0000029801.86489.50)

Pell, J. P., MacIntyre, K., Walsh, D., Capewell, S., McMurray, J.J., Chalmers, J.W., Boyd, J.H., Finlayson, A.R., Stewart, S., and Redpath, A.D. (2002) Time trends in survival and readmission following coronary artery bypass grafting in Scotland, 1981-96: retrospective observational study. British Medical Journal, 324 . pp. 201-202. ISSN 0959-535X (doi:10.1136/bmj.324.7331.201)

Petrie, M., Caruana, L., Berry, C., and McMurray, J. (2002) 'Diastolic heart failure' or heart failure caused by subtle left ventricular systolic dysfunction? Heart, 87 (1). pp. 29-31.

Petrie, M., Caruana, L., Berry, C., and McMurray, J. (2002) "Diastolic heart failure" or heart failure caused by subtle left ventricular systolic dysfunction? Heart, 87 . pp. 29-31.

Pfeffer, M., and McMurray, J. (2002) Myocardial infarct - No one size fits all. Circulation, 105 (22). pp. 2577-2579.

Seed, A., Hillier, C., Berry, C., Johnston, F., Brown, A., Petrie, M., and McMurray, J. (2002) Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition. Clinical Science, 103 (1). 13P. ISSN 0143-5221

Seed, A., Hillier, C., Berry, C., Johnston, F., Petrie, M., and McMurray, J. (2002) Evidence that a novel orally active NEP/ECE inhibitor blocks the vasoconstrictor response to big endothelin in human resistance arteries. Clinical Science , 103 (1). 14P.

Stewart, S., Blue, L., Walker, A., Morrison, C., and McMurray, J. (2002) An economic analysis of specialist heart failure nurse management in the UK - Can we afford not to implement it? European Heart Journal, 23 . pp. 1369-1378. (doi:10.1053/euhj.2001.3114)

Stewart, S., Demers, C., Murdoch, D., McIntyre, K., MacLeod, M., Kendrick, S., Capewell, S., and McMurray, J. (2002) Substantial between-hospital variation in outcome following first emergency admission for heart failure. European Heart Journal, 23 . pp. 650-657. (doi:10.1053/euhj.2001.2890)

Stewart, S., Jenkins, A., Buchan, S., McGuire, A., Capewell, S., and McMurray, J. (2002) The current cost of heart failure to the National Health Service in the UK. European Journal of Heart Failure, 4 . pp. 361-371.

Stewart, S., MacIntyre, K., Chalmers, J., Boyd, J., Finlayson, A., Redpath, A., Pell, J., Capewell, S., and McMurray, J. (2002) Trends in case-fatality in 22,968 patients admitted for the first time with atrial fibrillation in Scotland, 1986-1995. International Journal of Cardiology, 82 . pp. 229-236.

Stewart, S., McIntyre, K., Capewell, S., and McMurray, J. (2002) Heart failure in a cold climate - Seasonal variation in heart failure-related morbidity and mortality. Journal of the American College of Cardiology, 39 . pp. 760-766.

Stewart, S., and McMurray, J. (2002) Palliative care for heart failure - Time to move beyond treating and curing to improving the end of life. British Medical Journal, 325 (7370). pp. 915-916. ISSN 0959-535X

Berry, C., and McMurray, J. (2001) Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone. American Journal of Medicine , 111 (7). p. 587. ISSN 0002-9343 (doi:10.1016/S0002-9343(01)00927-5)

Stewart, S., Hart, C.L., Hole, D.J., and McMurray, J.J.V. (2001) Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart, 86 (5). pp. 516-521. ISSN 1355-6037 (doi:10.1136/heart.86.5.516)

Bacquet, P. et al. (2001) Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II). European Heart Journal, 22 . pp. 1021-1031.

Berry, C., Anderson, N., Kirk, A., Dominiczak, A., and McMurray, J. (2001) Renin angiotensin system inhibition is associated with reduced free radical concentrations in arteries of patients with coronary heart disease. Heart, 86 (2). pp. 217-220.

Berry, C., Brosnan, M., Alexander, M., Hamilton, C., McMurray, J., and Dominiczak, A.F. (2001) Mechanisms of oxidative free radical generation in human arteries. Clinical Science , 101 (2). 7P.

Berry, C., and McMurray, J. (2001) Serious adverse events experienced by patients with chronic heart failure taking spironolactone. Heart, 85 (4). E8.

Berry, C., and McMurray, J. (2001) Undertreatment of heart failure has high cost to patients. British Medical Journal, 322 (7288). pp. 731-732. ISSN 0959-535X

Berry, C., Murdoch, D., and McMurray, J. (2001) Economics of chronic heart failure. European Journal of Heart Failure, 3 . pp. 283-291.

Berry, C., Norrie, J., and McMurray, J. (2001) Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2. American Journal of Cardiology, 87 (5). pp. 606-607.

Berry, C., Stewart, S., Payne, E., McArthur, J., and McMurray, J. (2001) Electrical cardioversion for atrial fibrillation: outcomes in 'real-life' clinical practice. International Journal of Cardiology, 81 . pp. 29-35.

Blue, L. et al. (2001) Randomised controlled trial of specialist nurse intervention in heart failure. British Medical Journal, 323 . pp. 715-718. ISSN 0959-535X (doi:10.1136/bmj.323.7315.715)

Capewell, S., MacIntyre, K., Stewart, S., Chalmers, J., Boyd, J., Finlayson, A., Redpath, A., Pell, J., and McMurray, J. (2001) Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study. Lancet, 358 . pp. 1213-1217.

Caruana, L., Petrie, M., McMurray, J., and MacFarlane, N. (2001) Altered diaphragm position and function in patients with chronic heart failure. European Journal of Heart Failure, 3 . pp. 183-187.

Coats, P., Johnston, F., MacDonald, J., McMurray, J., and Hillier, C. (2001) Signalling mechanisms underlying the myogenic response in human subcutaneous resistance arteries. Cardiovascular Research, 49 . pp. 828-837.

Coats, P., Johnston, F., MacDonald, J., McMurray, J., and Hillier, C. (2001) Endothelium-derived hyperpolarizing factor - Identification and mechanisms of action in human subcutaneous resistance arteries. Circulation, 103 . pp. 1702-1708.

Davie, A.P., Rumley, A., Lowe, G.D.O., and McMurray, J.J.V. (2001) Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure. Thrombosis and Haemostasis, 86 (6). pp. 1585-1586. ISSN 0340-6245

Fisher, C., Johnston, F., Hillier, C., and McMurray, J. (2001) Relaxin, a newly described cardiac hormone, is a more potent vasodilator than atrial natriuretic factor in human resistance arteries. Circulation, 104 (17 Sup). II.

Hillier, C., Berry, C., Petrie, M., O'Dwyer, P., Hamilton, C., Brown, A., and McMurray, J. (2001) Effects of urotensin II in human arteries and veins of varying caliber. Circulation, 103 . pp. 1378-1381.

Hillier, C., Petrie, M.C., Love, M.P., Johnston, F., MacLean, M.R., and McMurray, J.J.V. (2001) Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure. Clinical Science, 101 . pp. 45-51.

Jhund, P., Davie, A., and McMurray, J. (2001) Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. Journal of the American College of Cardiology, 37 . pp. 1234-1238.

Jhund, P., Dawson, N., Davie, A., Sattar, N., Norrie, J., O'Kane, K., and McMurray, J. (2001) Attenuation of endothelin-1 induced vasoconstriction by 17 beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease. Journal of the American College of Cardiology, 37 . pp. 1367-1373.

Love, M., and McMurray, J. (2001) Endothelin receptor antagonists and cardiovascular diseases of aging. Drugs and Aging, 18 (6). pp. 425-440.

Luscher, T., Ruschitzka, F., Anand, I., Konstam, M., Mcmurray, J., Notter, T., and Cohn, J. (2001) EARTH: EndothelinA receptor antagonist trial in heart failure. Rationale and design. Heartdrug, 1 (6). pp. 294-298.

MacIntyre, K., Stewart, S., Capewell, S., Chalmers, J., Pell, J., Boyd, J., Finlayson, A., Redpath, A., Gilmour, H., and McMurray, J. (2001) Gender and survival: A population-based study of 201,114 men and women following a first acute myocardial infarction. Journal of the American College of Cardiology, 38 . pp. 729-735.

MacIntyre, K., Stewart, S., Chalmers, J., Pell, J., Finlays, A., Boyd, J., Redpath, A., McMurray, J., and Capewell, S. (2001) Relation between socioeconomic deprivation and death from a first myocardial infarction in Scotland: population based analysis. British Medical Journal, 322 . pp. 1152-1153. ISSN 0959-535X (doi:10.1136/bmj.322.7295.1152)

McDonagh, T., Cunningham, A., Morrison, C., McMurray, J., Ford, I., Morton, J., and Dargie, H. (2001) Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart, 86 . pp. 21-26.

McDonald, J., Petrie, M., Padmanabhan, N., Hillier, C., Connell, J., and McMurray, J. (2001) Non-ace mediated angiotensin II production. Clinical Science , 100 (2). 8P.

McDonald, J., Padmanabhan, N., Petrie, M., Hillier, C., Connell, J., and McMurray, J. (2001) Vasoconstrictor effect of the angiotensin-converting enzyme-resistant, chymase-specific substrate [Pro(D)(11)-Ala(12)] angiotensin I in human dorsal hand veins - In vivo demonstration of non-ACE production of angiotensin II in humans. Circulation, 104 . pp. 1805-1808.

McMurray, J.J.V. (2001) Angiotensin II receptor antagonists for the treatment of heart failure: what is their place after ELITE-II and Val-HeFT? Journal of the Renin-Angiotensin-Aldosterone System, 2 . pp. 89-92. ISSN 1470-3203

McMurray, J. (2001) Reduced costs with bisoprolol treatment for heart failure: An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II). European Heart Journal, 22 (12). pp. 1021-1031.

McMurray, J. (2001) What is suspected heart failure with preserved left ventricular systolic function? Reply. British Medical Journal, 322 (7280). p. 239. ISSN 0959-535X

McMurray, J. (2001) Heart failure - Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction. Heart, 86 . pp. 97-103.

Mcmurray, J. (2001) Carvedilol reduces supraventricular and ventricular arrhythmias after myocardial infarction: Evidence from the CAPRICORN study. Circulation, 104 (17 Sup). II.

Mcmurray, J. (2001) Endothelium-derived hyperpolarizing factor in human pressurised small subcutaneous resistance arteries may be a product of phospholipase A2 and cytochrome P450 metabolism. British Journal of Pharmacology, 133 (Procee). 67P.

Mcmurray, J. (2001) An economic analysis of specialist heart failure nurse management in the UK: Can we afford not to implement it? Circulation, 104 (17 Sup). II.

Mcmurray, J. (2001) The incidence and natural history of heart failure during 20-year follow-up of 15,406 men and women: The Renfrew/Paisley Study. Circulation, 104 (17 Sup). II.

Mcmurray, J., Cohen-Solal, A., Dietz, R., Eichhorn, E., Erhardt, L., Hobbs, R., Maggioni, A., Pina, I., Soler-Soler, J., and Swedberg, K. (2001) Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. European Journal of Heart Failure, 3 (4). pp. 495-502.

Morris, S., McMurray, J., Spiers, A., and Jardine, A. (2001) Impaired endothelial function in isolated human uremic resistance arteries. Kidney International, 60 . pp. 1077-1082. ISSN 0085-2538

Murdoch, D., McDonagh, T., Farmer, R., Morton, J., McMurray, J., and Dargie, H. (2001) ADEPT: Addition of the AT(1) receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: Hemodynamic and neurohormonal effects. American Heart Journal, 141 . pp. 800-807. (doi:10.1067/mhj.2001.114802)

Petrie, M., and McMurray, J. (2001) Changes in notions about heart failure. Lancet, 358 (9280). pp. 432-434.

Petrie, M., Berry, C., Stewart, S., and McMurray, J. (2001) Failing ageing hearts. European Heart Journal, 22 . pp. 1978-1990. (doi:10.1053/euhj.2000.2558)

Petrie, M., Hillier, C., Johnston, F., and McMurray, J. (2001) Effect of neutral endopeptidase inhibition on the actions of adrenomedullin and endothelin-1 in resistance arteries from patients with chronic heart failure. Hypertension, 38 . pp. 412-416.

Petrie, M., McDonald, J., Hillier, C., Morton, J., and McMurray, J. (2001) Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans. British Journal of Clinical Pharmacology, 52 (2). pp. 165-168. ISSN 0306-5251 (doi:10.1046/j.0306-5251.2001.01428.x)

Petrie, M., Padmanabhan, N., McDonald, J., Hillier, C., Connell, J., and McMurray, J. (2001) Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. Journal of the American College of Cardiology, 37 (4). pp. 1056-1061. ISSN 0735-1097 (doi:10.1016/S0735-1097(01)01111-1)

Seed, A., and McMurray, J. (2001) Acute endothelin A receptor blockade in heart failure. Circulation, 103 (18). E94-E94. ISSN 0009-7322

Seed, A., Love, M.P., and McMurray, J.J. (2001) Clinical experience with endothelin receptor antagonists in chronic heart failure. Heart Failure Reviews, 6 (4). pp. 317-323. ISSN 1382-4147 (doi:10.1023/A:1011408425878)

Stewart, S., Blue, L., Capewell, S., Horowitz, J.D., and McMurray, J.J. (2001) Poles apart, but are they the same? A comparative study of Australian and Scottish patients with chronic heart failure. European Journal of Heart Failure, 3 (2). pp. 249-255. ISSN 1388-9842 (doi:10.1016/S1388-9842(00)00144-6)

Stewart, S., MacIntyre, K., Hole, D.J., Capewell, S., and McMurray, J.J.V. (2001) More 'malignant' than cancer? Five-year survival following a first admission for heart failure. European Journal of Heart Failure, 3 (3). pp. 315-322. ISSN 1388-9842 (doi:10.1016/S1388-9842(00)00141-0)

Stewart, S., MacIntyre, K., MacLeod, M.M.C., Bailey, A.E.M., Capewell, S., and McMurray, J.J.V. (2001) Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. European Heart Journal, 22 (8). pp. 693-701. ISSN 0195-668X (doi:10.1053/euhj.2000.2511)

Stewart, S., MacIntyre, K., MacLeod, M.M.C., Bailey, A.E.M., Capewell, S., and McMurray, J.J.V. (2001) Trends in hospitalization for heart failure in Scotland, 1990-1996 - An epidemic that has reached its peak? European Heart Journal, 22 (3). pp. 209-217. ISSN 0195-668X (doi:10.1053/euhj.2000.2291)

Capewell, S., Livingston, B.M., MacIntyre, K., Chalmers, J.W.T., Boyd, J., Finlayson, A., Redpath, A., Pell, J.P., Evans, C.J., and McMurray, J.J.V. (2000) Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in Scotland. European Heart Journal, 21 (22). pp. 1833-1840. ISSN 0195-668X (doi:10.1053/euhj.2000.2318)

Caruana, L., Petrie, M.C., Davie, A.P., and McMurray, J. (2000) Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. British Medical Journal, 321 . pp. 215-218. ISSN 0959-535X (doi:10.1136/bmj.321.7255.215)

McDonagh, T., Robb, S.D., Murdoch, D.R., Morton, J.J., Ford, I., Morrison, C.E., Tunstall-Pedoe, H., McMurray, J., and Dargie, H. (1998) Biochemical detection of left-ventricular systolic dysfunction. Lancet, 351 (9095). pp. 9-13. ISSN 0140-6736 (doi:10.1016/S0140-6736(97)03034-1)

Caro, J., Klittoch, W., McGuire, A., Ford, I., Norrie, J., Pettitt, D., McMurray, J., and Shepherd, J. (1997) The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. British Medical Journal, 315 . pp. 1577-1582. ISSN 0959-535X (doi:10.1136/bmj.315.7122.1577)

McDonagh, T.A., Morrison, C.E., Lawrence, A., Ford, I., Tunstall-Pedoe, H., McMurray, J.J.V., and Dargie, H.J. (1997) Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet, 350 (9081). pp. 829-833. ISSN 0140-6736 (doi:10.1016/S0140-6736(97)03033-X)

Book Section

McInnes, G.T. (2007) Diabetes and hypertension. In: Fisher, M. and McMurray, J.J. (eds.) Diabetic Cardiology. Series: Diabetes in practice . Wiley, Chichester, pp. 135-174. ISBN 9780470862049

This list was generated on Fri Oct 31 15:22:29 2014 GMT.